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The epithelial sodium channel (ENaC), is assembled as a heterotrimer composed of three 
homologous subunits α or δ, β, and γ and is selectively permeable to Na+ ions. ENaC plays 
an essential role in the regulation of sodium transport in the renal connecting tubule and 
collecting duct. Mutations in ENaC subunits cause various disorders including the low and 
high blood pressure conditions pseudohypoaldosteronism-I and Liddle syndrome 
respectively. In renal principal cells, ENaC cell surface population is tightly regulated by 
hormones such as aldosterone and vasopressin, and through protein trafficking pathways 
that transport ENaC to and from the cell surface.  
 ENaC is internalized from the plasma membrane mainly via clathrin-coated 
vesicles after ubiquitination of ENaC subunits. Like most endocytic cargos, ENaC can 
follow the degradative pathway promoted by ubiquitin fusion or a recycling pathway after 
deubiquitination and sorting on early endosomes (EE). One of the endosomal protein 
sorting machines is the retromer complex that concentrates membrane proteins into 
nascent tubules formed through the action of sorting nexin (SNX-BAR) proteins. Thus, on 
the early endosomes, retromer binds to its cargos through SNX3, then recruits Wiskott–
Aldrich syndrome and SCAR homologue (WASH) complex to endosomes which mediates 
CCC (COMMD1-10/CCDC22/CCDC93) complex recruitment in turn. The WASH complex 
promotes the formation of endosomal branched F-actin networks and stabilizes recycling 
tubules for cargo entry. For the release of tubules, the CCC complex phosphorylates 
myotubularin-related protein 2 (MTMR2). MTMR2 then converts endosomal 
phosphatidylinositol-3-phosphate (PI(3)P) to phosphoinositide (PI) which causes 
disassembling of WASH complex that likely leads to the endosomal actin depletion and 
thereby release of cargo tubules. Previous studies in our lab showed that all COMMD 
(COpper Metabolism MURR1 or COMM domain containing) family proteins of the CCC 
complex interact with ENaC and further studies revealed that when COMMD1, -3 and -9 
were overexpressed but interestingly when COMMD10 knocked down, ENaC surface 
activity is reduced. The aim of this study is to investigate the role of COMMDs in ENaC 
trafficking.  
 For this study, Fischer Rat Thyroid (FRT) cells with stable COMMD10 knockdown 





KD FRT epithelia were transiently transfected with αβγ-ENaC for ENaC study. Cell surface 
activity of ENaC was studied by Ussing assay measuring ENaC amiloride-sensitive current 
(Isc). Then cell surface population and internalization of ENaC was quantified by cell 
surface biotinylation and endocytosis assay, respectively and the results suggested that 
ENaC cell surface population is reduced by COMMD10 KD. Endogenous ENaC cell surface 
activity was also studied and the results suggested that transient COMMD10 KD also 
reduces ENaC cell surface activity in the mCCDcl1 cell line. Further, recycling assays 
suggested the reduction of ENaC cell surface population is linked with a recycling defect 
deriving from COMMD10 depletion. Immunocytochemistry was used to show the 
endosomal localization of COMMD10 on Rab5-, and Rab7-positive endosomes confirming 
a role for COMMD10 in endosomal sorting, while localization of COMMD10 on Rab11-
positive endosomes proposes that COMMD10 may be involved in the translocation of 
recycling vesicles to the plasma membrane. To investigate regulation of COMMDs the 
effect of aldosterone on COMMD mRNA levels was tested and showed no significant 
changes, while aldosterone reduced protein levels of COMMD1 and 10. In contrast, 
calcium treatment induced protein levels of COMMD1 and 10.  
 The findings of this study furthers our understanding of the role of COMMD10 in 
ENaC trafficking, endosomal sorting and recycling of ENaC. Understanding this pathway 
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All living cells are in continuous interaction with their environment allowing certain 
molecules to move into and out of the cell. In eukaryotic cells, the pathway moving 
molecules toward the extracellular environment is known as forward or, anterograde 
trafficking, and the inward pathway bringing molecules into the cells is known as the 
reverse or retrograde trafficking. Materials newly synthesized in the endoplasmic 
reticulum (ER) are carried towards the Golgi complex, the trans-Golgi network (TGN), and 
are eventually exposed to the cell surface through exocytosis or moved to other 
intracellular membrane compartments such as endosomes or lysosomes. Transport in the 
opposite direction, that internalizes nutrients, sterols, lipoproteins, hormones, ligands, 
and transmembrane proteins such as receptors, transporters and ion channels from the 
plasma membrane through endocytosis and retrograde trafficking includes transport 
going from the plasma membrane towards the endosomal system, and from there to the 
TGN or from the Golgi to the ER or to the lysosome for degradation (Bonifacino & Rojas, 
2006; Chia et al., 2013). Thus the endocytic system intersects with the biosynthetic 
pathway.  
 Endocytic pathways can be subdivided into four categories: receptor (or clathrin)-
mediated endocytosis, caveolin-mediated endocytosis, macropinocytosis, and 
phagocytosis (Conner & Schmid, 2003). Macropinocytosis is an actin-driven evagination 
by which amoeboid cells ingest extracellular liquid and dissolved molecules. Phagocytosis 
is a Rho-family GTPase-mediated uptake of large pathogens, large debris such as the 
remnants of dead cells, and arterial deposits of fat (Aderem & Underhill, 1999; Hall & 
Nobes, 2000a). The best-studied endocytosis pathway is receptor-mediated endocytosis 
(RME), a multi-step process, in which clathrin-coated vesicles (CCV) are formed. The steps 
are: selecting the transmembrane cargo proteins and linking them to the clathrin coat by 
adaptor proteins, (2) the scission of CCVs, and (3) the uncoating of the endocytic vesicles. 
RME mediates turnover of plasma membrane lipids and proteins such as the epithelial 
sodium channel, low-density lipoprotein receptor, transferrin receptor, and growth factor 
receptors (Sorkin & Waters, 1993; Shimkets et al., 1997; Brodsky et al., 2001; McPherson 
et al., 2001; Conner & Schmid, 2003). Clathrin-coated budding also occurs at the 
membranes of the trans-Golgi network (TGN), from where cargo proteins such as 





system (Griffiths et al., 1988; Robinson, 2004). Among the other clathrin-independent 
endocytosis pathways, caveolin-mediated endocytosis is dynamin-dependent, occurs 
through the formation of caveolin coat and internalizes glycosphingolipids and some 
viruses into cells.  
 Regardless of the mode of endocytosis, after shedding their coats, the newly 
formed endosomes (also called primary endosomes), fuse with one another and with pre-
existing sorting endosomes which are known as early endosomes (EE). From the EE, the 
internalized cargos are recycled back to the cell surface or sent along the degradative 
route to the lysosome (Grant & Donaldson, 2009).  
 The recycling cargos, after generation of membrane tubules emanating from EE, 
can follow a fast recycling route, or a slow recycling route (Sheff et al., 1999; Sonnichsen 
et al., 2000). The fast recycling route is transport of cargos back to the plasma membrane 
from either the EE or an earlier stage, while the slow recycling route involves the 
transport of cargo from the EE to the endosomal recycling compartment (ERC), and from 
the ERC to the plasma membrane. But cargos, especially membrane proteins, that have 
been tagged with monoubiquitin, are corralled by the endosomal sorting complexes 
required for transport (ESCRT) complex machinery and enter the multivesicular body 
(MVB) pathway along with the lumenal content of the EE (Woodman & Futter, 2008). 
Multivesicular bodies are a transport intermediate between early and late endosomes 
(Gruenberg & Stenmark, 2004). Late endosomes are pre-lysosomal endocytic organelles 
that are defined by time and their more spherical shape and multivesicular structure. In 
the late endosomes, many proteins and lipids are degraded but not all. Therefore, they 
finally fuse with lysosomes creating a hybrid organelle to facilitate degradation by 
lysosomal acid hydrolases. 
 To target molecules to their correct destinations, they are sorted from lumenal 
content in EE. EEs are tubular–vesicular structures that have a lumenal pH of ∼6.0 
(Johnson et al., 1993) (and this acidification continues as endosomes mature into late 
endosomes). In the EEs, low lumenal pH mediates ligand release from their receptors and 
mix with internalized solute molecules (Mukherjee et al., 1997). This is the first step in 
the endocytic sorting. Membrane-deforming agents such as the SNX–BAR subcomplex 
promote formation recycling tubules on the EEs for cargos to be sorted and recycled back 
to the plasma membrane (van Weering et al., 2010). Retromer and Retriever are protein 
complexes that have a crucial role in endosomal sorting. Thus, Retromer and Retriever 





transported. Then, the recruited WASH complex mediates generation of actin-rich 
endosomal patches (Gomez & Billadeau, 2009) that stabilize recycling tubules and 
thereby allows cargo entry to these tubules (Puthenveedu et al., 2010), and the CCC 
complex disassembly WASH complex (Singla et al., 2019) and thereby, probably, stop the 
actin-stabilization and release the recycling tubules. 
 Well-established cellular trafficking plays a crucial role in maintaining the correct 
distribution of lipids and proteins in the plasma membrane, as well as in the TGN and 
endosomes. Defects in trafficking leads to a range of diseases, such as Alzheimer’s, 
Parkinson’s disease, and Liddle syndrome, depending on the origin of disorders (Uemura 
et al., 2004; Cooper et al., 2006; Bruns et al., 2007) .  
 As mentioned above, protein trafficking is very important for cell membrane lipids 
and proteins including ion channels. One of those ion channels is the epithelial sodium 
channel (ENaC) which located in kidney connecting tubule and collecting duct cells and 
mediates Na+ reabsorption. Cell surface population of ENaC is tightly regulated by protein 
sorting and trafficking pathways. In this project, the regulation of epithelial sodium 





1.2 Epithelial Sodium Channel: Function, Structure, and Regulation 
  
The epithelial sodium channel (ENaC), also known as the amiloride-sensitive sodium 
channel, is a non-voltage gated channel. The subunits that form ENaC constitute a sub-
family within the ENaC/Degenerin superfamily that encodes cationic channels blocked by 
amiloride and involved in the control of the body’s intracellular and extracellular fluid 
volumes and in the control of other distinct functions (Garty & Palmer, 1997). Thus, 
members of ENaC/DEG superfamily together with epithelial sodium channel (ENaC) 
subunits includes acid-sensing ion channels (ASICs) that are activated by protons 
(Waldmann et al., 1997; Kellenberger & Schild, 2002; Deval & Lingueglia, 2015; 
Kellenberger & Schild, 2015), FMRFamide-activated sodium channels (FaNaC) of 
invertebrates that are gated by ligands (Coscoy et al., 1998), the degenerins (DEG) of 





Drosophila melanogaster (Darboux et al., 1998),  ‘orphan’ channels that include brain-
liver-intestine sodium channel (BLINaC) (Sakai et al., 1999), human intestine sodium 
channel (hINaC) (Schaefer et al., 2000), mechanosensory channels responsible for touch 
sensation (O'Hagan et al., 2005), and chemosensory channels that respond to salt 
(Chandrashekar et al., 2010). 
 The human genome encodes nine ENaC paralogs grouped into two families based 
on their homology: four homologous genes - SCNN1A, SCNN1B, SCNN1G, and SCNN1D - 
encode appropriately the α, β, γ, and δ ENaC subunits belonging to the non-voltage gated 
sodium channel family and five homologous genes - ASIC1, ASIC2, ASIC3, ASIC4 and 
ASIC5 - belonging to the acid-sensing (proton-gated) ion channel (ASIC) family 
(Hanukoglu & Hanukoglu, 2016). In the Ensembl genome database (release 79) of 
vertebrate and eukaryotic species, there are currently 188 homologous ENaC subunit 
genes, however, BLAST searches in UniProt bacteria, fungi and plant protein sequence 





1.2.1 Distribution and Physiological Functions of ENaC 
 
 Acid-sensing ion channels (ASICs), the closest channel to ENaC with its structure, 
are H+-gated, voltage-insensitive, Na+-permeable ion channels that are closed in the 
resting state, and rapidly desensitize following activation by protons. ASICs are expressed 
in sensory neurons in the gastrointestinal tract, and play a role in acid-sensing within the 
gastrointestinal tract and may be involved in human sour taste sensing (Holzer, 2015). 
But more prominently ASICs are characteristic to mammalian nervous tissue and are 
expressed in the central and peripheral nervous systems having roles in nociception, 
mechanosensation, fear-related behavior and seizure termination (Chen et al., 1998a; 
Waldmann & Lazdunski, 1998; Deval & Lingueglia, 2015). 
 By comparison with ASICs, a number of immunohistochemical studies have 
revealed that ENaC is expressed in the epithelia of the lung, respiratory tract, male and 
female reproductive tracts, sweat and salivary glands, placenta, colon, taste buds, choroid 





located on the apical (outward-
facing) membranes of these epithelia 
(Hager et al., 2001; Coric et al., 2004; 
Rossier et al., 2015; Hanukoglu & 
Hanukoglu, 2016). More recent 
immunohistochemical (IHC) studies 
comparing tissue expression level of 
ENaC subunits in rodents, reported 
the highest levels of expression for 
the α, β and γ subunits in the kidney, 
lung, and colon (EMBL-EBI 
Expression Atlas database of gene 
expression 
(https://www.ebi.ac.uk/gxa/home) 
(Petryszak et al., 2014)). However, 
there are no IHC studies for δ ENaC in 
rodents as this subunit is not 
expressed in common rodent animal 
models such as mice and rats. 
Northern blot results revealed that 
the highest expression level of the 
human δ subunit are observed in 
pancreas, brain, testis and ovary 
while low levels are observed in the 
kidney and lung (Waldmann et al., 1995).  ENaC in the kidney, as a constitutively active 
channel, allows the flow of Na+ ions from the lumen into the principal cells of aldosterone-
sensitive distal nephron, connecting tubule and cortical collecting duct from where Na+ 
ions are moved out of the cell through the Na+K+-ATPase. A two-step process of Na+ 
transport comprises: (1) facilitated transport - driven by an electrochemical potential 
difference - mediated by ENaC across the apical membrane (from lumen into the cell) 
(Figure 1.1), and (2) active transport - driven by metabolic energy - mediated by Na+/K+‐
ATPase across the basolateral membrane (from cell to interstitium).  Na+ transport is 
accompanied by the flow of H2O transport via AQP2 across the apical membrane and via 
AQP3 and AQP4 across the basolateral membrane as a result of increased osmolarity in 
Epithelial sodium channel (ENaC) is located on the 
apical membrane of principal cells facing to lumen 
where it regulates the final step of Na+ reabsorption.  
The electrochemical potential difference, which drives 
Na+ absorption from the luminal fluid into the cell 
through ENaC, is generated by activity of the Na+/K+‐
ATPase on the basolateral membrane. Water follows 
Na+, through AQP2 in the apical membrane and then 
through AQP3 and AQP4 to basolateral side, thereby 
ENaC regulates ECF volume and blood pressure.  
Figure 1.1. ENaC activity in principal cells of 






the cells and then in the interstitium, respectively (Figure 1.1). In contrast to other sodium 
channels in the kidney, ENaC is the rate-limiting step for the regulation of Na+ 
reabsorption and thereby for the extracellular fluid (ECF) volume and blood pressure. The 
loss-of-function of ENaC leads to several disorders throughout the body such as 
extracellular fluid (ECF) volume depletion, hyperkalaemia, hypotension (Chang et al., 
1996; Pradervand et al., 1999; Lifton et al., 2001) known as pseudohypoaldosteronism 
type I (PHA-I). Gain-of-function mutations of ENaC lead to ECF volume expansion, 
hypertension, hypokalemia, low aldosterone levels, and metabolic alkalosis known as 
pseudoaldosteronism (Liddle syndrome) (Shimkets et al., 1994; Yamashita et al., 2001). 
 The functional importance of ENaC is not limited to those based on ENaC function 
in the kidney, the loss-of-function of ENaC leads also to an increase in the volume of 
airway surface liquid (ASL), and in the lung increased activity of ENaC (reduced inhibition 
of ENaC by chloride ions) contributes to the acute reduction of the airway surface liquid 
volume which leads to reduced clearance of foreign particles, microbes and viruses by 
reduced mucus contributing to the chronic infections characteristic of cystic fibrosis 
(Moore & Tarran, 2018). 
 Moreover, ENaC is richly expressed on cilia of multi-ciliated cells in the oviduct and 
in the uterine glands of the endometrium, which suggests the importance of ENaC 
function in oocyte transport through the oviduct for fertilization and embryo transport 
and implantation (Enuka et al., 2012) since they are all dependent on ciliary beating along 
the oviduct and in the uterus (Lyons et al., 2006; Coy et al., 2012). Interestingly, ENaC is 
also known as the salt taste "receptor" of the tongue (Chandrashekar et al., 2010; Oka et 
al., 2013).   
 
 
1.2.2 Structure of ENaC  
 
  In humans, there are four homologous ENaC subunits: α, β, γ, and δ that are 
encoded by genes SCNN1A, SCNN1B, SCNN1G, and SCNN1D. Cloned human ENaC subunits 
revealed that there are significant amino acid similarities with rat orthologues and ENaC 
proteins are highly conserved between species (McDonald et al., 1994; Voilley et al., 1994; 





 Various reports suggest that a functional, pore-forming channel can comprise an 
α-, together with a β- and a γ-subunit (Canessa et al., 1994b; Firsov et al., 1998) (Figure 
1.2). Although there are several architecture models for ENaC, such as tetrameric (Firsov 
et al., 1998) and trimeric 
assemblies like its homolog ASIC1, 
it is widely accepted that ENaC 
forms a heterotrimer structure 
(Staruschenko et al., 2005; Stewart 
et al., 2011), similar to the homo- 
or hetero-trimeric ASIC homologs 
(Jasti et al., 2007; Gonzales et al., 
2009). A recent precise structure 
analysis by cryo-electron 
microscopy revealed that a human 
single ENaC assembles with a 1:1:1 stoichiometry of α:β:γ subunits which sit next to each 
other to form a narrow tube through the membrane and a large extracellular domain 
arranged in a counter-clockwise manner (Noreng et al., 2018) (Figure 1.2).  
  Each ENaC subunit has two transmembrane domains - TM1 and TM2 with 
intracellular N- and C-termini. The TM1 and TM2 helices of three subunits comprise the 
ENaC pore where the pore is lined by TM2 helix of each subunit and is gated by a kink in 
the helix. During channel activation, conformational changes in the pore have not been 
elucidated. But it is assumed that kinks in TM2 helices are rotated away from the central 
axis to enable the ion permeation (Tien et al., 2014), because a similar gating mechanism 
was proposed for ASIC1, since ASIC, ENaC, FaNaCh and DEG proteins share many 
residues in common within TM2 (Jasti et al., 2007).  A narrow selectivity filter on the 
cytoplasmic side of the gate and negative electrostatic potential of the pore vestibule have 
most likely the main role in ion selectivity of these channels.  
 The characteristic feature of the ENaC pore is its ability to discriminate Li+ and Na+ 
from larger cations and all anions. ENaC’s permeation for Na+ and Li+ is 100- to 1,000-fold 
higher than for K+, and ENaC is absolutely impermeable to larger ions (Palmer, 1982). 
Another feature of the ENaC pore is its specific blocking by amiloride (Kashlan & Kleyman, 
2011) and its derivatives such as phenamil (Garvin et al., 1985; Klemens et al., 2017). The 
extracellular regions of ENaC which make approximately 70% of the mass of each subunit 
are composed of core β-sheet domains surrounded by peripheral α-helical domains. They 
Each subunit has two membrane-spanning domains (M1 and 
M2 (or transmembrane domains TM1 and TM2)) with 
intracellular N- and C-termini. Each of β and γ subunits 
contain a canonical “PY” motif in their C-terminal domain.   





sense various stimuli detected by different ENaC channels and are poorly conserved 
between these channels (Kashlan & Kleyman, 2011). Moreover, ENaC is activated through 
cleavage of α and γ subunits at multiple sites within their extracellular α-helical domains, 
by furin and non-furin proteases (Vuagniaux et al., 2002; Bruns et al., 2007; Kleyman et 
al., 2009; Rossier & Stutts, 2009; Passero et al., 2010). 
 The cytoplasmic N-terminal and C-terminal regions of the ENaC subunits are very 
important for interactions with cytoskeleton and with its regulatory proteins (Schild et 
al., 1996; Grunder et al., 1997; Chalfant et al., 1999; Diakov & Korbmacher, 2004).  
N-terminal domain. Although the N-termini of β and γ subunits in many species are 
highly conserved, the α and δ subunits show heterogeneity in both their sequence and 
length (Hanukoglu & Hanukoglu, 2016). Deletion of residues 2–67 in the N-terminal 
domain of the α subunit reduced endocytosis of ENaC and increased the half-life of the 
channel in the membrane (Chalfant et al., 1999) while the N-terminal domain of β and γ 
subunits includes a sequence characteristic of phosphatidylinositol 4,5-bisphosphate 
(PIP2) binding (which stimulates ENaC surface activity) and binding sites to other 
proteins (Yue et al., 2002). In the N-terminal domain, prior to the start of TM1, there are 
a series of 30 to 40 residues that are conserved in the four human ENaC paralogs as well 
as in many species examined (Hanukoglu & Hanukoglu, 2016). Moreover, a missense 
mutation (Gly37Ser) in this region of the β subunit causes multi-system 
pseudohypoaldosteronism (PHA) reducing the open probability (Po) of ENaC whereas it 
reduced channel activity in the α and γ subunits also, suggesting that this site has an 
important role in regulating channel gating (Grunder et al., 1997). 
Carboxy terminal domain. This domain contains sites of interaction with other proteins 
- cytoskeletal elements, signal transduction molecules, and ions that regulate ENaC 
function. An Arg-Lys rich region after TM2 in the β and γ subunits has a role in the binding 
of phosphatidylinositol triphosphate (PI3P) which has an allosteric effect on ENaC open 
probability (Pochynyuk et al., 2007b). The C-terminal domain also contains sites for 
phosphorylation of ENaC by some kinases such as protein kinase C (PKC) which enhances 
ENaC activity through binding with C-terminal domain of α subunit (Volk et al., 2000), as 
well as SGK1 (Diakov & Korbmacher, 2004), casein kinase 2 and ERK (Shi et al., 2002; 
Yang et al., 2006). Furthermore, ENaC directly interacts with F-actin through the α subunit 
C-terminal domain (Mazzochi et al., 2006; Sasaki et al., 2014). 
 In the C-terminal domain of α, β and γ (but not δ) ENaC subunits, there is a highly 





for Neural precursor cell Expressed Developmentally Down-regulated gene 4-2 protein 
(Nedd4-2). Nedd4-2, binding with its WW domains to the PY motif of ENaC, catalyzes 
ligation of ubiquitin to the ENaC subunits which is followed by the internalization of ENaC 
and eventual degradation in a proteasome or lysosome (Rotin & Staub, 2011). Mutations 
in the PY motif caused an increased pool of ENaC on the apical membrane as a result of 
reduction in ENaC ubiquitination (Bruns et al., 2007), hence the Liddle syndrome is also 
a result of missense mutations in the β or γ subunit PY motif (Schild et al., 1996). Also, 
Nedd4-2 knockout mice display increased ENaC activity/levels (Boase & Kumar, 2015; 




1.2.3 Hormonal Regulation of ENaC 
 
Extrinsic and intrinsic factors regulate ENaC and change the expression level, single-
channel properties, and intracellular trafficking of the channel. These factors include 
hormones, Na+, Cl−, protons, proteases (proteolytic processing of extracellular loops), and 
shear stress (Kashlan & Kleyman, 2011; Althaus et al., 2012; Kellenberger & Schild, 2015; 
Knoepp et al., 2020).  By those factors, ENaC cell surface activity is regulated through two 
mechanisms: 1) changing the open probability (PO) of the channel mainly through 
cleavage in the extracellular loops of α and γ ENaC subunits (Bruns et al., 2007) by channel 
activating proteases (CAPs); 2) regulating the trafficking of ENaC to and from the apical 
membrane. 
 A number of hormones such as aldosterone (Verrey, 1999), arginine vasopressin 
(AVP) (Reif et al., 1986; Ecelbarger et al., 2001), insulin (Marunaka et al., 1992),  
endothelin (Gilmore et al., 2001), cortisol (corticosterone in rats), oxytocin, and atrial 
natriuretic peptide (Zeidel et al., 1988) can alter ENaC expression and/or function 
throughout the body. Aldosterone, vasopressin, insulin, and cortisol enhance ENaC-
mediated current while oxytocin and atrial natriuretic peptide lower the current 
increasing or decreasing the channel's open probability and/or cell surface abundance, 
respectively (Herness, 1992; Gilbertson et al., 1993; Janér et al., 2011). Among these 
hormones, aldosterone and vasopressin play the key role in the kidney of mammals 





1.2.3.1 Aldosterone  
 
Physiologic range of mineralocorticoid hormone aldosterone concentrations regulates 
epithelial sodium channel (ENaC) along the aldosterone-sensitive distal nephron (ASDN). 
The ASDN comprises the late distal convoluted tubule (DCT2), the connecting tubule 
(CNT) and the entire collecting duct (CD). In ASDN, ENaC is regulated by aldosterone 
through multiple pathways, from receptor occupancy to microRNA, from transcription to 
intracellular signaling pathway and from translation to channel PO as described in more 
detail below (Figure 1.3). All ASDN cells express high levels of the mineralocorticoid 
receptor (MR), the glucocorticoid receptor (GR), and the enzyme 11-beta-hydroxysteroid-
dehydrogenase type 2 (11β-HSD2) (Loffing et al., 2001). The MR and the GR are hormone-
activated transcription factors that can bind both mineralocorticoid and glucocorticoid 
hormones. Mineralocorticoid receptor (MR) occupancy by aldosterone occurs during 
circadian cycles and both MR and glucocorticoid receptor (GR) occupancy occurs during 
salt restriction or acute stress (Geering et al., 1985).  
 Although both MR and GR act as aldosterone and cortisol receptors, MR is the high-
affinity type 1 receptor (Kd = 0.5 to 3 nmol/l), and GR is the low-affinity type 2 receptor 
(Kd = 14 to 65 nmol/l) (Arriza et al., 1987; Hellal-Levy et al., 1999). Although the 
corticosteroid levels in the plasma (cortisol in humans and corticosterone in rats) exceed 
the plasma concentrations of aldosterone by 100-1000-fold, the ASDN is 
mineralocorticoid specific by its high expression of 11β-HSD2. 11β-HSD2 rapidly 
hydrolyzes the physiological corticosteroids to their inactive metabolites (the cortisol to 
cortisone and the corticosterone to 11-dehydrocorticosterone) (Odermatt & Kratschmar, 
2012).  
In ASDN, aldosterone has an impact on ENaC surface expression by two ways: early 
phase response and late response. Early phase of aldosterone action is mainly related to 
the mineralocorticoid receptor (MR) occupancy whereas the late response correlated 
with occupancy of the glucocorticoid receptor (GR) (Gaeggeler et al., 2005). Moreover, the 
early phase of aldosterone action is achieved by aldosterone-induced regulatory proteins 
acting on the preexisting transport machinery (Chen et al., 1999), that starts in 20-60 min 
after aldosterone stimulation. In contrast, the late response is mediated through 
transcription of the αENaC subunit starting ∼3 h after hormone addition (Girardet et al., 





Early-phase aldosterone-mediated phosphorylation of Serum and Glucocorticoid-
regulated Kinase 1 (SGK1) upregulates ENaC by phosphorylating Nedd4-2 (Balderhaar et 
al., 2010; Hallows et al., 2010; Ke et al., 2010; Lang & Stournaras, 2013). Nedd4-2 is an E3 
ubiquitin-protein ligase that ubiquitinates cell surface ENaC and leads to its 
internalization (Zhou et al., 2007). Phosphorylation of Nedd4-2 by SGK1 fosters 
interaction of Nedd4-2 with a chaperone protein 14-3-3 which prevents Nedd4-2-
dependent ENaC ubiquitination and subsequent degradation (Schild et al., 1996; Snyder 
et al., 2002; Snyder et al., 2004; Liang et al., 2006; Zhou et al., 2007) (Figure 1.3). It is 
reported that isoforms of 14-3-3 protein also are induced by aldosterone that participate 
in regulation of ENaC (Liang et al., 2006). Extracellular signal–regulated kinases (ERK) 
phosphorylates sites on ENaC and increases its affinity for Nedd4-2 binding (Falin & 
Cotton, 2007). Glucocorticoid-induced leucine zipper (GILZ) is an aldosterone-induced 
protein that disrupts the activation of ERK thereby GILZ prevents the phosphorylation of 
specific sites on ENaC leading to a decrease in Nedd4-2-mediated ENaC internalization 
(Soundararajan et al., 2005; Bhalla et al., 2006). Recently, a novel aldosterone-induced 
protein - ankyrin G (AnkG) was identified to be involved in vesicular transport of ENaC to 
apical membrane via the constitutive recycling pathway in mouse cortical collecting duct 
cells (Klemens et al., 2017).  
 As a late phase of response, in the kidney, aldosterone upregulates ENaC activity 
through increasing transcription of αENaC but not β- and γ-subunits (Asher et al., 1996) 
which fully contrasts with mRNA regulation of ENaC subunits by aldosterone in the colon. 
Thus, in the kidney, β- and γ-subunit mRNAs of ENaC and in the colon α-subunit mRNA 
are expressed constitutively (Asher et al., 1996) and β- and γ-subunit expression in the 
colon is increased by aldosterone (Johnson et al., 1998; Masilamani et al., 1999). In 
amphibian distal tubule principal cells (A6 cells), transcription and translation of α, β, and 
γ subunits of ENaC occur in a fashion where none of the subunits is limiting for the 
production of channels and both transcription and translation of ENaC is enhanced by 
aldosterone. Transcription is increased twofold, whereas increase in translation results 
in a fourfold in the rate of synthesis of the three subunits (Alvarez de la Rosa et al., 2002).  
 Aldosterone also stimulates SGK1 transcription along the entire ASDN 
simultaneously where the expression of both of ENaC and SGK1 overlaps  (see the review 
(Lee et al., 2008a)).  Moreover, aldosterone induces cleavage of α- and γ- but not β- 
subunits of ENaC to increase Po (Masilamani et al., 1999; Ergonul et al., 2006).  





which was identified as an early aldosterone-induced gene product, in contrast to another 
ENaC-deubiquitinating enzyme UCH-L3 (Boulkroun et al., 2008). 
  
Aldosterone regulates ENaC through both an intracellular signalling pathway and a transcriptional 
pathway. Started with mineralocorticoid receptor occupancy, intracellular signalling pathway represents 
early phase impact of aldosterone where SGK1 phosphorylates the ubiquitination enzyme Nedd4-2. The 
phosphorylation prevents the Nedd4-2 ubiquitination of ENaC and as well as ENaC degradation. In ASDN 
cells, glucocorticoid receptor occupancy with aldosterone leads to the transcription and translation of 
αENaC subunits resulting in increased ENaC at the cell surface, representing the late phase response to 
aldosterone. Once GR and MR bind aldosterone, they undergo conformational changes, homo-or hetero-
dimerize, translocate into nucleus and regulate ENaC expression by binding to DNA sequences known as GC 
response elements (GREs). 
 
Furthermore, there are also reports showing that aldosterone alters microRNA 
expression in mouse Cortical Collecting Duct (mCCD) cells to regulate ENaC activity 
(Butterworth et al., 2011; Edinger et al., 2014). Thus aldosterone downregulates some 
species of miRs (mmu-miR-335-3p, mmu-miR-290-5p, and mmu-miR-1983) in mCCD 
cells. Reducing the expression of these miRs separately or in combination increased 
ENaC-mediated sodium transport. These miRs directly bind to the 3’ untranslated region 
of a novel aldosterone and miR-regulated protein ankyrin 3 (Ank3). The overexpression 
of Ank3 increased ENaC current while the knockdown of Ank3 decreased the current in 
mCCD epithelia (Edinger et al., 2014; Liu et al., 2017). 





Moreover, in the whole organism as a negative feedback pathway, ENaC 
abundance also regulates plasma aldosterone level (through plasma Na+ level and 
extracellular fluid volume). Thus, αENaC knockout exhibited clinical signs of PHA1 and a 
6-fold increase in plasma aldosterone levels (Hummler et al., 1997).  
Although the role of aldosterone in ENaC regulation has been extensively studied, 
it is likely that other aldosterone-induced proteins in the kidney are involved in ENaC 
regulation. For example, it is still not known if or how aldosterone affects the protein 




The ENaC activity generates an osmotic gradient that induces the vasopressin-dependent 
water reabsorption via the water channels AQP2 in the apical and AQP3 and AQP4 in the 
basolateral plasma membrane of the principal cells. This mechanism is a connection point 
for the vasopressin-mediated water regulation and ENaC regulation in the ASDN.  
Vasopressin upregulates ENaC surface population through increasing the intracellular 
amount of cAMP (Reif et al., 1986). ENaC is known to be stimulated by cAMP/PKA 
activation (Garty & Palmer, 1997; Snyder, 2000; Morris & Schafer, 2002; Snyder et al., 
2004; Butterworth et al., 2005a; Klemens et al., 2017). cAMP activates cAMP-dependent 
protein kinase A (PKA) which prevents the ubiquitination of ENaC through 
phosphorylating Nedd4-2 on the same three residues (Snyder et al., 2004) that SGK1 does 
in the aldosterone signalling pathway (Figure 1.4). However, Liddle's syndrome 
mutations were shown to disrupt the cAMP-mediated translocation of the epithelial Na(+) 
channel to the cell surface (Snyder, 2000) suggesting cAMP-mediated upregulation of 
ENaC through Nedd4-2 pathway is negligible. Furthermore, vasopressin increases 
transcription and translation of both γ- and β-ENaC in rat cortical collecting duct RCCD1 
cells (Djelidi et al., 1997) and chronic desmopressin (dDAVP; a synthetic analogue of 8-
arginine vasopressin) infusion increased the abundance of β-, and γ-ENaC and had little 








1.2.3.3 Insulin  
Insulin also regulates ENaC activity positively through a similar pathway that includes 
both SGK1 and AKT1(also known protein kinase B), a protein structurally very similar 
to SGK1. AKT1 is also activated by the phosphoinositide 3-kinase (PI3-K)/ 
phosphoinositide-dependent kinase 1 (PDK-1) pathway, phosphorylates Nedd4-2 
and upregulates ENaC activity (Figure 1.4) (Lee et al., 2007; Baquero & Gilbertson, 
2011). Insulin induces ENaC current by stimulating cellular SGK1 and AKT1 activity 
via PI3-K/PDK-1 pathway instead of SGK1 and AKT1 expression (Lee et al., 2007; 
Mansley et al., 2016). Thus, binding of insulin to its receptor (IR) leads to activating 
tyrosine phosphorylation of insulin receptor substrate (IRS) which activates the PI3K. 
PI3K converts PIP2 into PIP3, which recruits Akt-kinase to the cell membrane. PIP3 
activates PDK1 to phosphorylate threonine 308 site in Akt1. However, for the full 
activation of Akt, serine 473 phosphorylation by mammalian target for rapamycin 
complex 2 (mTORC2) is also required (Gabbouj et al., 2019). 
 
Aldosterone upregulates ENaC activity through a fast Sgk1 – Nedd4-2 pathway, as well as more slowly 
through promoting the transcription of α-ENaC and Sgk1 and the proteolytic cleavage of α- and γ-ENaC. 
Insulin promotes activation of the enzyme PI3-K in the fast aldosterone pathway. Insulin also follows the 
same aldosterone’s fast pathway, while vasopressin inactivates Nedd4-2 through the cAMP-PKA pathway.  
Note that Nedd4-2 is a common point for all of the three hormones. 
 






1.2.4 Cellular regulation of ENaC 
 
1.2.4.1 Biosynthesis of ENaC 
 
ENaC subunits are cotranslationally inserted into the endoplasmic reticulum (ER) and 
their assembly likely occurs in the ER. During ENaC translation, N-linked oligosaccharides 
may be added at multiple specific sites (N-glycosylation) (May et al., 1997; Cheng et al., 
1998; Alvarez de la Rosa et al., 2002). Consensus sites for N-linked glycosylation are Asn-
X-Ser/Thr, which in rat α-, β-, and γ-subunits are repeated six, twelve, and five times, 
respectively (Canessa et al., 1994a; Snyder et al., 1994).  Another post-translational 
modification of channels is Cys palmitoylation, a quality control process that is essential 
for the proper folding and ER exit of several multitransmembrane proteins (Lam et al., 
2006; Gonnord et al., 2009). Mueller and coworkers showed that β and γ ENaC subunits, 
but not the α subunit, are modified by Cys palmitoylation. Cys palmitoylation of the β 
subunit modulates Po of channel, possibly by stabilizing the open state of the channel 
(Mueller et al., 2010). Specific chaperones, that participate in proper folding of ENaC 
subunits, in assembly of subunits to a single channel and in targeting the misfolded ENaC 
subunits for degradation in the ER, include members of luminal heat shock protein 40 
(Hsp40), the small heat shock protein alpha A-crystallin, and calreticulin (Goldfarb et al., 
2006; Kashlan et al., 2007; Sugahara et al., 2009; Buck et al., 2010; Buck et al., 2017). ENaC 
has a motif within the C-terminal cytoplasmic domain of the α subunit (αRSRYW620 in 
murine ENaC) that facilitates its exit from the ER (Mueller et al., 2010).  
 As the assembled ENaCs exit the ER, the channels pass through the Golgi where 
most N-glycans on channels are processed and the channels are cleaved, and the trans-
Golgi network where channels are sorted into clathrin coated vesicles that are delivered 
to the apical membrane. Prior to channel assembly, high mannose N-linked glycans are 
removed by endoglycosidase H (Endo H) enzyme in the medial Golgi complex. But on 
assembled channels, N-glycans are modified to Endo H-resistant forms (Alvarez de la 
Rosa et al., 2002; Hughey et al., 2003). However, still newly synthesized ENaCs are 
delivered to the plasma membrane in two forms: ENaC with processed N-glycans and 
cleaved α- and γ-subunits; and with non-processed N-glycans and full-length subunits 





through Golgi and trans-Golgi network where subunits are processed that represent the 
pool of active, functional channels while another population of channels bypass the Golgi 
and trans-Golgi network processing that represent a functionally inactive pool of channels 
(Hughey et al., 2004; Caldwell et al., 2005; Sheng et al., 2006). Intracellular activation of 
ENaC is carried out by the protease furin while extracellular activation is catalyzed by 
prostasin (Caldwell et al., 2004; Hughey et al., 2004). Cleavage of the α subunit by furin 
releases 26 amino acids (Carattino et al., 2006) while cleavage of the γ subunit by furin 
and then by prostasin at a site distal to the furin cleavage site releases 43 residues leading 
to the activation of ENaC (Hughey et al., 2004; Bruns et al., 2007). Regulation of proteolytic 
cleavage of the inactive channels provides a potential mechanism to increase rates of Na+ 
transport in the distal nephron.  
Several channel-activating proteases (CAPs) are the main candidates identified as 
surface-bound proteases that activate ENaC at the cell surface (Vuagniaux et al., 2002; 
Adebamiro et al., 2005; Andreasen et al., 2006).  Catalytically inactive CAP1 (prostasin) 
fully stimulated ENaC, suggesting it has an indirect role in activating ENaC (Andreasen et 
al., 2006). In contrast to CAP1, both CAP2 and CAP3 stimulate ENaC through their catalytic 
activity (Vuagniaux et al., 2002).  
 The findings also suggest that ENaC may use cholesterol-rich domains (lipid rafts) 
to gain access to the apical membrane. In mCCD cells, lipid rafts have a role in the 
constitutive apical delivery of ENaC but is not involved in endocytosis-connected 
constitutive recycling pathways or cAMP/PKA-mediated recycling from a subapical pool 
of ENaC (Hill et al., 2007). ENaC activity stimulation by either forskolin (FSK) or 
aldosterone did not alter the lipid raft distribution of ENaC (Hill et al., 2007).  
 Pulse-chase studies revealed that the half-life of newly synthesized ENaC subunits 
is approximately 1 hour, while assembled channels that have exited the ER were 












1.2.4.2 Endocytosis of ENaC 
       
Although cleavage on the outer loops of ENaC increases its Po (Bruns et al., 2007), it 
doesn’t affect the channel’s surface abundance and half-life (Kabra et al., 2008). ENaC cell 
surface half-life has been estimated at approximately 20–30 minutes in cell model 
systems with ENaC overexpression (Butterworth, 2010), and then ENaC is internalized 
by endocytosis pathways. 
             It has been confirmed by many studies that the ENaC surface half-life and density 
is regulated through its ubiquitination by Nedd4-2 (an E3 ubiquitin-protein ligase). 
Ubiquitination is a signal for internalization that is the retrieval of a protein from apical 
membrane to early endosomes (EE) through a chain of complex protein interactions 
(Haglund & Dikic, 2012; Piper et al., 2014). Nedd4-2 contains a C2 domain, four WW 
domains that bind PY motifs (L/PPXY) and a ubiquitin ligase HECT (homologous with E6-
associated protein C-terminus) domain. Nedd4-2 interacts with the PY motif of ENaC 
through its WW domain and catalyzes ubiquitination of lysine residues in the N terminal 
domains of α, β, and γ ENaC through its HECT (homologous to the E6-AP C terminus) 
domain (Kamynina et al., 2001; Zhou et al., 2007; Rotin & Kumar, 2009; Rotin & Staub, 
2012). Inherited mutations of the PY motif in β or γ-ENaC (Shimkets et al., 1994) prevent 
Nedd4-2 interacting with ENaC causing Liddle syndrome (Snyder et al., 1995; Schild et al., 
1996). Liddle syndrome is characterized as constitutive ENaC activity at the cell 
membrane, causing continuous Na+ reabsorption that results in early onset hypertension 
(Abriel et al., 1999).  
 ENaC is internalized via mainly clathrin-coated vesicles (CME) that merge with the 
EEs (Wang et al., 2006), or via caveolae (Lee et al., 2009). Ubiquitin attached to ENaC 
recruits epsin that functions as an adaptor coupling protein because it contains an 
ubiquitin interaction motif (UIM) as well as a clathrin-binding motif (reviewed in (Wang 
et al., 2006)). Epsin binds to several internalization proteins, including clathrin itself, to 
promote internalization of cargo proteins such as ENaC. A part of epsin enters into the 
plasma membrane (interacting with PIP2) promoting membrane curvature, which is 
important for forming an invaginated pit (Messa et al., 2014). Then the ENaC carrying 
vesicles, coated by clathrin are dissected from the membrane by dynamin (Shimkets et al., 
1997), fuse with the EEs where ENaC can be sorted and recycled back to the apical 





remains ubiquitinated is recognized by the ESCRT complexes and is retained in LEs and 
lysosomes for degradation (Butterworth, 2010). ESCRT-0 complex consists of hepatocyte 
growth factor-regulated tyrosine kinase substrate (Hrs) and signal-transducing adaptor 
molecule (STAM) (Raiborg & Stenmark, 2009).  Both Hrs and STAM contain ubiquitin-
interacting motifs (UIMs), which allow them to bind to ubiquitinated proteins including 




1.2.4.3 Recycling of ENaC  
 
Although some of the endocytosed proteins travel from the EEs to the late 
endosomes and eventually to lysosomes for degradation, many plasma membrane 
proteins follow a recycling pathway, first through being deubiquitinated on the 
endosomes and sorted to tubular structures that are released from EEs and travel to 
recycling compartments (Amerik & Hochstrasser, 2004). ENaC is deubiquitinated by 
several deubiquitinating enzymes (DUBs) such as UCH-L3 and USP2-45. Both UCH-L3 and 
USP2-45 increased ENaC activity when overexpressed (Butterworth et al., 2009). 
Butterworth et al. reported that a decrease in steady-state Na+ transport occurs when the 
deubiquitinating action of UCH-L3 was blocked (Butterworth et al., 2007). They also 
detected the UCH-L3 biochemically in EEs and CCVs, based on which they suggest that 
deubiquitination of ENaC occurs near the apical surface soon after ENaC is retrieved. In 
contrast, USP2-45 has a direct deubiquitinating effect on ENaC, but the exact mechanism 
or location of this reaction has not been reported yet (Fakitsas et al., 2007). 
 There are many reports showing that membrane proteins can move from EEs to 
the plasma membrane (PM) through discrete endosomal populations such as bulk 
(constitutive) recycling and regulated recycling vesicles, subapical vesicles, recycling 
endosomes, etc. (Wang et al., 2000; Lampson et al., 2001; Maxfield & McGraw, 2004; 
Butterworth et al., 2005b) (Figure 1.5). However, the question “do these pathways 
communicate delivering ENaC from one pathway to another” has not been answered. The 
biosynthetic pathway involves delivery of the ENaC to PM localized onto lipid rafts (Hill 





independent of these rafts, utilizing other types of vesicles/endosomes. It has been shown 
that ENaC is recycled to the cell surface via constitutive recycling and separately via a 
cAMP-regulated recycling pathway (Butterworth et al., 2009; Butterworth et al., 2012; 
Edinger et al., 2012; Klemens et al., 2017). Furthermore, a Liddle's syndrome mutation 
was shown to abolish cAMP-mediated translocation of ENaC to the cell surface (Snyder, 
2000) suggesting ENaC is not delivered from the biosynthetic pathway to endosomes for 
recycling, otherwise, cAMP-mediated recycling should not be impaired completely. 
 After cAMP stimulation, ENaC is recruited from intracellular stores and inserted 
into the apical membrane (Kleyman et al., 1994; Snyder, 2000; Morris & Schafer, 2002), 
while further investigation showed that this insertion is through translocation of 
subapical vesicles (Butterworth et al., 2005a; Edinger et al., 2012). Translocation of 
subapical vesicles was found by measuring the apical membrane capacitance, however, 
the type of vesicles was not investigated or shown. This does not exclude the possibility 
that these vesicles may be recycling vesicles deriving from endosomal tubules. 
Butterworth et al. (2005) also identified that the initial cAMP-induced of ENaC delivery in 
CCD epithelium treated with brefeldin A (BFA) was not impaired, however the 
subsequent repetitive ENaC stimulations were significantly reduced. Thereby they 
identified the initial response to cAMP stimulation as an effect of this stimulation on ENaC 
recycling while the subsequent defective responses were presumed to be due to disrupted 
trafficking from the TGN to an intracellular pool of ENaC (Butterworth et al., 2005a). 
Furthermore, Butterworth et al. (2005) showed that newly synthesized ENaC is not 





















A portion of newly synthesized ENaC is trafficked to an intracellular pool simultaneously with constitutive 
ENaC delivery to the apical membrane through the biosynthetic pathway. ENaC delivery to the plasma 
membrane from the intracellular pool is regulated by the cAMP signalling pathway. ENaC is endocytosed in 
clathrin-coated vesicles (CCV) and can be constitutively recycled to the plasma membrane after 
deubqituitination (DUB) in the early endosome (EE). TGN=trans-Golgi network. LE=late endosome. ER 
=endoplasmic reticulum.  
 
 On the EEs, proteins are sorted for their destination. Protein sorting processes 
involve many protein complexes, including retromer, retromer-interacting complexes, 
and retriever (Arighi et al., 2004; Hsu & Prekeris, 2010; Seaman et al., 2013; McNally et 
al., 2017). The EEs are also enriched in phosphoinositide-3-kinase (PI3K), 
phosphatidylinositol 3-phosphate (PI3P), early endosome antigen 1 (EEA1) and small 
GTPases, Rab5 (Rodriguez-Boulan et al., 2004), sorting nexins (SNXs) that are involved in 
many processes such as sorting-complex recruitment, protein-sorting and cleavage of 
tubules to vesicles.  
 Similar to many vesicles, it is likely that ENaC-carrying vesicles also utilize the 
cytoskeleton and motor proteins to move towards the apical membrane. When actin was 
disrupted, recycling of ENaC to the apical membrane failed and moreover, direct 
(Cantiello et al., 1991) and indirect interactions between ENaC and F-actin have been 
reported. Interaction of α-ENaC with α-spectrin that binds to actin through actin-binding 





protein β-spectrin, is involved in maintaining the polarized distribution of ENaC within 
the apical membrane (Rotin et al., 1994; Zuckerman et al., 1999). Moreover, 
depolymerization of F-actin in mCCD epithelia using latrunculin A (LatA) before cAMP 
stimulation also was shown to reduce ENaC current in mCCD cell line (Butterworth et al., 
2005a). These results suggest that possibly LatA abolished endosomal F-actin and 
thereby stabilization of endosomal recycling tubules on endosomes which reduced ENaC 
entry into tubules resulting in less ENaC recycling to plasma membrane by cAMP 
stimulation. When more Na+ reabsorption is required, ENaC is pushed from these 
endosomes to the apical membrane to increase channel number that is regulated by 
extracellular signals (Loffing et al., 2001).  
 Moreover, actin remodeling at the surface of cellular compartments and at the 
plasma membrane regulates short-range membrane transport and facilitates various 
processes such as membrane budding, fusion, and fission (Eitzen, 2003; Egea et al., 2006; 
Anitei & Hoflack, 2011). Short-term treatment with Cytochalasin D (CytD) that 
disassembles F-actin, decreased ENaC activity when ENaC and RhoA were overexpressed 
in Chinese hamster ovary (CHO) cells. In contrast, treatment with colchicine, that destroys 
microtubules, did not have an acute effect  on ENaC activity (Karpushev et al., 2010). But 
another study that contradicts this result firstly confirming that RhoA promotes ENaC 
trafficking to the plasma membrane, but disrupting microfilaments showed little effect on 
the pattern of ENaC expression at/near the plasma membrane with channels remaining 
in clusters while mircotubule diruption led to marked reorganization of ENaC clusters 
at/near the membrane in COS-7 cell line (Pochynyuk et al., 2007a). Furthermore, 
microtubule disruption inhibited an arginine vasotocin (AVT)- stimulated secretory Cl− 
current but did not prevent activation of amiloride-sensitive Na+ transport in A6 cells 
(Xenopus laevis kidney cells) (Morris et al., 1998).  
 These data suggest that in ENaC recycling, F-actin is utilized in the endosomal 
sorting but microtubules in the movement of ENaC-carrying vesicles, however, the 
contradictious results with microtubule disruption needs to be further investigated. 
Members of the myosin and/or kinesin families are normally required for vesicle 
movement on the cytoskeleton (Bi et al., 1997; Langford, 2002). However, the motor 
proteins involved in ENaC vesicle transport or possible proteins that would directly link 
these vesicles to motor proteins on the cytoskeleton have not been identified. The only 





that has been shown to link cargo vesicles to kinesin to traffic along microtubules in 
neurons (Barry et al., 2014). 
 Once ENaC vesicles arrive at the apical membrane, fusion with the membrane is 
facilitated by soluble N-ethylmaleimide-sensitive factor attachment protein receptors 
(SNAREs) and SNARE binding proteins that induce SNARE complex formation. Disruption 
of these proteins prevent the exocytosis of ENaC vesicles with the apical membrane. It 
was also shown that syntaxin directly binds to the cytoplasmic tails of ENaC (Saxena et al., 




1.3 ENaC sorting and trafficking on and from the endosomes 
 
ENaC is produced and constitutively delivered to the apical membrane through 
biosynthetic pathway. ENaC is also delivered to the apical membrane from the 
intracellular pool that is stimulated by cAMP. However, there is another pathway of ENaC 
delivery to the apical membrane, named the constitutive recycling pathway. This pathway 
recycles newly internalized channels from EEs.  
On the endosomes, the internalized ENaC, like most endocytic cargos, is destined 
for either degradative or recycling pathways through several steps including 
deubiquitination and sorting. The protein sorting process on endosomes involves many 
protein complexes, including retromer, retriever, WASH and CCC complexes as well as 
Rab and SNX family proteins, (Arighi et al., 2004; Hsu & Prekeris, 2010; Seaman et al., 
2013; McNally et al., 2017). ENaC sorting on and recycling from endosomes through 















WASH complex is recruited onto endosomes by Rab5 and PI(3)P and induces endosomal F-actin formation 
which stabilizes SNX-BAR-mediated tubules for ENaC entry. ENaC is sorted and loaded into tubules by SNX3 
or SNX17 where the retromer is recruited and releases Rab7 and thereby separates the endosomal recycling 
domain from Rab7-dependent lysosomal fusion. When CCC complex is recruited by WASH complex, the CCC 
complex dissembles the WASH complex and thereby actin-stabilized recycling tubules are released from 
endosome. However, retriever is recruited by WASH and CCC complexes localized on endosomes. It is 
proposed that cargos including ENaC are sorted by retromer or retriever and enter WASH/actin/CCC 
complex-regulated recycling tubules emanating from endosomes and delivered to the PM after scission of 
a tubule or vesicle. 
 
1.3.1 Function of retromer and retromer interacting complexes  
      
Retromer core complex. Retromer, first discovered in yeast, plays an important role in 
endosomal protein sorting and trafficking. The retromer core complex or cargo-selective 
complex consists of Vps26 (vacuolar protein sorting 26), Vps29, and Vps35. Retromer is 
located on the cytosolic face of the early and late endosomes. But the retromer core 
complex proteins don’t contain a known lipid-binding domain. Recruitment of retromer 
onto the EEs is mediated by recognition of an effector of Rab7, PI3K, and SNX3 via its 
VPS35 retromer subunit (Rojas et al., 2008; Seaman et al., 2009; Harterink et al., 2011; 
Harrison et al., 2014) or through binding to Rab4, SNX27 via its VPS26 retromer subunit 
(Lauffer et al., 2010; Steinberg et al., 2013). These interactions promote retromer to 





capture integral membrane cargo and initiate cargo sorting (Harrison et al., 2014). 
Retromer mediates trafficking of multiple proteins including many receptors and ion 
channels (Burd & Cullen, 2014; Wang et al., 2018).  
 Electrophysiological studies in the McDonald laboratory showed that increasing 
retromer subunit VPS35 stability by pharmacological chaperone R55 enhanced the 
amiloride sensitive ENaC current in αβγENaC transfected FRT epithelia and in 
endogenous ENaC expressing mCCDcl1 epithelia (Cheung et al, paper in revision). 
Furthermore, VPS35 knockdown decreased the ENaC current suggesting that ENaC 
recycling is mediated by retromer. But the exact mechanism by which retromer regulates 
ENaC, and the location of this interaction in the cell needs to be investigated further.  
 
Rab family proteins. The Rab family is part of the Ras superfamily of small GTPases. 
Although retromer subunits don’t bind to Rab4, Rab5, Rab9, or Rab27 (Rojas et al., 2008), 
these proteins play a crucial role in retromer-mediated cargo trafficking. On the EEs, Rab5 
mediates the EE fusion (Gorvel et al., 1991). The fused endosomes are a place where the 
cargo sorting process is realized and that is why they are also called sorting endosomes 
(SE). On the early/sorting endosomes, Rab5 promotes PtdIns(3)P synthesis which is 
required for SNX3 to associate with membrane where the SNX3 recruits the retromer  
(Harterink et al., 2011) that regulates protein sorting.  
 Proteins from the EE can be recycled to the plasma membrane on retromer-coated 
vesicles using a rapid recycling pathway in a process mediated by Rab4 (Temkin et al., 
2011) or via slower recycling endosomes (RE) regulated by Rab11a and Rab8a 
(Goldenring, 2015). During maturation of EEs to late endosome, a key event is Rab 
conversion in which Rab5 is replaced by Rab7a, is a key event and is associated with 
production of membrane tubules (van Weering et al., 2012). Rab7a recruits retromer thus 
allowing sorting and localization of cargo proteins to those tubules (Priya et al., 2015). 
The late endosomes that acquire Rab9 are involved in retromer-dependent recycling of 
cargos to the TGN (van Weering et al., 2012; Dong et al., 2013).  
 Among the Rab family proteins, Rab4 and Rab27 were reported to downregulate 
ENaC current in an immortalized human colonic epithelia HT-29 (Saxena et al., 2005; 
Saxena et al., 2006a; Saxena et al., 2006b). Later studies demonstrated that 
overexpression of Rab11a and Rab11b upregulate ENaC surface expression in CHO cells 





Sorting nexin (SNX) family. The SNX family is composed of 10 members in yeast and 33 
members in mammals (Carlton et al., 2005; Seet & Hong, 2006). A characteristic feature 
of all of these SNXs is to bear a specific type of Phox homology (PX) domain - the SNX–PX 
domain (Teasdale & Collins, 2012) through which they bind to phosphatidylinositols 
(most commonly PI(3)Ps) and this mediates recruitment to the early endosomal 
membranes. According to their members’ domain organization, the SNX family can be 
divided into 5 subfamilies: the SNX–PX, SNX–BAR, SNX–FERM, SNX–PXA–RGS–PXC and 
SNX–MIT subfamilies (Teasdale & Collins, 2012). Members of the SNX–BAR subfamily, as 
well as SNX17 and SNX27 of the SNX–FERM subfamily and SNX3 of the SNX–PX subfamily, 
are involved in the retromer-mediated endosomal sorting and trafficking. 
 The SNX–BAR subfamily. All SNX-BAR family members bear a phox homology 
(PX) domain and a C-terminal BAR (Bis/ amphiphysin /Rvs) domain, which allows SNX–
BARs to form specific homo- and hetero-dimers, a C-shaped structure. Members of the 
SNX–BAR category are involved in different steps of trafficking. Thus, SNX9, 18 and 33 are 
thought to be involved in endocytosis (Lundmark & Carlsson, 2009; Park et al., 2010), 
SNX4 in transport from EEs to recycling endosomes (Traer et al., 2007), and SNX8 in 
endosome-to-TGN trafficking (Dyve et al., 2009). SNX1, SNX2, SNX5, SNX6 form a 
retromer-interacting SNX–BAR dimer subcomplex which is a combination of two SNXs: 
SNX1 or SNX2 and SNX5 or SNX6 (Wassmer et al., 2007). As two of these SNX–BARs 
dimerize, the PX-domains interact with PI(3)P while the BAR-domains bends the 
endosome membrane to form tubular-carriers for retromer cargo in addition to their 
sensing the membrane curvature function (Zimmerberg & McLaughlin, 2004). 
Furthermore, SNX5 and -6 have been shown to bind to cargos as well (Simonetti et al., 
2017). 
SNX4 plays a role in the transport of transferrin receptor (TfnR) from EEs to 
recycling endosomes in association with the motor protein dynein through dynein 
interactor KIBRA (Traer et al., 2007).  ENaC was pulled down with KIBRA, further studies 
showed that knocking down KIBRA and as well SNX4, increased ENaC current (Cheung et 
al, paper in revision). 
 The SNX–PX subfamily. SNX3 is a member of the SNX–PX subfamily of SNXs and 
bears only a characteristic SNX–PX domain. SNX3 localizes to the endosome through the 
binding of its SNX–PX domain to PI3P in the endosomal membrane (Xu et al., 2001). After 
binding to its cargo, SNX3 recruits retromer to the EE interacting with and binding to the 





recycling of its cargo from endosomes to the TGN which is reported for the WLS receptor 
(Harterink et al., 2011). But SNX3 increases total and plasma membrane levels of α and γ 
ENaC in HEK-293 cells and surface expression of ENaC in mCCDcl1 cells through the 
vasopressin-induced stabilization of endogenous SNX3 suggesting that SNX3 rescues 
ENaC from the degradative pathway (Boulkroun et al., 2008). Boulkroun and colleagues 
also reported that SNX3 physically interacts with αENaC. 
 The SNX–FERM subfamily. Members of this subfamily contain an atypical FERM 
(protein 4.1/ezrin/radixin/moesin) domain or ‘FERM-like’ domain C-terminal to the 
SNX–PX domain (Ghai et al., 2011). The SNX–FERM subfamily has three members: SNX17, 
SNX27 and SNX31. SNX17 and SNX31 are similar and each contain only the SNX–PX and 
FERM-like domain. SNX27 is larger than SNX17 and bears SNX–PX FERM-like domains 
and a post-synaptic density 95/discs large/zonula occludens (PDZ) domain N-terminal to 
the SNX–PX domain.   
 SNX27 interacts with the retromer and the WASH complex which leads to the 
generation of tubules on the endosomal membrane and the retrieval of receptors to the 
plasma membrane (Temkin et al., 2011). Electrophysiological studies in McDonald 
laboratory revealed that SNX27 knockdown didn’t change ENaC current significantly in 
mCCDcl1 or in FRT epithelia (Cheung et al, paper in revision). 
 It is well known that SNX17 regulates endosomal sorting of various cargos such as 
amyloid precursor protein (APP) and low-density lipoprotein (LDL) receptor-related 
protein (LRP) (van Kerkhof et al., 2005; Lee et al., 2008b). It was previously reported that 
α5β1 integrin recycling depends on SNX17 (Steinberg et al., 2012). But SNX17-ENaC 
regulation should be investigated. Previous studies showed that knockdown of SNX17 
reduced ENaC current and cell surface population, and SNX17 was co-
immunoprecipitated with ENaC (Scott, 2019)(Thesis, Master of Science). 
 
WASH complex. The WASH complex (Wiskott-Aldrich syndrome protein and SCAR 
homologue (WASH)) consists of five subunits; WASH complex subunit 1 (WASH1 or 
WASHC1), FAM21 (or WASHC2), CCDC53 (or WASHC3), Strumpellin and WASH 
Interacting Protein (SWIP or WASHC4) and strumpellin (or WASHC5) (Harbour et al., 
2012). The WASH complex, together with Arp2/3, cortactin (an Arp2/3 activator) and 
branched F-actin were shown to stabilize endosomal tubules for sequence-dependent 
sorting (Puthenveedu et al., 2010). But previously, it was shown that the WASH complex 





demonstrating that WASH depletion leads to the elongation of Tf-labelled tubules 
(Derivery et al., 2009). However, it was shown that WASH does not act on TfR-loaded 
constitutive recycling tubules (Puthenveedu et al., 2010) as Derivery and coworkers also 
showed that the WASH complex localizes on the endosome itself instead of Tf-labelled 
tubules (Derivery et al., 2009). Elongation of Tf-positive tubules, could be due to the 
impaired back flow of membrane through sequence-dependent recycling in WASH 
depleted cells leaving the constitutive recycling pathway as the only way to mediate 
membrane back flow. Furthermore, if the WASH complex can promote effective fission of 
membrane tubules, then increased WASH activity (through overexpression or CCC-
depletion) should possibly cause intensive tubule fission and recycling rather than 
leaving cargo trapped in accumulated endosomal F-actin as reported (Campion et al., 
2018; Singla et al., 2019).  
 Previous studies showed that overexpression of WASH complex subunits WASHC1 
and knockdown of WASHC2 in FRT epithelia significantly decreased ENaC current 
(Cheung et al. paper in revision) suggesting that normal WASH complex level is required 
for normal stabilization of ENaC loaded recycling tubules. Thus, when WASH subunits are 
overexpressed, tubules are trapped by accumulated endosomal actin and when knocked 
down, tubules are less stabilized for cargo (including ENaC) entry according to a model 
describing roles of WASH complex and endosomal F-actin (Puthenveedu et al., 2010). 
 
CCC complex. The CCC complex (COMMD1-10/CCDC22/CCDC93) interacts and 
colocalizes with both retromer and the WASH complex (Harbour et al., 2012; Phillips-
Krawczak et al., 2015) and consists of three components: a subcomplex of COMMD 
proteins, coiled-coil domain-containing protein 22 (CCDC22) and coiled-coil domain-
containing protein 93 (CCDC93). All ten members of the COMMD protein family can 
associate with the CCC complex (Starokadomskyy et al., 2013; Li et al., 2015; Phillips-
Krawczak et al., 2015). 
 Recent studies showed that the trafficking of many retromer-mediated cargos is 
dependent on COMMD proteins. Thus, low-density lipoprotein receptor (LDLR), copper 
transporter ATP7A, Na-K-Cl cotransporter, and CFTR are particularly dependent on 
COMMD1 (Drevillon et al., 2011; Smith et al., 2013; Phillips-Krawczak et al., 2015; Bartuzi 
et al., 2016), whereas the Notch receptor is particularly dependent on COMMD9 (Li et al., 





-containing endosome binding actin/tubulin although COMMDs themselves possess no 
apparent intrinsic enzymatic activity (Burstein et al., 2005; Campion et al., 2018). 
 Previous studies showed that COMMD1 directly interacts with and downregulates 
ENaC (Biasio et al., 2004; Ke et al., 2010). Later studies showed that all of COMMD1-10 
proteins co-immunoprecipitate with ENaC and overexpression of COMMD3 and 9 reduce 
ENaC surface activity likely by increasing ENaC ubiquitination and endocytosis (Chang et 
al., 2011; Liu et al., 2013). However, COMMD10 plays a converse role in regulation of 
ENaC. Thus, stable knockdown of COMMD10 decreased ENaC current reducing ENaC cell 
surface population in FRT cells (Ware et al., 2018). Interestingly, the stable knockdown of 
COMMD10 decreased endogenous VPS35 protein level compared to control FRT epithelia 
(Cheung et al. paper in revision). 
 In further experiments, ENaC was co-immunoprecipitated with CCDC22 and 
knockdown of CCDC22 decreased ENaC current reducing cell surface population of ENaC 
which was confirmed by cell surface biotinylation assay (Cheung et al. paper in revision). 
  
Association of retromer with various SNXs at the endosomal membrane provides 
diversity in cargo recycling. For recycling of mannose-6-phosphate receptors and 
Sortilin/SorlA to the trans-Golgi network (TGN), retromer associates with SNX1 or SNX2 
and SNX5 or SNX6 (Bonifacino & Rojas, 2006) while to deliver the WLS receptor to the 
TGN, retromer interacts with SNX3 (Wassmer et al., 2009; Lucas et al., 2016). However, 
when retromer engages SNX27 and the WASH complex, the directionality of the recycling 
changes, and this complex mediates the recycling of a large number of membrane 
proteins, including metal and glucose transporters, to the plasma membrane (Steinberg 
et al., 2013). A model for retromer- and retriever (discussed below) -mediated endosomal 





1.3.2 Function of Novel Complex Retriever 
 
Retrieval and recycling of many plasma membrane proteins, including α5β1 integrin, do 





SNX27. Recently, McNally et al. reported the discovery of a different multiprotein complex 
essential for retromer-independent, but SNX17-dependent recycling of α5β1 integrin 
(McNally et al., 2017).  It was previously reported that α5β1 integrin recycling depends on 
SNX17 (Steinberg et al., 2012).  
 Proteomic analysis carried out by McNally et al. (2017) revealed that functional 
SNX17 is physically linked to the C16orf62, DSCR3, and VPS29 proteins. Their further 
investigations showed that C16orf62, DSCR3 and VPS29 form a heterotrimeric complex 
with similarity to retromer (Figure 1.6) but this complex doesn’t associate with retromer 
or SNX27, suggesting that they form a retromer-independent protein-sorting machine 
which was called ‘retriever’ by McNally et al (2017). 
 There are some similarities and differences in the function of retriever and 
retromer. Endogenous retriever and retromer reside on the same endosomal subdomain 
but this is distinct from the ESCRT ‘degradative’ subdomain. The retriever complex 
requires the CCC and WASH complexes for endosomal localization while retromer itself 
recruits the WASH complex. Interestingly, in the CCC complex of this novel multiprotein 
complex, only seven of the ten human COMMDs were found to be involved while in 
retromer CCC all 10 COMMDs are thought to be involved (Starokadomskyy et al., 2013). 
Suppression of single elements of retriever revealed that the CCC complex fully perturbs 
the localization of retriever to endosomes without affecting retromer, while suppression 
of SNX17 isn’t involved, and DSCR3 and C16orf62 are partially involved (McNally et al., 
2017). Retriever-mediated recycling is required for the retrieval and recycling of cell 
surface cargos. 
 But how does the cargo-bound retriever complex exit the endosome? SNX17, 
colocalizing with its cargo low‐density lipoprotein receptor (LDLR), was clearly found on 
the endosomal membrane as well as on the emerging recycling tubules, reminiscent of 
SNX-BAR/retromer tubules (van Kerkhof et al., 2005). Considering that no SNX-BAR–
retriever interaction was identified, it is difficult to predict whether retriever-containing 
budding tubules also hosts retromer and or if there are two classes of tubules.  
Retriever-mediated cargo selection step is realized by SNX17 where SNX17 binds 
to ΦxNPxY, ΦxNxxY or ΦxNPxF sequence motifs of cargos through its FERM-like domain 
(Ghai et al., 2013; Stiegler et al., 2014). Analysis of the ENaC amino acid sequence may 
support the hypothesis that retriever can be involved in ENaC trafficking. Amino acid 
sequence analysis shows that although there are no ΦxNPxY, ΦxNxxY or ΦxNPxF binding 





βENaC subunit contains a possible SNX17 binding motif matching ΦxNxxF in its 
cytoplasmic C-terminal domain.  
 
 
1.3.3 COMMD1-10 proteins 
 
The COMMD family proteins (COMMD1-10) contain a conserved C-terminal motif known 
as the COMM domain [Copper Metabolism Murr1 (mouse U2af1-rs1 region 1)] that 
consists of a 70–85 leucine-rich amino acid sequence (Burstein et al., 2005). The COMM 
domain facilitates the interaction of COMMD proteins allowing them to dimerize and exist 
in homo- and heterodimer forms in vivo and in addition the COMMD domain is needed 
for interaction with many other proteins (Maine & Burstein, 2007; Healy et al., 2018). 
 COMMD1, the first identified member of this family and previously known as 
MURR1, has a number of distinct functions, such as (1) inhibition of transcription factor 
NF-κB, (2) control of copper metabolism (mutations in MURR1 results in copper toxicosis 
in an inbred canine strain (Bedlington terriers) reviewed in (Burstein et al., 2005)), and 
in concert with the WASH complex COMMD1 regulates the recycling of copper transporter 
ATP7A (Phillips-Krawczak et al., 2015), (3) regulation of hypoxia-inducible factor 1 
(HIF1) (van de Sluis et al., 2007), and (4) regulation of epithelial ion transport through 
Na-K-2Cl cotransporter (NKCC1)(Smith et al., 2013), cystic fibrosis transmembrane 
conductance regulator CFTR (Drevillon et al., 2011), and ENaC (Biasio et al., 2004). 
COMMD1, is required for endosomal sorting of the low-density lipoprotein receptor (LDL-
R), therefore increasing plasma low-density lipoprotein (LDL) levels (Bartuzi et al., 2016). 
Another investigation showed that COMMD1 is involved in membrane protein trafficking 
through binding to phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] with its C-
terminal domain (Burkhead et al., 2009). 
 The mechanisms to explain all of these functions that COMMD1 and other 
members of the family are participating in, are not known at the moment, but recent 
studies suggest the possibility of involvement in the ubiquitin pathway that may be a 
common point, because COMMD1 promotes the ubiquitin-conjugating ability of ubiquitin 
ligase complexes formed with a cullin protein backbone (Maine et al., 2007). But COMMD1 
has variable effects on proteins and this may be dependent on targeting different 





For example, COMMD1 interacts with NKCC1 via its N-terminal domain while with δENaC, 
ATP7A, CFTR, COMMD2–10, HIF1α, and NF-κB via its C-terminal COMM domain. This may 
be the reason that COMMD1 increases ubiquitination of NF-κB subunits, ENaC subunits, 
and NKCC1, while it decreases the ubiquitination of CFTR (reviewed in (McDonald, 
2013)). 
1.3.4 COMMD Family Proteins in ENaC trafficking 
 
A link between the protein-sorting function of retromer and ENaC trafficking was firstly 
discovered when previous studies demonstrated that COMMD1, a subunit of the 
retromer-interacting protein complex CCC, binds to the C-terminal domain of δENaC as 
well as α-, β- and γENaC (Biasio et al., 2004; Ke et al., 2010) and inhibits sodium current 
when COMMD1 is coexpressed with either αβγ or δβγENaC in Xenopus oocytes (Biasio et 
al., 2004). But dissection of the C-terminal domain in δENaC rescued δβγENaC from 
inhibition.  COMMD1 reduces ENaC surface expression through binding to SGK1, likely 
preventing SGK1’s ability to phosphorylate Nedd4-2, and resulting in increased 
ubiquitination of ENaC (Ke et al., 2010). Ke et al. (2010) also reported that COMMD1 
colocalises with ENaC in collecting duct cells.  
To demonstrate the role of other COMMD family members in ENaC trafficking, the 
McDonald lab implemented further experiments. Liu et al. (2013) investigated COMMD(2-
10) and concluded that all the other COMMD family members also interact with ENaC and 
that COMMD3 and -9 inhibit Isc-amiloride and reduce the cell surface expression of ENaC 
in FRT cells. Endogenous COMMD3 is expressed in the cytosol but not in the nucleus, while 
COMMD9 is expressed throughout the cell including the nucleus (in HEK 293 cells), and 
they also are colocalized with ENaC in some of the same cell lines such as rat collecting 
duct cells. All these data led them to suggest that COMMD3 and -9 may be endogenous 
regulators of ENaC through SGK1-Nedd4-2-ubiquitination pathway and aldosterone may 
disrupt this pathway (which is an important part for my project).  
 COMMD10 is a member of the CCC complex and interacts with a number of 
retromer proteins. COMMD10 is thought to function similar to its homologs, but there is 
not enough evidence yet. Unpublished studies have shown that COMMD10 interacts with 
Arf1, COPI-associated protein (COPI, a protein complex that coats vesicles transporting 





above-mentioned data, with this project we focus on interaction and possible roles of 




1.4 Aims and Objectives 
 
1. What is the mechanism by which COMMD10 regulates ENaC?  
1.1 Quantification of apical surface population rate of ENaC in ENaC-transfected 
COMMD10 and control knockdown FRT cells  
1.2 Determining the knockdown effect of COMMD10 on ENaC endocytosis and 
recycling  
1.3 Does COMMD10 KD change microfilament organization in FRT epithelia?  
    
2. Which endosomal domain does COMMD10 localize to?  
2.1 Identify if COMMD10 localizes on Rab5-positive endosomes  
2.2 Identify if COMMD10 localizes on Rab7a positive endosomes in U2OS and in FRT 
cells  
2.3 Identify if COMMD10 localizes on Rab11-positive recycling endosomes in U2OS 
and FRT cells  
2.2 Identify if ENaC and retromer (VPS35) are co-localized 
 
3. How are COMMD proteins regulated? 
3.1 How are mRNA levels and protein levels of COMMD1-10  regulated by 
aldosterone?  
3.2 How are mRNA levels and protein levels of COMMD1 and 10  regulated by 


























2. Materials and Methods 
















2.1 List of antibodies 
        
Table 2.1. List of antibodies used in this study. 






Anti-COMMD 1 COMMD 1 Polyclonal Rat 1 :  1000 4°C / Overnight Raised in 
McDonald lab, 
(Ke et al., 2010) 
Anti-COMMD 3 COMMD 3 Polyclonal Rat 1 :  1000 4°C / Overnight Raised in 
McDonald lab, 
(Liu et al., 
2013) 
Anti-COMMD 9 COMMD 9 Polyclonal Rat 1 :  1000 4°C / Overnight Raised in 
McDonald lab, 








Monoclonal Rabbit 1 :  4000 4°C / Overnight Sigma-Aldrich 
H3663 








Monoclonal Mouse 1 :  1000 4°C / Overnight Sigma-Aldrich 
F3165 
Anti-SGK1 serine 78 (P-P-
SP -P-S) 
































Polyclonal Rabbit 1 :  1000 4°C / Overnight StressMarq 
Biosciences inc. 
SPC-405D 
Anti-P4D1 Mono and 
poly ubiquitin 








Polyclonal Goat  1:1000 4°C / Overnight Abcam  
ab10099 
Secondary Antibodies 
Anti-Rat-HRP Rat IgG Polyclonal Goat 
1 : 10 000 


















1 : 10 000 RT / 1 hour Santa-Cruz  
sc-2020 
       
Alexa-Fluor Conjugated Secondary Antibodies 
Anti-Rabbit-
AF488 




 Goat IgG Polyclonal 
 























2.2 List of plasmids 
 













1 α-ENaC pMT3 DH5α high copy / 37°C Ampicillin (McDonald et al., 
1994; McDonald et 
al., 1995) 
2 β-ENaC pMT3 DH5α high copy / 37°C Ampicillin (McDonald et al., 
1994; McDonald et 
al., 1995) 
3 γ-ENaC pMT3 DH5α high copy / 37°C Ampicillin (McDonald et al., 
1994; McDonald et 
al., 1995) 
4 β-HA-ENaC pMT3 DH5α high copy / 37°C Ampicillin (Snyder et al., 1994) 
5 HA-COMMD10 pMT3 DH5α high copy / 37°C Ampicillin (Biasio et al., 2004) 
6 Flag-WASH1 pGW1 DH5α high copy / 37°C Ampicillin Gift from Craig 
Blackstone NIH 
7 COMMD10-GFP pEBB DH5α high copy / 37°C Ampicillin Gift from Ezra 
Burstein, UT 
Southwestern, USA 
8 COMMD10-YFP pEBB DH5α high copy / 37°C Ampicillin Gift from Ezra 
Burstein, UT 
Southwestern, USA 
9 COMMD1-GFP pEBB DH5α high copy / 37°C Ampicillin Gift from Ezra 
Burstein, UT 
Southwestern, USA 
10 YFP-Fam21 pGW1 DH5α high copy / 37°C Ampicillin Gift from Craig 
Blackstone NIH 
11 Rab5a-mCherry pDsRed-C1 DH5α high copy / 37°C Kanamycin (Taylor et al., 2011) 
12 Rab7a-DsRed pDsRed-C1 DH5α high copy / 37°C Kanamycin (Choudhury et al., 
2002) 




pCSDest2 DH5α high copy / 37°C Ampicillin Addgene /107318 
15 Cre 
recombinase 
pCS2+    DH5α high copy / 37°C Ampicillin Addgene /31132 
16 I Donor DNA 
Seq 
pcDNA3.1 DH5α high copy / 37°C Ampicillin GenScript / 
U678MEC140_2 
17 II Donor DNA 
Seq 






2.3 Plasmid maintenance 
 
 
2.3.1 Bacterial transformation 
 
In this study, plasmids were transformed into DH5α E.coli cells (genotype: F– endA1 glnV44 
thi-1 recA1 relA1 gyrA96 deoR nupG purB20 φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK–
mK+), λ–) through CaCl2-technique as follows. 
 Overnight culture of the competent bacteria was grown in LB broth medium (10 g 
Bacto-tryptone, 5 g yeast extract, 10 g NaCl – per liter) at 37°C without shaking. About 2 
h before starting the transformation, 1.0 mL of the overnight culture was inoculated in 
100 mL of fresh LB broth with rapid shaking at 37°C. Then, 5 mL aliquot for each 
transformation reaction was transferred to sterile plastic centrifuge tubes and cooled on 
ice for 10 min. The cells were pelleted by centrifugation for 5 min at 5000g at 4°C and 
then resuspended in 25 mL of cold 0.1M CaCl2. After incubation on ice for at least 20 min, 
the cells were again pelleted by centrifugation for 5 min at 5000g at 4°C. The cells were 
again resuspended in 0.2 mL of cold 0.1M CaCl2 and transferred to sterile tubes. 0.1 mg of 
DNA (plasmid) was added to each tube and incubated on ice for 30 min. Heat-shock was 
performed by placing the bottom 2/3 of the tube into a 42°C water bath for 45 secs after 
which the tubes were placed on ice for 2 min. Then 800 μl LB broth without antibiotic was 
added into tubes and the tubes were incubated at 37°C in a shaking incubator for 45 min. 
Although this step is not critical for ampicillin resistance it is very important for other 
antibiotic resistances, as it gives the bacteria time to generate the antibiotic resistance 
proteins encoded in the plasmid backbone after which they will be able to grow on the 
antibiotic containing agar plates. After incubation, all of the transformation (centrifuged 
and resuspended in a smaller volume of LB) was plated onto a 10 cm LB agar plate (7.5 g 
agar, 5 g tryptone, 5 g NaCl, and 2.5 g yeast extract – per liter) containing antibiotic. Plates 
were warmed up to room temperature before plating and then incubated in a 37°C 
incubator overnight. Next day, a small amount of bacteria was streaked onto new LB agar 





 For the LB agar media, filter sterilized antibiotics were added at 100 µg/mL final 




2.3.2 Streaking, inoculating and stocking bacterial culture 
 
A small amount of bacteria was streaked on new LB agar plates to produce single colonies 
for ease of collection. After overnight incubation, using a sterile pipette tip, a single colony 
without any satellite colonies was isolated and added into 150 mL of liquid LB broth + 
ampicillin at 100 µg/mL concentration. The culture was incubated in a shaking incubator 
with 220 rpm velocity at 37°C overnight. 
 
Creating Bacterial Glycerol Stocks. Bacterial glycerol stocks are important when future 
experiments may need more plasmid DNA since the plasmid will already be in the desired 
bacteria stored in glycerol. Glycerol stabilizes the frozen bacteria, preventing damage to 
the cell membranes and keeping the cells alive for many years at -80°C. To prepare a stock 
for the bacteria, 600 μL of an overnight culture was added to 600 μL of sterile 50% 
glycerol solution (25% final concentration) in a cryovial and gently pipetted up and down 
to make a uniform solution and then frozen at -80°C.  
 To recover bacteria from the glycerol stock, a small amount of the frozen bacteria 
was scraped off from the top with a pipette tip and inoculated in LB broth media to avoid 




 2.3.3 Midiprep production of plasmid DNA from bacterial cells 
 
All plasmids used in this project were purified using a NucleoBond® Xtra Midi EF plasmid 
purification kit (Macherey-Nagel) following the manufacturer’s instructions for Midi 
preparation. The principle of this purification kit is based on a classic method developed 
by Birnboim and Doly (Birnboim & Doly, 1979). The bacterial cells are lysed by an 





a strong base sodium hydroxide (NaOH). The NucleoBond® Xtra Column, provided in the 
kit, contains NucleoBond® Xtra Silica Resins that consists of hydrophilic, macroporous 
silica beads functionalized with MAE (methyl-amino-ethanol). Under acidic pH 
conditions, the functional group provides a high overall positive charge density that 
allows the negatively charged phosphate backbone of nucleic acids including plasmid 
DNA to bind with high specificity and the nucleic acids are only released with elution 
buffer. 
 Briefly, 150 mL of overnight bacterial cultures were centrifuged at 6000g, 4°C for 
15 min. After resuspending the pellet with 8 mL of resuspension buffer, bacterial cells 
were lysed with 8 mL of lysis buffer gently mixing and incubating the mixture at room 
temperature for 5 min. The NucleoBond® Xtra Column together with the corresponding 
NucleoBond® Xtra Column Filter was equilibrated with equilibration buffer (12 mL). The 
lysate was neutralized with 8 mL of neutralization buffer and the entire mixture was put 
into the column filter. Nucleic acids entered the column by gravity flow simultaneously 
removing debris by the specially designed column filter. Then the column filter and 
column were washed with 5 mL of equilibration buffer to wash down any plasmids 
adhering to the filter. After removal of the filter, the column was washed with 8 mL of 
wash buffer. Plasmids loaded into the column were eluted with 5 mL of elution buffer and 
collected in a 15 mL tube. Plasmids were loaded into a NucleoBond® Finalizer after adding 
3.5 mL isopropanol to the 5 mL of eluate. The finalizer was washed with 70% ethanol (2 
mL) and air dried with a 30 mL syringe. Plasmids were then eluted with 700 μL of milliQ 















2.3.4 Determination of plasmid concentration and verification of plasmid DNA 
 
Plasmid yield was determined by 
MaestroNano® Spectrophotometer. 
Plasmids were verified by digesting 
with EcoRI enzyme since all our 
plasmids contained EcoRI digestion 
site in their multiple cloning site 
(MCS) as shown in an example 
plasmid (Figure 2.1). To digest the 
plasmids, a digestion reaction was 
prepared as follows: 
Plasmid DNA   1 μg  
10x H buffer  2 μL 
ECoR I    0.5 μL 
mQH2O                       to complete 20 
μL                  
 
After mixing gently by pipetting samples were incubated at 37°C in a heatblock for 1 h. 




2.4 Polynucleotide analysis experiments 
 
 
2.4.1 RNA extraction and determination of concentration  
 
RNA extraction with early (on column) DNase I treatment. This method was used to 
extract mRNA used for identification of mRNA levels of COMMD proteins under 
aldosterone treatment. To lyse and homogenize cells, 0.4 mL TRIzol (Invitrogen) was 
added directly onto the mCCDcl1 cells grown on 24 mm filters and mechanically scraped 
directly from the filters, collected, and stored at -80°C.  
pcDNA3.1+ plasmid backbone in which I and II Donor 
DNA sequences were purchased. The backbone also 
contains ampicillin and neomycin resistance genes. 
Donor DNA sequences were inserted into multiple 
cloning site (MCS) where the EcoRI enzyme target site is 
also located. 





 RNA extraction was performed using the RNeasy Micro Kit (Qiagen, Cat 
No: 74004) according to the manufacturer’s guidelines. The lysates were thawed at 65°C 
for 5 min and mixed by repetitive pipetting. A distinct phase separation was obtained by 
centrifuging after addition of chloroform to lysates, where RNA was in the aqueous phase, 
protein was extracted into the organic phase, and DNA was at the interface. After adding 
one volume of 80% EtOH to the aqueous phase, the mixture was transferred to a Qiagen 
Micro-RNeasy column and centrifuged for 30 secs at 9,200 g. The column together with 
bound RNA in it was washed with 350 μL of Buffer RW1.  
To erase any trace of genomic DNA (gDNA), an early (on column) DNase I 
treatment step was included in the protocol. DNase I treatment was performed using the 
RNase-Free DNase Set supplied together with the RNeasy Micro Kit. 80 μl DNase I + RDD 
solution was added into the column and incubated for 15 min at RT. After subsequent 
washes of the column with 350 μL Buffer RW1, 500µL Buffer RPE and then 500µL 80% 
EtOH, the RNA was eluted from the column with 2 x 20 µL RNase-free water.  
 
Concentration and purity of the RNA. After elution, the concentration and purity of the 
RNA was verified using the 260-to-280-nm optical density ratio on a Synergy 2 Multi-




2.4.2 Ethanol precipitation of RNA 
 
Ethanol precipitation of RNA was used to extract mRNA used for identification of mRNA 
levels under calcium treatment. mCCDcl1 cells were lysed by TRIzol as described above 
(2.4.1) and the aqueous phase containing RNA was transferred to a new tube. This method 
was also used to precipitate in vitro synthesized RNA that was utilized for gene knockout 
experiments as explained below.  
 For precipitation of RNA synthesized in vitro 0.1 volume of 3M sodium acetate (pH 
5.2) and 2.5 volume of ice cold 100% ethanol were added to the RNA samples. The 
mixtures were vortexed thoroughly and precipitated at -80˚C for 1 hour. Then samples 





with 0.5mL of ice cold 75% ethanol and span at 4˚C for 10 mins each time. The supernatant 
was removed and the pellet air-dried. Then the pellet was resuspended in an appropriate 
volume of nuclease free water (UltraPure Water, Invitrogen, Cat.No: 10977015) and 
stored at -80 ˚C. 
 
 
2.4.3 cDNA synthesis 
 
Complementary DNA (cDNA) is DNA synthesized from a single-stranded RNA (e.g., 
messenger RNA (mRNA) or microRNA) template in a reaction catalyzed by a DNA 
polymerase referred to as reverse transcriptase. cDNA for real-time PCR was synthesized 
with 500 ng of extracted RNA (2.4.1) using the PrimeScript RT Reagent Kit (Perfect Real 
Time) (TaKaRa bio, Cat. No: RR037B). The reverse transcription reaction for cDNA 
synthesis setup is as follows:  
Reagent       Amount  
5X PrimeScript Buffer (for Real Time)*  2 μL   
Random 6mers      0.5 μL   
Oligo dT Primers            0.5 μL   
RT Enzyme Mix I        0.5 μL   
750 ng RNA      …. μL 
RNase Free water     …. μL to make 10 μL 
              
* Contains dNTP Mixture and Mg2+. 
  
The synthesis was performed in a heat block at 37°C for 15 min followed by a 5 sec 
incubation at 85°C to inactivate the reverse transcription enzyme. The same ratio of 
reverse transcription reagents, in the absence of the RT enzyme mix, was used for a 
negative control (-RT control) for each set of experiments. The RT product cDNA was 
diluted 5 times to (10 ng/µL) and used in RT-qPCR directly or stored in a freezer at -20°C. 
cDNA sequence and sizes were determined with NCBI Reference Sequence searches 







2.4.4 Quantitative Reverse Transcription PCR (RT-qPCR)  
 
Polymerase Chain Reaction (PCR) is a method widely used to make many copies of a 
specific DNA segment using synthetic primers and template DNA (Mullis, 1990), however, 
in the quantitative reverse transcription PCR (RT-qPCR), as a template, cDNA (reverse-
transcribed from RNA) is used (Porcher et al., 1992). qPCR method is based on monitoring 
the amplification of a targeted DNA molecule during the PCR procedure (Valasek & Repa, 
2005).  
 By RT-qPCR, mRNA levels of COMMD1-10 under aldosterone treatment in mCCD 
epithelia were quantified. PCR was performed in 96- well plates in 10-μl reactions where 
the reaction contents were as follows:  
 
Reagent     Volume (for 10 μl) Final conc. 
SYBR Premix Ex Taq (2X)  5 μl    1X 
ROX Reference Dye (50X)   0.2 μl    1X 
PCR Forward Primer (10 μM)   0.2 μl    0.1 μM 
PCR Reverse Primer (10 μM)   0.2 μl    0.1 μM 
Template (10 ng/µL)   1 μl 
Ultra-pure water    6.8 μl 
 
RT-qPCR reactions were analyzed using the CFX Connect Real Time System 
instrument (Bio-Rad). PCR conditions were 95°C for 10 min of denaturation, then 40 
cycles of (95°C for 15 s, 58°C for 30 sec), and a melting curve detection of 65°C to 95°C 
(0.05°C). Results were collected by and initially analyzed by BioRad CFX Manager 3.1 
software.  Primer sequences (KiCqStart® SYBR® Green Primers, Sigma, Cat.No: 
KSPQ12012), size of amplicons and reaction parameters are shown in the Table 2.3. 
 
Table 2. 3 List of RT-PCR primer sequences and reaction parameters. 
Gene   Primer sequences  Cycle  Tmelting °C cDNA 
Size bp 
COMMD1 Forward 5’- GAG GAC TTC TCA AGT CTA TTG -3’  40 54.6 165 
 Reverse 5’- CTC TCG GAT TTT TAT CTT GTG G -3’ 40 61.4  
COMMD2 Forward 5’- GAA CTA TTC TGA ACG AGT TAG C -3’ 40 56.4 173 
 Reverse 5’- GTC TGT CTG CAA GAA ATG AG -3’ 40 57.5  
COMMD3 Forward 5’- CTA CTG GGA AGT ATA GGC AG -3’ 40 55.6 83 
 Reverse 5’- AGT TGG TTG GTC TTT ATC TG -3’ 40 55.7  
COMMD4 Forward 5’- AAA TTT CCT CTG TGA AGC TG -3’ 40 58.5 77 





Gene   Primer sequences  Cycle  Tmelting °C cDNA 
Size bp 
COMMD5 Forward 5’- GGC TAC TGT GGT TAG TAC C -3’ 40 53.5 90 
 Reverse 5’- CAG TTG GAT GGT GTA AGT ATG -3’ 40 57.0  
COMMD6 Forward 5’- GGC CAG CTT ATA GAT TTT CAG -3’ 40 59.4 154 
 Reverse 5’- ATT GTG GAA TTG TCA TCT CG -3’ 40 60.0  
COMMD7 Forward 5’- GTA TAT GGA ACT AAC CTT GCC -3’ 40 56.7 196 
 Reverse 5’- GCT GAG ACT CTT GGT TTT AG -3’ 40 55.7  
COMMD8 Forward 5’- AAA CTT CTC TGA GGA AGA GAC -3’ 40 55.8 104 
 Reverse 5’- GCT TGA TCT CAT TTC TCC TAC -3’ 40 57.0  
COMMD9 Forward 5’- AGA AAG CCT GCT AGA TAA GAC -3’ 40 55.0 195 
 Reverse 5’- TCC ACG ATG ATT TTT GTC AG -3’ 40 61.1  
COMMD10 Forward 5’- AAT TCA ATC ACA AGG AGC TG -3’ 40 59.3 159 
 Reverse 5’- ATA TAC TTG GGC AGT GTC TC -3’ 40 54.8  
SGK1 Forward 5’- ATC CTG AAG AAG AAA GAG GAG -3’ 40 58.1 137 
 Reverse 5’- ATG TAG TCC AGG ACA AAG TAG -3’ 40 54.9  
ACTB (β-
actin) 
Forward 5’- GAT GTA TGA AGG CTT TGG TC -3’ 40 58.6 
96 




2.4.5 Gel electrophoresis 
 
Gel electrophoresis is a technique used to separate polynucleotide fragments (or 
proteins). Polynucleotides migrate toward the anode in the presence of electric current 
as they are negatively charged. The agarose gel acts as a sieve to selectively impede the 
migration of the DNA and RNA in proportion to its mass and because their mass is 
generally proportional to their length and charge, although topology (e.g, circularity, 
secondary structures) can also affect the migration, making nucleotide chains appear 
longer on the gel than they actually are.  
 For optimal separation based on the size of DNA or RNA used in this project, 
samples were analyzed using 1%, 1.5%, 2%, or 3% agarose gels. To prepare agarose gels, 
1, 1.5, 2, or 3 g agarose powder per 100 mL of gel was mixed and melted in 1xTAE buffer 
(Tris (40mM), Acetate (20mM) and EDTA (1mM; Life Technologies, 25200-056). The DNA 
or RNA samples were loaded into separate gel lanes together with Gel Loading Dye (6X) 
(NEB, N3200S) and run simultaneously with 1 kb Plus DNA Ladder (NEB, N3200S) at 100 





100 μL of 10% SDS solution or 10 mg (0.001 % final concentration) was added into the 
1xTAE buffer and gave the expected results. To visualize the polynucleotides in the gel, an 
appropriate amount of SYBR Safe dye (Invitrogen™ S33102) was used based on the gel 





2.5 Protein analysis experiments 
 
2.5.1 Preparation of protein samples for Western blotting 
 
Cell Lysis. Cells to be lysed for Western blotting were washed with phosphate-buffered 
saline (PBS; Sigma, P4417) twice or thrice after aspirating the media. For direct Western 
blotting assays, T-TBS lysis buffer [1% Triton X-100 in Tris-Buffered Saline (TBS) (50 mM 
Tris·HCl and 150 mM NaCl, pH 7.4–7.5) with the addition of protease inhibitors (10 μg/mL 
phenylmethylsulfonyl fluoride (PMSF), 2 μg/mL aprotinin, 2 μg/mL leupeptin and 1 
μg/mL pepstatin) or 40 μl/mL 25x cOmplete™ Protease Inhibitor Cocktail (Sigma, Cat.No: 
11836153001) prior to use] was used. Lysis buffer (400 μL for 60 mm plate, 250 μL for 
35 mm plate) was added directly onto cells and incubated for 10 mins on ice with rotation 
on a shaking platform. Then the cells were collected with a cell scraper and centrifuged at 
full speed (16000 g) at 4°C for 10 minutes to pellet cell debris in a benchtop 
microcentrifuge. After determining (only for some experiments) the protein 
concentrations, samples were boiled at 95°C for 5 minutes with addition of 5x Laemmli 
loading buffer (4% SDS, 20% glycerol, 0.004% bromophenol blue, 0.125M Tris-Cl, pH 6.8, 
10% 2-mercaptoethanol (added immediately before use)). Once the samples were ready, 
they were loaded onto a SDS-PAGE gel or stored at -20°C. 
Determination of protein concentration. Protein concentration was determined using 
the DC™ Protein Assay Kit (Bio-Rad, 5000111) following the manufacturer’s standard 
assay protocol. Five dilutions of BSA protein standard containing from 0.2 mg/ml to about 
1.5 mg/ml protein in PBS were prepared. Triplicate samples of 5 µl of standards and 
samples were pipetted into a 96-well plate. Then 25 µl of reagent A and S mixture (20 µl 





200 μL reagent B into each well. After 15 min of incubation, absorbances were measured 
at 750 nm on a SpectraMax® i3x Multi-Mode Microplate Reader (Molecular Devices) 
where the data was collected by SoftMax® Pro Software (Molecular Devices). 
 
 
2.5.2 Gel preparation for SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
  
Depending on the protein mass, 6% - 15% SDS-PAGE gels were used to separate proteins. 
In Table 2.4, reagents used for 8% separation gel and for 4% stacking gel are given as an 




Table 2.4. Preparation of 8% separation gel and 4% stacking gel. 
Separation Gel - 8%  10 mL  Stacking Gel - 4%  5 mL 
Reagents Volume  Reagents Volume 
H2O 4.7 ml  H2O 3 ml 
Tris–HCl (1.5 M, pH 8.8) 2.5 ml  Tris–HCl (0.5 M, pH 6.8) 1.25 ml 
SDS, 10% 100 µl  SDS, 10% 50 µl 
Acrylamide/bis (30% 1610156; 
Bio-Rad) 2.66 ml  
Acrylamide/bis (30% 1610156; Bio-Rad) 
665 µl 
Ammonium persulfate (APS), 10% 50 µl  Ammonium persulfate (APS), 10% 25 µl 
TEMED (Bio-Rad) 5 µl  TEMED (Bio-Rad) 5 µl 
 
 
After the separation gel solidified (as the gel polymerizes), the stacking gel (4%) was 
poured on top of the separation gel and a comb was added to make wells. The completely 
polymerized gels were used immediately or they were stored at 4°C wrapped in wet paper 









2.5.3 Western Blotting 
 
Protein samples (up to 50 μL) and 7 μl prestained protein marker (Precision Plus 
Protein™ Dual Color Standards, 1610374) were loaded into separate wells of the gel and 
run in a Hoefer Mini-Vertical system (Hoefer) applying 100-150 V across the SDS-PAGE 
gel. Then proteins were transferred from SDS-PAGE gel to polyvinylidene difluoride 
(PVDF) membrane by the semi-dry method. Briefly, 12 pieces of filter paper and PVDF 
membrane (7cm x 8cm) were cut, then, filter papers were soaked in transfer buffer (5x 
Transfer buffer (20% MeOH, 25mM Tris base, 129mM glycine) + 20ml MeOH + 60ml 
mqH2O) and PVDF membranes were activated firstly in MeOH and then in transfer buffer 
for 2- 4 minutes. When the running gel was finished, a stack of 6 filter papers + membrane 
+ gel + 6 filter papers, was prepared and put into the gel transfer equipment. The current 
was set to 0.8A/cm2 of gel surface (45mA for one 7x8 cm gel) and run for 2 hours.  
After the transfer step, membranes were incubated with 5% non-fat milk powder 
(Fonterra NZ) in TBS-T (1x TBS + 0.1% Tween 20 (Life Technologies, 85114)) for 1 hour 
to reduce background interference and increase signal-to-noise ratio through minimal 
non-specific binding of antibody. After the blocking step, the membranes were blotted 
with primary antibody solution (see Table 2.1 for conditions for each antibody). The 
membranes were washed three times with TBS-T for 10 min each and then incubated 
with secondary antibody conjugated with horseradish peroxidase (HRP) for 1 hour at 
room temperature, then washed as above. For chemiluminescent signal detection 
Amersham™ ECL™ Prime Western Blotting Detection Reagent was used and blots were 
imaged by either exposing the membranes to X-ray film in a dark room or in a Syngene 




2.5.4 Analysis of Western blot results 
 
Western blot images on X-ray films were scanned by densitometer and saved in the 
recommended 16 bit .tif image format while the images taken by the Syngene Imager were 
saved directly in the same format. The FiJi image processing software (the distribution 





detected on the Western blots. The procedure of blot analysis using FiJi is as follows: After 
opening an image, a profile plot representing the relative density of the contents of the 
rectangle over each lane was created by the Rectangular Selections tool from the FiJi 
toolbar. The Straight Line selection tool was used to enclose the peak thereby separating 
it from background noise. Once all of the peaks have been highlighted by Wand tool that 
sends the area measurements into the Results window, and the area measurements were 
converted to a percentage of total size of all of the highlighted peaks by the Label Peaks 
function (Analyze>Gels>Label Peaks).  
To calculate the relative density of the peaks, the percent values for each sample 
was divided by the percent value for the standard (usually base control for the 
experiment, mostly β-actin, but for some experiments, GAPDH). Then, relative densities 
of each sample were divided by the relative density of its own loading-control to obtain 




2.6 Cell culture 
 
2.6.1 Cell lines; identification and maintenance 
 
2.6.1.1 Fischer Rat Thyroid (FRT) cells 
 
Identification. Fischer Rat Thyroid (FRT) cells were derived from normal thyroid gland 
(Ambesi-Impiombato & Coon, 1979) of a Fischer rat, a strain (from Rattus norvegicus) that 
was originated by mating F344 rats purchased from a local breeder (Fischer) by M.R. 
Curtis (Columbia University, Institute for Cancer Research, 1920). FRT cells, although 
derived from normal thyroids, do not express thyroid functions in vitro and are adapted 
to an artificial in vitro environment (Ambesi-Impiombato & Coon, 1979). FRT cells form 
polarized epithelia with a high transepithelial resistance when grown on permeable filter 
supports. Although they don’t express endogenous ENaC (Snyder, 2000), they do express 





Lipofectamine 3000 reagent (Thermo Scientific, Cat. No: L3000008), making them a very 
useful tool to study any proteins (tagged- or non-tagged) including ENaC.          
Cell culture. In this project, all three FRT cell lines (FRT, FRT control knockdown (KD) 
and FRT COMMD10 KD) were maintained in Kaighn’s Modification F-12 media (Sigma 
Aldrich, New Zealand), supplemented with 10% (v/v) fetal bovine serum (FBS, Life 
Technologies, New Zealand), 1% (v/v) pen/strep (10 U/ml penicillin, and 100 μg/ml 
streptomycin (Life Technologies, NZ)). FRT control KD and FRT COMMD10 KD cell lines 
were kindly provided by Dr. Adam W. Ware (Ware et al., 2018). To maintain stable 
expression of short-hairpin RNA (shRNA) in FRT control and COMMD10 KD cell lines, the 
cells were treated with 2 µg/mL puromycin antibiotic after each passaging step, whereby 
only cells containing shRNA-encoding pLKOtrc plasmid packaged by lentivirus were 
selected.  
 FRT cells were passaged once they reached complete confluency. For that purpose, 
complete media was aspirated and cells were washed with prewarmed sterile PBS and 
then incubated with 1 mL trypsin-EDTA (0.25% Trypsin, 1mM EDTA) (Life Technologies, 
25200072). Upon dissociation of cells, 1 mL complete medium was added to the plate to 
neutralize the trypsin activity. Cell suspension was collected into an Eppendorf tube and 
then centrifuged for 4 mins at 300 g, in a benchtop centrifuge. Cells were resuspended in 
a prewarmed complete medium and seeded at a ratio of 1:6. 
Freezing. For freezing, FRT cells were resuspended in F-12 full media (F-12 Ham media 
+ 10% (v/v) FBS + 1% (v/v) Pen/Strep) + 10% (v/v) DMSO (dimethylsulfoxide) and 
placed in cryovials that were immediately placed in an isopropanol chamber and stored 
at –80°C overnight. Next day, the frozen cells were transferred into specific storage boxes 





2.6.1.2 Mouse cortical collecting duct clone 1 (mCCDcl1) cells 
 
Identification. Mouse cortical collecting duct clone 1 (mCCDcl1) cells were obtained from 





University of Lausanne) where the cell line was developed. This cell line derived from a 
single clone which was transformed spontaneously to a dividing cell line after 
microdissection of wild type mouse cortical collecting duct. The mCCDcl1 cell line is an 
immortal cell line, but they are not immortalized by any known cell immortalization 
systems like SV40, hTERT etc. and interestingly this cell line was called “immortalized” 
only in one paper (Assmus et al., 2017). Like cortical collecting duct, mCCDcl1 cell line 
also comprises two types of cells - principal cells and intercalated cells (α and β), and most 
importantly, the mCCDcl1 cell line exhibits almost all features of principal cells (Gaeggeler 
et al., 2005). Thus, mCCDcl1 cells:  
 are polarized into an epithelial monolayer when cultured on filter supports;  
 transport ions, predominantly sodium via endogenous ENaC down an electrogenic 
gradient established by the Na+-K+ ATPase, and transports potassium via apical 
(more precisely, secretes K+ via ROMK (Fodstad et al., 2009)) and basal (via Na+-
K+ ATPase and Kir4.1/Kir5.1 channels (Vinciguerra et al., 2005; Lachheb et al., 
2008)) potassium channels; 
 transport water predominantly through endogenous AQP2 in the apical 
membrane and AQP3 only at the basolateral side (Gaeggeler et al., 2011);  
 express vasopressin receptor type 2 (V2R) predominantly at the basal side (but 
precisely on the ratio of 87 : 13 basal and apical side, respectively) (Hasler et al., 
2008);  
 express a significant level of functionally active MR and GR, as well as 11β-
hydroxysteroid dehydrogenase type 2 (11β-HSD2) enzyme which metabolizes 
cortisol into cortisone (or corticosterone into 11β-dehydrocorticosterone) and 
which makes cortisol to bind MR and/or GR;                
 responds to physiological concentrations of aldosterone (K(1/2)= 0.3 nM) 
(Gaeggeler et al., 2005; Fodstad et al., 2009), arginine vasopressin (AVP) as low as 
1 pM (Gaeggeler et al., 2011) and insulin (20nM) (Gonzalez-Rodriguez et al., 2007) 
with an increased Na+ transport. 
 
These features makes the mCCDcl1 cell line a very useful tool for ENaC study. 
Cell culture. mCCDcl1 cells were cultured essentially as described previously (Gaeggeler 
et al., 2005; Mansley et al., 2015) and used between passages 28 and 36. Stocks were 





membrane filters for stimulation experiments (Corning, 3407) and electrophysiologic 
studies (Corning, 3801). Cells were routinely cultured in phenol-red free DMEM/ Ham’s 
F12 (Sigma, Cat № D2906-10L) medium supplemented with: 2% (v/v) FBS, 1% (v/v) 
100X Insulin-Transferrin-Selenium Supplement (concentration in g/L: Insulin 1.00, 
Transferrin 0.55, Sodium Selenite 0.00067; Gibco), 1% (v/v) penicillin-streptomycin 
(5000 U/mL; Life Technologies, NZ), 1% (v/v) 100X Glutamax (Gibco), triiodothyronine 
(T3; 1 nM), epidermal growth factor (EGF, 100 ng/mL) and dexamethasone (50 nM), until 
they were confluent. Medium was changed every second day and passaged as for FRT 
cells. For electrophysiological studies after two times feeding with growth medium, media 
was changed to “filter cup medium” (full media without EGF, FBS and less dexamethasone 
(3 nM)), but for specific drug treatments, cells were incubated in drug-free DMEM/ Ham’s 
F12 sterile medium for the last 24 hours (including treatment period). 
Freezing. Same protocol as for passaging was followed, however the cells were 
resuspended in cold FBS + 10% (v/v) DMSO. The homogeneous cell suspension aliquoted 
into cryogenic storage vials and followed the storage steps given in the section 2.6.1.1.        
 
2.6.1.3 U2OS cells 
 
Identification. The U2OS cell line, also known as the 2T cell line, was derived in 1964 
from tibia bone tissue of a fifteen-year-old human female suffering from osteosarcoma 
(Ponten & Saksela, 1967). U2OS cells exhibit epithelial adherent morphology and they are 
not immortalized cells. U2OS cells are positive for insulin-like growth factor I (IGF-I) and 
II (IGF II) receptors. These cells share many similar features to undifferentiated 
osteoprogenitors including a high proliferative capacity (Zhang et al., 2014) with a high 
invasion and migration potential (Lauvrak et al., 2013). Widened cell shape makes them 
an excellent tool for fluorescent microscopy experiments. 
Cell culture. U2OS cells were grown on 35 mm tissue culture treated plastic plates 
(Corning, Cat.No:430165) in DMEM medium (Life Technologies, NZ) supplemented with 
10% (v/v) FBS (Life Technologies, NZ), and 1% (v/v) penicillin–streptomycin (Life 
Technologies, NZ) in an incubator at 37 °C, humidified, with 5% CO2. The complete growth 






Freezing. U2OS cells were resuspended in cold DMEM full media + 10% (v/v) DMSO. The 
homogeneous cell suspension was aliquoted into cryogenic storage vials and followed the 
storage steps given in the section 2.6.1.1. 
 
 
2.6.2 Thawing the cell stocks 
 
To thaw cells of all cell lines kept in a -80˚C freezer or liquid nitrogen, pre-warmed 
complete growth medium appropriate for the cell line was added directly into cryovials 
in a laminar flow hood without placing them into a 37°C water bath. The cell suspension 
was transferred into a centrifuge tube containing 4 mL of pre-warmed complete growth 
medium and the procedure repeated if frozen cells remained in the cryovial. The cell 
suspension was centrifuged at approximately 300 × g for 3.5 minutes in a benchtop 
centrifuge. The supernatant was aspirated without disturbing the cell pellet. Cells were 
gently resuspended in complete growth medium, and transferred into the appropriate 




2.6.3 Transient transfection 
 
Transient transfection was performed under HSNO (Hazardous Substances and New 
Organisms) Act Approval APP201859 (development of new organisms), University of 
Otago.  
 
2.6.3.1 Lipofection - cationic lipid mediated transfection 
 
Lipofectamine is formulated with cationic lipids with positively charged head groups and 
neutral helper lipids, which results in a liposomal structure with a positive surface charge 
in water. Upon interacting with negatively charged nucleic acids, the cationic liposomes 
form clusters of aggregated vesicles. At a critical density, the nucleic acids are condensed 





the complex with the negatively charged cell membrane. This interaction mediates the 
delivery of the nucleic acids directly across the plasma membrane which helps to bypass 
the endosomal-lysosomal route (Simoes et al., 2005). 
 Lipofectamine® 3000 (Thermo Scientific, Cat. No: L3000008) in this project was 
used to transfect plasmids into FRT epithelia and siRNA into mCCDcl1 cells following the 
manufacturer’s instructions, although the latter did fail. Briefly, on the second day of 
seeding cells (when plates were 80-90% confluent), 3 μL (per 35 mm plate, Corning, 
Cat.No:430165) of Lipofectamine® 3000 and 1 μg DNA plus 2 μL of P3000 (or 20 pmol 
siRNA without P3000) was mixed with 100 μL of serum- and antibiotic-free medium in 
two separate tubes, then after 5 min of incubation, the Lipofectamine mixture was added 
onto the nucleic acid mixture, incubated for 15-20 min and added onto cells dropwise. 
Cells were incubated with this transfection mixture plus 2 mL of serum-free medium for 




2.6.3.2 Lipofection in suspension 
 
In highly differentiated cells, depleting cell polarity and tight junction (TJ) protein 
complexes (claudin-1 and occludin) by rinsing cells with trypsin before transfection was 
shown to increase transfection efficiency by ~3 times (Rybakovsky et al., 2019). It was 
hypothesized that transfection efficiency would be enhanced by depleting TJ proteins and 
making the side of the cells normally adhering to the cell culture plate available for 
transfection. By trypsinizing cells and transfecting them directly in this form in 
suspension resulted in improved transfection efficiency for mCCDcl1 cells. Lipofection in 
suspension (for adherent cells) also differs with transfection time from the classic 
lipofection, where the cells are transfected on the second day of their seeding.  
 Briefly, the Lipofectamine-nucleic acid mixture (without cells) was prepared as 
described in section 2.6.3.1. Cells were trypsinized, collected and gently resuspended 
directly in the Lipofectamine – nucleic acid mixture or cells were resuspended in 50 μL 
complete medium per transfection and then added into the Lipofectamine – nucleic acid 





nucleic acids to be transfected, at RT. The mixture was pipetted gently up and down every 
2.5 minutes to avoid the cells pelleting and then cells were transferred to plates 
containing the appropriate medium. This method was used to deliver siRNA and plasmids 
into mCCDcl1 cells. The sequence for mouse COMMD10 siRNA (Sigma) are as follows: “5-
CACUGCAGCAGCAACUAGA[dT][dT]-3” which was used at a concentration of 120 pM per 
3×105 cells. However, FRT cells were found to have less survival percentage by this 
method. After suspension transfection, mCCDcl1 cells were incubated in full growth 





2.7 Aldosterone stimulation assay  
 
For aldosterone stimulation experiments, mCCDcl1 cells were grown on permeable 
membrane filters (on 12 mm Snapwells for electrophysiological studies or on 24 mm 
Transwells for qPCR and Western blotting) to produce an epithelial monolayer with fully 
polarized epithelial features (Misfeldt et al., 1976; Cereijido et al., 1978; Wakabayashi et 
al., 2007) and incubated with growth medium (changing every second day to fresh 
medium) over a period of 5 days from seeding to experiment. On the fifth day of seeding, 
cells were incubated with filter cup medium, a medium similar to complete medium but 
containing only 3 nM dexamethasone and without EGF and FBS. Subsequently, on the next 
day, cells were incubated for a further 24 h in DMEM/Ham’s F12 medium referred to as 
‘stimulation medium’.  Towards the end of the 24-hour incubation, the ‘stimulation 
medium’ was supplemented with 300 nM aldosterone in DMSO or just DMSO (as vehicle 
control) for various time periods. After the drug-treatment periods, amiloride-sensitive 
ENaC current was measured as described in section 2.8.2.  
 Aldosterone was used from a 10 mM stock solution in 100% DMSO and diluted to 
the final 300 nM concentration in DMEM/F12 medium, based on the concentration used 
to investigate aldosterone stimulation of ENaC activity in other studies (Gaeggeler et al., 







2.8 Electrophysiological studies with FRT and mCCDcl1 epithelia 
 
 
2.8.1 Electrophysiological studies with FRT epithelia 
 
FRT cells were seeded at a density of 4x105 per Snapwell filters (0.4 μM pore size, 12 mm 
Snapwell, Corning® Costar, 3801) and grown in full media (F12+10% FBS + 1% 
pen/strep) at 37°C in a humidified atmosphere of 5% CO2. Next day when plates were 70-
90% confluent, the cells were transfected with plasmids encoding α-, β-, andϒENaC (0.2 
μg total). To measure amiloride-sensitive ENaC short circuit current (Isc-amiloride, or just 
Isc), the filters were mounted into an Ussing chamber 72 h after transfection. 1x Ringer’s 
solution (135 mM NaCl, 1.2 mM MgCl2, 4.2 mM K2HPO4, 0.6 mM KH2PO4, 10 mM HEPES, 
1.2 mM CaCl2 – pH 7.4) was added to each side of the epithelium in the chamber. Two 
voltage sensing electrodes and two current passing electrodes were inserted into the 
ports (on each side of the epithelium). Chambers were maintained at 37°C and bubbled 
continuously with 100% O2 which fixed the pH at 7.4 (Figure 2.2). The epithelia were 
clamped under short-circuit conditions and transepithelial resistance (Ω·cm2) was 
monitored by applying potential pulses (5 mV for 1 sec every 120 sec) across the 
epithelium (Hamilton, 2011) using a voltage-clamp (Physiologic Instruments, VCC MC8). 
 During current measurements with FRT control and COMMD10 KD epithelia, as 
the cells equilibrated in the Ringer’s solution, the current became constant for a period of 
1-2 minutes that was followed by adding 10 μM amiloride (final concentration) to the 
apical side of the epithelium, which causes a sudden decrease in the current. This is due 
to rapid blockage of the pore of all ENaC channels by amiloride (Kleyman & Cragoe, 1988). 
The Isc and transepithelial resistance were recorded using the Acquire and Analyse 2.3 
program (Physiologic Instruments). 
 For FRT epithelia, only experiments showing ≥ 300 Ω·cm2 transepithelial 
resistance were included in analyses. ENaC Isc in control KD epithelia was normalized to 
one and Isc for COMMD10 KD that was measured in the same experiment was compared 













FRT control and COMMD10 KD cells were transfected with plasmids encoding ENaC subunits and 72 hours 
post-transfection, the epithelia were mounted into the Ussing chamber and bathed with Ringer’s solution. 
The chamber was constantly bubbled with 100% O2. When Isc was constant, 10 μM amiloride was added to 





2.8.2 Electrophysiological studies with mCCDcl1 cells 
 
For all electrophysiological experiments, mCCDcl1 cells were subcultured onto 
permeable polystyrene Snapwells™ (12 mm) at a density of 3×l05 cells per Snapwell. Cells 
were kept on filters for 6 days in growth medium which was changed every second day, 
then filter cup medium, or a minimal medium that contained only DMEM and Ham's F12 
plus any treatment drug, was added for the last 24 hours. 
 Snapwell inserts were mounted into an Ussing chamber and set up as explained in 
section 2.8.1. The bathing solution – the Ringer’s solution (pH 7.4) consisted of 120 mM 
NaCl, 25 mM NaHCO3, 10 mM D-glucose, 3.3 mM KH2PO4, 0.8 mM K2HPO4, 1.2 mM MgCl2, 
and 1.2 mM CaCl2. 10 μM amiloride was added to the apical bath to determine ENaC-
mediated transepithelial short-circuit currents. Amiloride at this concentration is 





expected to inhibit ENaC activity by 95% in mCCDcl1 cells (Mansley et al., 2018). The 
remaining 5% of current is probably generated through non-ENaC mediated ion 
transports such as the sodium reabsorption that occurs through thiazide-sensitive 
transport in beta-intercalated cells (β-IC) (Assmus et al., 2017). A representative trace of 
ENaC Isc is provided in Figure 2.3, considering that mCCDcl1 epithelia would better reflect 
the Isc measurement procedure, producing endogenous and higher ENaC Isc than FRT 
epithelia. As a further confirmation of amiloride-sensitive current, after adding the 
amiloride, the chamber was washed and the ENaC Isc measurement was repeated. 
  With mCCDcl1 cells, ENaC cell surface activity in COMMD10 or VPS35 knockdown 
epithelia, and regulation of ENaC by aldosterone or extracellular calcium were studied. 
For mCCDcl1 epithelia no quality control was defined as transepithelial resistance in 
almost all experiments was higher than 300 Ω·cm2. In all experiments, Isc in control 
epithelia was normalized to one and Isc for others that were measured in the same 
experiment were compared to the normalized control. Statistical analysis was performed 
using GraphPad Prism v8.3.1.  
mCCDcl1 cells were grown on permeable polystyrene Snapwells™, 144 hours after passaging the cells, ENaC 
Isc was measured. Upon current stabilization, 10 μM amiloride was added in the apical Ringer’s solution. As 
the Isc stabilized at the lowest level upon amiloride blockage, recording was stopped in the software and 
the amiloride was washed out. Current recording was started again and after short recovery period of the 
current, another 10 μM of amiloride was added apically. 
Figure 2.3. A representative trace of ENaC Isc measured in an Ussing chamber with mCCDcl1 
epithelia. 
Isc recording stopped 





2.9 Cell surface biotinylation assay 
 
To quantify ENaC apical surface populations, a protein biotinylation protocol modified 
from a protocol published by Butterworth et al. (2005), (Butterworth et al., 2005a) was 
used. For this experiment, FRT epithelia with stable expression of control shRNA or 
COMMD10 shRNA were used. Cells (4×105) were cultured on 35 mm plates (Corning, 
Cat.No. 430165) in Kaighn’s Modification F-12 media (Sigma-Aldrich, New Zealand) 
supplemented with 10% FBS and 1% pen/strep. The following day, cells were transfected 
with 0.3 μg total plasmid DNA encoding each of α-ENaC, β-HA ENaC, and γ-ENaC (0.1 μg 
for each ENaC subunit). Next day, surface proteins were labelled with biotin (EZ-Link™ 
Sulfo-NHS-LC-Biotin) (Life Technologies, New Zealand, final conc. 1mg/mL) in borate 
buffer (85 mM NaCl, 4 mM KCl, 15 mM Na2B4O7) for 20 minutes with incubation on a 
rotating platform on ice. The Sulfo-NHS-LC-Biotin is water soluble and is an uncleavable 
reagent that reacts with lysine residues of only surface proteins on the whole cells 
because the negatively charged reagent does not permeate cell membranes. The non-
attached biotins were quenched using a quenching solution (PBS + 10% FBS) for one 
minute, then washed out with PBS. 
 Cells were lysed using biotinylation lysis buffer (50 mM EDTA, 10 mM Tris pH7.4, 
1% NP-40, 0.4% sodium deoxycholate, plus protease inhibitors) for 10 minutes with slow 
rotation on ice. To separate surface proteins bound to beads from the intracellular 
proteins, NeutrAvidin beads (Pierce™ NeutrAvidin™ UltraLink™ Resin Cat.No. 53150) 
were used. The beads were washed twice with cold PBS before use and added onto lysates 
(50-100 μL of bead suspension). After overnight incubation at 4°C on a rotating platform, 
the lysates were centrifuged at low speed (550 g) in a benchtop microcentrifuge. The 
pellet was washed four times with lysis buffer plus protease inhibitors after transferring 
the supernatant fractions into new tubes. Both fractions were boiled at 95˚C with addition 
of 5 x sample buffer and resolved by 8% SDS-PAGE. The samples were immunoblotted 
using anti-HA antibody (Sigma, Cat.No. H3663) at a 1:2500 dilution to detect β-HA ENaC. 
Western blotting procedures and analysis were performed as described in sections 2.5.3 
and 2.5.4 above. The density of bands representing cell surface ENaC in control KD cells 
was normalized to one and cell surface ENaC in COMMD10 KD was compared to the 
normalized control. Statistical analysis was performed using One-sample t-test on 





2.10 Endocytosis assay 
 
For ENaC endocytosis experiments, cell surface proteins were labeled as described in the 
cell surface biotinylation assay (section 2.9), and then a method for endocytosis and biotin 
reduction steps was developed from the literature (Gabriel et al., 2009; Gao et al., 2012; 
Cihil & Swiatecka-Urban, 2013). The method is based on labeling of cell surface ENaC, 
allowing them to be internalized, then separating and detecting biotin labelled-
internalized-ENaC on Neutravidin beads, leaving unlabeled cytosolic and surface ENaCs 
in the non-bound fraction (Figure 2.4).  
FRT cells, stably expressing control shRNA and COMMD10 shRNA were cultured 
on 60 mm plates (Corning, Cat.No. 430196) at a density of 5 × 105 in Kaighn’s Modification 
F-12 media (Sigma-Aldrich Cat.No.F6636), supplemented with 10% FBS and 1% 
pen/strep. On the second day after seeding, upon 70-80% confluency, cells were 
transfected with plasmids encoding α-, β-HA, and γENaC subunits (1 µg of each) using 
Lipofectamine 3000 as described in 2.6.3.1. After 48 hours, cells were incubated with 
cleavable biotin (EZ-link sulfo NHS-SS-biotin; Thermo Scientific Cat.No: 21331, final conc. 
1 mg/mL) for 30 min after which the unreacted biotins were removed with quenching 
buffer (1% BSA in PBS) for 1 min at 4°C. To allow surface proteins to be internalized, four 
groups of cells were incubated for 0, 2, 5, or 10 minutes at 37°C bathed with warm PBS++ 
(PBS supplemented with 1.5 mM MgCl2, 0.2 mM CaCl2, (pH 7.4)). 
After the incubation period, cells were washed six times for 15 min each in biotin 
stripping reagent L-glutathione (GSH) buffer (75 mM NaCl, 1 mM MgCl2, and 0.1 mM CaCl2, 
50 mM GSH, 80 mM NaOH, and 10% FBS) to release the biotin groups from labelled, but 
uninternalized proteins during the incubation periods. Initially to quench the excess 
glutathione, iodoacetamide buffer (50 mM iodoacetamide, 1% BSA in PBS) was used. 
However, due to its corrosive feature, the glutathione quenching step by iodoacetamide 
was excluded from the protocol. But despite the exclusion of iodoacetamide buffer, 
biotinylation of intracellular proteins was still sometimes observed, possibly due to the 
membrane fragility of FRT cells. Cells were lysed after washing three times with warm 
PBS++. Whole cell lysate (WCL) aliquots were then taken from each sample. The 
biotinylated and internalized proteins in the remaining lysates were bound by 
NeutrAvidin beads at 4°C overnight rotating. All steps from biotinylation to lysis were 


















FRT cells transiently expressing ENaC subunits were treated with biotin to label all cell surface proteins at 
4°C. Then, the cells were incubated for various time periods at 37°C to initiate internalization which was 
followed by reducing biotins from the non-internalized proteins. Cells were lysed and biotin-bound proteins 
including ENaC were precipitated with NeutrAvidin beads that was followed by Western blot experiment 
to quantify internalized ENaC at given time periods. 
 
To pellet the biotin-protein (including ENaC) complexes bound to beads, lysates 
were centrifuged at 550 g for 5 min in a benchtop microcentrifuge. The pellets were 
washed with biotinylation lysis buffer four times and 40 μL of sample buffer was added. 
The pellets and also WCLs were boiled at 95°C for 5 min to detach the beads from 
biotinylated proteins. Samples were separated by 10% SDS-PAGE gel and β-HA-ENaC 
detected by immunoblotting using anti-HA antibody (Sigma-Aldrich, Cat.No. H3663, at a 
1:2500 dilution). As a loading control for cytosolic ENaC, β-actin was immunoblotted 
using anti-β-actin antibody (Sigma-Aldrich A5441, at a 1:5000 dilution). Results were 










2.11 Recycling assay 
 
An ENaC recycling assay was developed according to the assays conducted by Klemens et 
al. (Klemens et al., 2017). The method is based on measuring of current produced by 
ENaCs delivered to the plasma membrane by cAMP stimulation. To measure current 
generated by ENaC channels recycled from intracellular pools, cells were treated with 5 
μM forskolin (Sigma, Cat. No: 93049) which stimulates the cAMP-regulated intracellular 
recycling pool. 
mCCDcl1 cells were transfected with mouse control siRNA or siRNA against 
COMMD10 in suspension and seeded on permeable 12 mm Snapwells as described in 
sections 2.6.3.2 and 2.6.1.2. After 120 hours, Snapwells were mounted into an Ussing 
chamber and the amiloride-sensitive current was measured as described in section 2.8.2. 
As the baseline current stabilized, the time was labelled on the plot in the software and 5 
μM forskolin was added to the basolateral side of the epithelia continuing to measure the 
Isc. At the peak of forskolin-stimulated current (which was achieved in 8-10 minutes and 
which was followed by a continuous current reduction), 10 μM amiloride was added 
apically.  
The labelled Isc value on the baseline current before forskolin addition was 
subtracted from the value at the peak of forskolin stimulated Isc. Isc in control KD epithelia 
was normalized to one and Isc for COMMD10 KD that was measured in the same 
experiment was compared to the normalized control. Statistical analysis was performed 




2.12 Fixed- and live-cell imaging  
 
2.12.1 Immunocytochemistry (ICC) 
 
mCCDcl1 cells were seeded on 13 mm coverslips placed in 35 mm plastic plates. The cells 
were grown in complete growth medium overnight. Next day, cells were fixed with 4% 
PFA in PBS for 20 min at RT. To permeabilize cells, the samples were incubated for 30 min 





incubated in blocking buffer (PBS, 0.05% Triton X-100 and 1% BSA) for 1 hour at RT, and 
then in primary antibody at 1:200 dilution overnight at 4°C. Samples were washed with 
PBS three times each for 5 minutes at RT. Incubation with secondary antibodies (Alexa 
Fluor - conjugated) was performed in blocking buffer at 1:500 dilutions, for 1 hour, at RT, 
in the dark, with gentle shaking which was followed with three washes with PBS each for 
5 minutes. 
 All procedures up to this step were performed in plastic plates. Then coverslips 
were transferred onto microscope slides labelled with the sample name. To mount the 
coverslips, VECTASHIELD® HardSet™ Mounting Medium with DAPI (Vector Laboratories) 
was used.  Firstly, a drop of mounting medium was added onto coverslips with a pipette 
and incubated for 15 min at RT, then incubated overnight at 4°C to harden.  
 To image the cells, a Nikon A1 Inverted Confocal Laser Microscope was used with 
60x magnification (60× PlanApo (oil immersion) objective) applying appropriate filters. 
The images were acquired by Nikon Elements AR and the data exported from Nikon 




2.12.2 Actin staining with a fluorescent phallotoxin 
 
To evaluate microfilament organization and intensity, F-actin was stained with a 
fluorescent phallotoxin – phalloidin (Life Technologies, A12379 or A34055). Phalloidin 
stock solution was prepared following the manufacturer’s instructions, at a concentration 
of 6.6 µM which is equivalent to approximately 200 units/mL.  
 FRT and U2OS cells were grown on 13 mm coverslips placed in 35 mm plastic 
plates overnight in complete media. The coverslips were washed twice with prewarmed 
phosphate-buffered saline, pH 7.4 (PBS) followed by fixation of the sample in 3.7% 
formaldehyde solution in PBS for 10 minutes at RT. After fixation, the cells were washed 
twice with PBS, permeabilized with 0.1% Triton X-100 in PBS for 3-5 min in petri the dish 
and then washed again twice with PBS. For blocking, the fixed cells were incubated with 
PBS + 1% BSA for 20–30 min. For staining of actin filaments, 5 µL of phallotoxin stock 
solution was diluted in 200 µL PBS per coverslip. The staining solution was placed on the 
coverslips directly in petri dishes, and incubated for 20 minutes at RT. To avoid 





the incubation. The samples were washed again twice with PBS. The mounting, image 
acquisition and data analysis was performed as described in section 2.12.1. 
 
 
2.12.3 Live-cell imaging and linear pixel analysis of endosomal localization 
 
To visualize COMMD10 protein on Rab5-, Rab7-, and Rab11-positive endosomes, Rab5a-
mCherry, Rab7-DsRed, or Rab11-DsRed and COMMD10-GFP plasmids were coexpressed 
in U2OS and FRT COMMD10 stable knockdown cells. Cells were grown and transfected as 
described in sections 2.6.1 and 2.6.3.1, respectively. To avoid overexpression-related 
COMMD10 protein aggregation, COMMD10 stable knockdown cells were used and also 
after less than 24 hours post-transfection, images of living cells were acquired using a 
Nikon A1R inverted confocal microscope equipped with 60× PlanApo (1.49 NA, oil 
immersion) objective or Olympus FV3000 microscope equipped with a temperature-, 
humidity-, and CO2 -controlled chamber and 60× or 100× objectives. Image acquisition 
with the Nikon A1R was performed at RT, while Olympus FV3000 microscope was 
performed at 37oC in an incubator, however, similar results were observed. Analyses 
were performed on endosomes with extended tubules observed mostly in time lapse 
movies to ensure the tubule-like structures were attached to endosomes rather than 
being another structure moving or passing around them. Lifetimes of tubules were 
calculated by manually tracking the tubules over time-lapse series.  
 Images were analyzed using FiJi software (https://imagej.net/Fiji) based on a 
previous report performing similar experiments (Puthenveedu et al., 2010). For 
estimating COMMD10 enrichment, a line was drawn along the endosome and tubule-like 
structure, and the Plot Profile function was used to measure pixel values. For obtaining 
the average value plot across multiple endosome-and-tubule-like structures, the length of 
these compartments was first standardized and then the linear pixels were normalized to 











2.14 Statistical analyses 
 
All statistical analysis was performed using GraphPad Prism v8.3.1. For the analysis of 
non-normalized paired data, a paired t-test method was used. For the analysis of paired 
but normalized data, where “control” was normalized to 1 and “treated” was compared to 
the normalized control, a one-sample t-test method was used. To compare a variable 
measured in three or more groups, one-way analysis of variance (ANOVA) or two-way 
ANOVA was used. The P values of the statistical tests were regarded as significant if 
P<0.05, P<0.01, P<0.001, or P<0.0001 and indicated as *, **, ***, or ****, respectively. 
Individual experiment numbers are indicated with “N” while biological replicates are 
indicated with “n”.  
 Most of the statistical data is described as mean of samples plus the standard 
deviation (SD), the degree to which individuals within the sample differ from the sample 
mean (Bondy & Zlot, 1976). However, for some results, to show how precisely the data 
defined the mean rather than showing the variability, sample means are described 
together with standard error of the mean (SEM), as this method was used in previous 
reports for describing how precisely the means of pixel distributions through endosomes 
overlap, (Puthenveedu et al., 2010; Vistein & Puthenveedu, 2013; Bowman et al., 2016). 
In addition, average current traces is also described with means plus SEM where no 





















3. What is the mechanism by which the 




















3.1 COMMD10 KD decreases apical surface population of ENaC in FRT 
cells  
 
The activity of ENaC in the apical membrane determines the extent of Na+ reabsorption 
across an epithelium. To downregulate Na+ transport, ENaC is removed from the apical 
membrane through internalization (Shimkets et al., 1997; Wang et al., 2006; Wiemuth et 
al., 2007) having an apical membrane half-life of 20-30 minutes in ENaC over-expressing 
cells (Alvarez de la Rosa et al., 2002; Hanwell et al., 2002). Internalized ENaC is delivered 
to early endosomes where ENaC destined for recycling back to the plasma membrane is 
sorted into a pathway distinct from proteins that are sent for lysosomal degradation. This 
occurs in both endogenously expressing CCD cells and in ENaC over-expressed cells 
(Rotin et al., 2001; Butterworth et al., 2005a). 
 Starokadomskyy and coworkers showed that COMMD10, like all the other COMMD 
family proteins, is part of the CCC complex that includes CCDC22 and CCDC93 
(Starokadomskyy et al., 2013) which together allow for CCC complex recruitment to 
endosomes (through interaction with FAM21 and the retromer complex) (Phillips-
Krawczak et al., 2015). Recently, it was also shown that the CCC complex is very important 
for the recruitment of another multiprotein complex, retriever, that functions in 
endosomal sorting like retromer (McNally et al., 2017). Many reports have showed 
evidence for various COMMDs regulating the trafficking of membrane proteins such as 
ATP7A, Na-K-2Cl cotransporter, CFTR, LDL-R, Notch signaling receptor etc. (Drevillon et 
al., 2011; Smith et al., 2013; Li et al., 2015; Phillips-Krawczak et al., 2015; Bartuzi et al., 
2016; McNally et al., 2017). All these data suggest that the CCC complex including 
COMMD10 plays a role in membrane protein trafficking. 
 Studies in the McDonald laboratory showed that overexpression (OE) of the 
COMMD1 protein downregulates ENaC surface expression possibly through the SGK1 – 
Nedd4-2 endocytic pathway (Ke et al., 2010). Further studies demonstrated that all of the 
COMMD family members interact with ENaC (Ke et al., 2010; Liu et al., 2013), and 
COMMD3 and -9’s ENaC regulation is similar to COMMD1 (Liu et al., 2013), while the 
knockdown (KD) of COMMD10 decreased ENaC current (Ware et al., 2018).  
  Based on the literature and these previous studies, we hypothesized that 
COMMD10 KD decreases the cell surface population of ENaC. To identify if the ENaC cell 





surface biotinylation assay was performed. Prior to starting this assay, the COMMD10 KD 
FRT cell line was tested to confirm that COMMD10 protein was decreased and that ENaC 





3.1.1 Confirmation of stable COMMD10 KD in FRT epithelia by Western blot 
 
FRT control KD and COMMD10 KD cell lines were provided by Dr. Adam Ware (Ware et 
al., 2018). The FRT cell lines stably express shRNA against non-target (control) and 
COMMD10 mRNA, respectively. The cells were grown and maintained as described in 
section 2.6.1.1. No difference was observed in the growth rate of these two cell lines. To 
confirm that the COMMD10 protein is still silenced by the shRNA in the FRT cells, a 
Western blot assay (see section 2.5) was performed. This assay was performed at several 
later time points in the PhD study to confirm COMMD10 KD for various experiments. The 
results showed that the COMMD10 protein level was silenced in a range from 100% 
knockdown to 53% knockdown with a mean value of 79% (1 for control KD vs 0.21±0.14 
for COMMD10 KD cell line, One-sample t-test, P<0.0001, N=3, n=7, from different assays 
and various samples) (Figure 3.1, A and B). The reason for such a variability could be the 





















A, Representative western blot for COMMD10. FRT control and COMMD10 knockdown cells lysates were 
analyzed on a 15% SDS-PAGE gel, and anti COMMD10 antibody and anti-β-actin antibody was used for 
detecting. B, Pooled results from quantification of Western blots by densitometry and normalization to actin 





3.1.2 COMMD10 KD reduces ENaC ISC in FRT epithelia 
 
Based on the preliminary results, to confirm if ENaC current in COMMD10 KD epithelia is 
still decreased, electrophysiological studies were performed with ENaC-transfected FRT 
control and COMMD10 KD epithelia.  
 Briefly, FRT cells were seeded onto Snapwell filters. Next day, the cells were 
transfected with plasmids encoding αβγ-ENaC (0.2 μg total) as described in section 
2.6.3.1. Although FRT epithelia don’t express ENaC endogenously (Snyder et al., 2000), 
after transfection with plasmids encoding α-, β-, and γENaC, a robust amiloride-sensitive 
current could be measured. ENaC Isc was measured in Ussing chamber experiments (72 
h after transfection) as described in section 2.8.1. ENaC Isc in FRT control KD epithelia 
was measured around 0.2 – 0.7 μA/cm2 (0.56 ± 0.15 μA/cm2, N=5) which is consistent 
with previous studies (Ware et al., 2018; Cheung & Hamilton, paper in revision) and 









Isc in control KD epithelia was normalized to one and Isc for COMMD10 KD was compared 
to the normalized control. The results showed that the ENaC Isc was significantly reduced 
in FRT COMMD10 KD epithelia compared to control KD epithelia (1 for control KD vs 
0.43±0.19 for COMMD10 KD epithelia, One-sample t-test, **P<0.01; N = 5, Figure 3.2 A and 
B) consistent with previous results reported in (Ware et al., 2018). The ISC difference 




A, Representative current tracings for Isc in FRT control and COMMD10 KD (C10 KD) epithelia.  B, Pooled 
current measurements. ENaC Isc in FRT control KD epithelia was normalized to 1 and the ENaC Isc in 
COMMD10 KD epithelia was compared to the normalized control. One-sample t-test, **P<0.01, mean ± SD; 




3.1.3 COMMD10 KD reduces ENaC cell surface population in FRT epithelia  
 
The ENaC Isc measurement results confirmed that the cell surface activity of ENaC is 
reduced with COMMD10 KD, however it is not known whether this reduction is due to 
diminished channel number at the cell surface or decreased channel open probability (Po). 
Quantification of ENaC at the cell surface was performed to test the hypothesis that 
knockdown of COMMD10 resulted in a change in ENaC levels at the cell surface. 
 To quantify ENaC apical surface population, cell surface protein biotinylation 
assays were performed as described in section 2.9. Thus FRT control and COMMD10 KD 
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cells were transfected with 0.3 μg ENaC (0.1 μg from each of α-ENaC, β-HA ENaC, and γ-
ENaC subunit) encoding plasmids. Twenty-four hours after transfection the cell surface 
proteins were biotinylated and the non-attached biotins were removed with PBS plus 
10% FBS. 
 Cells were lysed using biotinylation lysis buffer and biotinylated proteins including 
surface ENaC were bound to NeutrAvidinTM beads.  To separate surface proteins bound to 
beads from the intracellular proteins, lysates were centrifuged at low speed to produce 
two fractions: a cell surface protein and a cytosolic protein fraction. Proteins from both 
fractions were resolved by 8% SDS-PAGE, proteins were transferred onto membrane by 
western blotting and β-HA-ENaC was detected using anti-HA antibody.  
 Western blot analysis of cell surface β-ENaC supported the hypothesis that 
COMMD10 KD decreased ENaC population at the cell surface as quantification showed 
significantly less ENaC at the cell surface in COMMD10 KD cells compared with the surface 
β-ENaC in control KD cells (Figure 3.3 A). If KD of COMMD10 disrupts ENaC recycling, it 
was expected rate of ENaC recycling would be decreased thus reducing ENaC cell surface 
population. Figure 3.3 A, B shows there was not a significant decrease in the cytosolic 
ENaC with COMMD10 KD. Cell surface and cytosolic β-ENaC of control KD cells were 
normalized to 1 and cell surface and cytosolic β-ENaC of COMMD10 KD cells were 
compared to the normalized control, respectively. The general results from all 
experiments can be seen more clearly in relative β-ENaC levels in control and COMMD10 
KD cells (Figure 3.3 B), thus, COMMD10 KD reduced cell surface ENaC 32% significantly 
(1 for control cells vs 0.68 ± 0.15 for C10 KD cells, One-sample t-test, *P˂0.05, means ± 
SD; N=4.).  
 There is evidence in the literature showing other plasma membrane proteins 
accumulate on endosomes if recycling is impaired (Liu et al., 2012a; Liu & Grant, 2015; 
Norris et al., 2017; Singla et al., 2019). Therefore, in this study, ENaC cell surface levels 
may be lower because ENaC is trapped in endosomal compartments due to insufficient 








A, Representative western blots of cell surface and cytosolic β-ENaC from FRT control and COMMD10 KD 
cells. B, Pooled results showing β-ENaC fold change in cell surface and cytosolic COMMD10 KD cells relative 
to control KD cells. COMMD10 KD reduced cell surface population of ENaC in FRT COMMD10 KD cells 
compared to control KD cells while cytosolic ENaC was not changed. One-sample t-test (separately for 
surface and cytosolic ENaC pairs), *P˂0.05, means ± SD; N=4. 
 
 Based on these results, it was hypothesized that cell surface ENaC population 
should be regulated by COMMD10 in many cell types including endogenous ENaC 
expressing cells, as the CCC complex is known to be a common complex in endosomal 
sorting for many membrane proteins (Bartuzi et al., 2016; McNally et al., 2017; 




3.2 Transient knockdown of COMMD10 decreases endogenous ENaC Isc 
in mCCD epithelia 
 
ENaC has been convincingly shown to traffic through the endosomal pathway both in 
endogenously expressing CCD cells and in ENaC over-expressed MDCK cells (Rotin et al., 
2001; Butterworth et al., 2007). It is thought that internalized ENaCs are sorted on 
endosomes through a retromer-mediated process. It was reported that CCC complex 
components (including COMMD10) colocalize with retromer in the early endosome 
(Phillips-Krawczak et al., 2015). The results shown in Figure 3.2 and 3.3 suggest that 
stable COMMD10 KD (plasmid expressing shRNA) reduces ENaC current in ENaC 
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transfected FRT cells by decreasing ENaC population at the cell surface. Similar results 
have been found for transient KD of CCDC22 (Cheung et.al., paper in revision). 
 In the first step to studying the effect of transient KD of COMMD10 on endogenous 
ENaC current in mCCD epithelia it was hypothesized that transient COMMD10 
knockdown reduces ENaC Isc. To test this hypothesis, COMMD10 was transiently knocked 




3.2.1 Confirmation of transient COMMD10 KD in mCCD cells 
 
Previous studies have shown a short half-life (23.5 mins) for COMMD10 protein based on 
results from a cycloheximide-based protein chase assay ((Ware, 2017), PhD thesis). This 
suggests that silencing COMMD10 transiently using siRNA should achieve sufficient KD 
since silencing resulting from mouse COMMD10 siRNA can be assessed as early as 24 
hours post transfection and should last 5-7 days after transfection according to the 
manufacturer’s data (Sigma). Delivery of mouse COMMD10 siRNA oligonucleotides into 
mCCDcl1 cells, that endogenously expresses COMMD10 protein (see Figure 3.4 A), was 
performed by lipofection as described in section 2.6.3.1 and as recommended by the 
manufacturer. Western blot analysis was used to assess the success of COMMD10 KD, 
however results were inconsistent probably because this cell line is more difficult to 
transfect. Optimization of COMMD10 knockdown was carried out by changing the 
concentration of siRNA (40, 80 and 100 pM) and increasing the post transfection time by 
lysing the cells on the 3rd, 4th, and 5th day after transfection. 
A new COMMD10 siRNA was purchased from a different company (Dharmacon; 
the sequences have not been provided by the company), but western blot analysis again 
showed a failure of this siRNA to knockdown COMMD10 protein level. 
Attempts were made to optimize transfection of both siRNAs into the mCCD cells 
including: use of different transfection media (sterile medium, antibiotic-free complete 
medium, complete media), calcium phosphate mediated transfection, electroporation and 
a reverse transfection method but consistent knockdown was not achieved. In parallel, 
siRNA against VPS35 was used as a positive control, and the VPS35 protein level also was 





At this point in the PhD, several months were dedicated to designing and then 
testing a CRISPR-Cas9-mediated system to knockout COMMD10, VPS35, VPS35L and 
clathrin light chain (Clta) in mCCD cells. Further, multiple attempts were made to achieve 
knockout of these genes, however this approach was not successful. The methodology and 
results from these experiments are presented in detail in appendix A. 
 Successful transfection of plasmids into mCCD cells in suspension (as described in 
section 2.6.3.2) was achieved in later experiments (section 5.4.4). Then this method was 
used for siRNA transfection. The Western blot analysis showed consistent KD of 
COMMD10 (Figure 3.4 A). Densitometry analysis of the Western blot results showed a 
significant 45% average decrease in COMMD10 protein level.  COMMD10 protein level in 
control KD cells was normalized to 1 and COMMD10 in COMMD10 KD cells was compared 
to the normalized control (1 for control KD, 0.55 ± 0.12 for COMMD10 KD cells, One-
sample t-test, ****P<0.0001; N=4, n=8.) which was sufficient for the next experiments 
(Figure 3.4 B).  
 
mCCD cells were transfected with either control siRNA or COMMD10 siRNA in suspension and grown for 
electrophysiological studies. 120-hours post-transfection, the epithelia were used in Ussing assay following 
which they were immediately lysed and analyzed by western blot with anti-COMMD10. A, Representative 
western blots of four individual experiments reflecting COMMD10 protein levels in siControl and 
siCOMMD10 transfected cells. B, Pooled results showing COMMD10 fold change in COMMD10 KD cells 
relative to control KD cells. COMMD10 protein level in control KD cells was normalized to 1 and that in 
COMMD10 KD cells was compared to the normalized control. One-sample t-test, ****P<0.0001, mean ± SD; 












3.2.2 Endogenous ENaC Isc was reduced by silencing COMMD10 protein level 
 
mCCDcl1 cells were transiently transfected in suspension with siControl or siCOMMD10 
as described in section 2.6.3.2 and directly seeded into 12 mm Snapwells. The epithelia 
were maintained for electrophysiological studies as described in section 2.8.2. However, 
to ensure a sufficient population of siRNAs was present, the current was measured after 
120 h instead of 168 h. Considering that Ussing chamber settings may influence the 
results, every Control-COMMD10 KD pair of plates that the current was measured with 
on the same day were mounted, set, or referenced to the Ussing chamber settings 
separately. The cells were lysed immediately after Ussing experiment to identify 
COMMD10 protein level to allow alignment of COMMD10 protein level with the 
COMMD10 KD - ENaC Isc proportional change.   
 In electrophysiological studies, non-treated or non-transfected mCCDcl1 epithelia 
showed a baseline ENaC Isc of approximately 25.4 ± 11.7 μA/cm2 with a transepithelial 
resistance of approximately 513 ± 201 Ω·cm2 (n = 31) which is not consistent with the 
previous reports providing approximately 5-10 μA/cm2 baseline ENaC Isc and a 
resistance of 2000 - 5000 Ω/cm2 for mCCDcl1 epithelia (Gaeggeler et al., 2005; Gonzalez-
Rodriguez et al., 2007; Gaeggeler et al., 2011; Mansley et al., 2015; Mansley et al., 2018). 
But this could be due to the different materials used for these experiments by others. For 
example, in these experiments, cells were seeded onto polystyrene Snapwells and the 
epithelia were bathed in Ringer’s solution while in some of the reports collagen-coated or 
polycarbonate Transwells were used to obtain high transepithelial resistance (Gaeggeler 
et al., 2005). 
 For each epithelium mounted in the Ussing apparatus current measurement was 
initiated and when the current stabilized amiloride was added to the apical solution to 
inhibit Na+ transport through ENaC. The current decrease upon amiloride addition from 
the flatlined point to the farthest decrease was taken as the basal current. Representative 
current traces for siControl and siCOMMD10 transfected epithelia are shown in Figure 3.5 
A. Mean basal current for control and COMMD10 KD epithelia from 7 individual 
experiments and 11 samples is given in Figure 3.5 C. Analysis of results for mCCD epithelia 
with control or COMMD10 KD showed up to a ~26% reduction in Isc with COMMD10 KD 
(1 for control KD and 0.74 ± 0.25 for COMMD10 KD epithelia; One-sample t-test; **P<0.01 





mean resistance was also reduced in COMMD10 KD epithelia (480 ± 130 for control KD 
and 340 ± 80 for COMMD10 KD epithelia; Paired t test, *P<0.05, mean ± SD. N=7, n=11) 
and upon amiloride addition, the resistance was increased, probably due to the blockage 













A, A graph showing mean Isc data series over the last 20 minutes acquired from Ussing experiment. n = 8.  
B, A graph showing mean resistance data series over the last 20 minutes acquired from Ussing experiments. 
n = 8.  C, Pooled ENaC Isc results showing significant reduction in COMMD10 KD epithelia. Isc in control KD 
epithelia was normalized to 1 and that in COMMD10 KD epithelia was compared to the normalized control. 
One-sample t-test, **P<0.01, mean ± SD relative to Isc in control KD epithelia. N=7, n=11. D, Pooled 
transepithelial resistance (Rt) results showing significantly reduced Rt in COMMD10 KD epithelia. Paired t-




Figure 3. 5. COMMD10 KD reduces endogenous ENaC Isc. 
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The slight increase in resistance upon amiloride addition reveals that “open ENaCs” do 
not play a big role in the epithelial resistance (Figure 3.5 B) while the average reduction 
in resistance in COMMD10 KD suggests that by COMMD10 KD, like ENaC, many other cell 
surface proteins including tight junction proteins contributing to resistance were also 
downregulated (as recycling of TJ proteins were linked with Rab5, Rab4, and Rab11, as 
well as Rab7-positive endosomes (Stamatovic et al., 2017)). 
 Reduction in endogenous ENaC Isc in mCCD COMMD10 KD epithelia once more 
confirms that COMMD10 plays a crucial role in cell surface activity of ENaC. Although 
these results together with results from quantification of cell surface channels show that 
COMMD10 regulates cell surface population of ENaC rather than its open probability, 
however, it is still not clear by what mechanism COMMD10 contributes to the steady state 
level of ENaC.  
 Other studies in the McDonald laboratory that shed light on role of COMMD10, 
revealed that COMMD10 KD increases the endocytosis of TfR and delays the recycling of 
the transferrin-TfR complex in FRT cells (Ware et al., 2018). Therefore, it was 
hypothesized that COMMD10 can regulate ENaC cell surface population similarly through 



















3.3 Determining the knockdown effect of COMMD10 on ENaC 
endocytosis and recycling 
 
To downregulate Na+ reabsorption in the kidney, ENaC is removed from the apical 
membrane of CCD cells through mainly Nedd4-2-dependent internalization (Shimkets et 
al., 1997; Wang et al., 2006; Wiemuth et al., 2007) having an apical membrane half-life of 
around 20-30 minutes (Alvarez de la Rosa et al., 2002; Hanwell et al., 2002). Internalized 
ENaC destined for recycling back to the plasma membrane are sorted from those that are 
sent for lysosomal degradation in early endosomes both in endogenously expressing CCD 
cells and in ENaC over-expressed cells (Rotin et al., 2001; Butterworth et al., 2005a).  
 Endosomal sorting of cargos is mediated by retromer and retriever complexes and 
both of these complexes were shown to function in concert with the CCC complex, to 
which the COMMD family proteins belong (Harbour et al., 2012; Phillips-Krawczak et al., 
2015; Bartuzi et al., 2016; McNally et al., 2017). Although, the transferrin receptor (TfR) 
is the best known constitutively recycled receptor and only its 24.4% was found in 
actin/sorting nexin/retromer or retriever tubular (ASRT) endosomal microdomains 
(Puthenveedu et al., 2010), studies showed that COMMD10 KD increases the endocytosis 
of TfR and delays the recycling of the transferrin-transferrin receptor complex (Ware et 
al., 2018). However, there is also evidence that silencing COMMD proteins reduce the 
recycling of plasma membrane proteins such as ATP7A, Na-K-2Cl cotransporter, CFTR, 
LDL-R, Notch signaling receptor (Drevillon et al., 2011; Smith et al., 2013; Li et al., 2015; 
Phillips-Krawczak et al., 2015; Bartuzi et al., 2016), suggesting that COMMD10 KD can also 
downregulate ENaC activity through increasing its endocytosis and/or delaying its 
recycling. Furthermore, previous results showed that ENaC current was reduced in 
COMMD10 KD FRT and mCCD epithelia (section 3.1.2 and 3.2.2.) and this is a result of a 
decrease in cell surface ENaC population (section 3.1.3). To identify if the decrease of 
ENaC cell surface population is the result of accelerated internalization or delayed 









3.3.1 Knockdown effect of COMMD10 on ENaC endocytosis 
 
3.3.1.1 Less ENaC is internalized and more intracellular ENaC is accumulated in 
COMMD10 KD cells 
  
ENaC endocytosis assays were performed as described in section 2.11. Briefly, FRT cells 
stably expressing control shRNA and COMMD10 shRNA were transfected with plasmids 
encoding α-, β-HA, and γENaC subunits. The cells were treated with cleavable biotin 48 
hours post transfection and to allow the labelled proteins to be internalized, cells were 
then incubated for 0, 2, 5, or 10 minutes at 37°C bathed with warm PBS++. After each 
incubation period, cells were washed six times in biotin stripping reagent GSH buffer to 
release the biotin groups from labelled, but uninternalized proteins. Cells were lysed, 
whole cell lysates (WCL) were taken from each sample and then biotinylated proteins 
bound to Neutravidin beads were pelleted by centrifugation. Proteins in the washed 
pellets and whole cell lysates were separated by 8% SDS-PAGE, and β-HA ENaC was 
visualized by Western blot assay using anti-HA antibody (Figure 3.6 A). All surface, 
internalized and whole cell lysate ENaC bands were normalized to β-actin bands of the 
appropriate whole cell lysate visualized using anti- β-actin antibody. 
 Cell surface ENaC levels in non-reduced control cells was normalized to 1 while all 
the other cell surface and internalized ENaC samples, were expressed as the percent of 
that normalized control (first bar in the Figure 3.6 B). Statistical analysis was conducted 
using the GraphPad Prism. Two-way ANOVA (applying Fisher's LSD test) were used to 
compare and demonstrate any difference between control and COMMD10 KD surface and 
internalization at each time point. The P values of the statistical tests were recorded and 
regarded as significant if *P˂0.05 and **P˂0.01, (means ± SD, N=4). 
 Western blot analysis showed that cell surface ENaC level in biotinylated but not-
reduced COMMD10 KD cells was significantly less than in control cells (1.00 for control 
vs 0.61±0.27 for COMMD10 KD cells, **P<0.01; first pair of bars in the Figure 3.6 B) 
consistent with the cell surface biotinylation results (3.1.3) that was previously reported 
(Ware et al., 2018). Evaluation of the cell surface ENaC levels served as cell surface control 





western blot image of four individual experiments, cell surface and internalized ENaC, 
WCL ENaC, β-actin and COMMD10 protein levels were demonstrated (Figure 3.6 A).  
 At the 0 min time point (that served as a control for L-glutathione-mediated biotin 
reduction), the efficiency of biotin reducing by L-glutathione was around 10% in control 
KD cells, which was expected and acceptable (3rd bar in Figure 3.6 B)(Cihil & Swiatecka-
Urban, 2013). However, in two of four experiments, in COMMD10 KD cells, large blots of 
β-HA ENaC (4th bar in Figure 3.6 B), simultaneously with large blots β-actin were 
observed, probably due to the plasma membrane being damaged in FRT cells 
(representative blots are provided in Appendix F). 
 At the 2 min time point, COMMD10 KD shows significantly delayed ENaC 
endocytosis significantly (0.35±0.24 for control vs 0.08±0.07 for COMMD10 KD epithelia, 
*P<0.05; 3rd pair of bars in Figure 3.6 B). Less internalized ENaC in COMMD10 KD cells 
after 2 min incubation may be the result of a decreased surface population in COMMD10 
KD. 
 At 5 min, the difference in mean endocytosis rates of ENaC in control and 
COMMD10 KD cells became smaller demonstrating no significant difference (0.26±0.20 
for control vs 0.13±0.09 for COMMD10 KD cells, 4th pair of bars in Figure 3.6 B) which is 
consistent with previous transferrin uptake results (Ware et al., 2018).  
 Interestingly, at the 10 min time point, the internalized ENaC level in COMMD10 
KD cells was significantly increased (0.12±0.11 for control vs 0.44±0.23 for COMMD10 KD 
cells, *P<0.05; 5th pair of bars in Figure 3.6 B). It is possible that this represents 
intracellular ENaC accumulation in the COMMD10 KD cells. Non-biotinylated cells were 
taken as a negative control (last pair of bars in Figure 3.6 B) for biotinylation. 
  To demonstrate better the internalized ENaC levels proportional to the surface 
ENaC levels, the surface ENaC levels of both of non-reduced control and COMMD10 KD 
cells were normalized to 1 and the internalized ENaC levels of each time point was 
compared to the normalized control or COMMD10 KD surface levels, respectively. Then a 
two-way ANOVA was performed (applying Fisher's LSD test) (Figure 3.6 C). Figure 3.6 C 
provides a better view of how the internalized ENaC levels in control KD cells gradually 
decreased while in COMMD10 cells internalized ENaC levels increased (control vs 
COMMD10 KD cells: Non-red, 1.00 ±0.0 vs 1.00±0.0; at the 2 min, 0.35±0.24 vs 0.12±0.10 
(*P<0.05); at 5 the min, 0.26±0.20 vs 0.29±0.27; at the 10 min, 0.12±0.11 vs 0.74±0.19 





inside the COMMD10 KD cells and thereby escapes reduction at the cell surface because 
recycling is impaired. 
FRT control and COMMD10 KD cells were transfected with plasmids encoding α-,β-HA, and γ-ENaC 
subunits, biotinylated with cleavable biotins, incubated for 0, 2, 5, and 10 minutes at 37°C to start 
endocytosis. After the incubation step, biotin on the cell surface were reduced with L-glutathione, lysed, 
then ENaC was precipitated with NeutrAvidin beads. A, Representative western blots using anti-HA and 
anti-β-actin. The upper panel shows cell surface and internalized β-HA ENaC while the bands below are 
from whole cell lysates (WCL). B, Relative endocytosis. ENaC internalization in COMMD10 KD cells was 
significantly delayed after 2 min, not changed after 5 min but increased significantly after 10 min. β-HA 
ENaC cell surface level in non-reduced control cells was normalized to 1. Then cell surface level of ENaC in 
COMMD10 KD cells and internalized ENaC values of each time point were normalized to that of non-reduced 
control cells. C, Internalized ENaC levels proportional to the cell surface ENaC levels, where the surface 
ENaC levels of both of non-reduced control and COMMD10 KD cells were normalized to 1 and the 
internalized ENaC levels of each time point was compared to the normalized control or COMMD10 KD 
surface levels, respectively. D, Whole cell lysate ENaC levels that showed no significant changes in 
COMMD10 KD cells compared to that of control KD cells as expected. Non-Red—non-reduced, Non-Biot —
non-biotinylated.  Data shown as mean ± SD relative to normalized ENaC surface level of control KD 
epithelia. Two-way ANOVA (Mult. comp.-Fisher's LSD test). N=4. *P˂0.05, **P˂0.01 
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 ENaC levels in whole cell lysate were normalized and compared by the same way 
as the surface and internalized ENaC levels. Thus, whole cell lysate ENaC level of non-
reduced control KD cells (first bar in the Figure 3.6 D) was normalized to 1 and whole cell 
lysate ENaC levels of all control and COMMD10 KD cells at each time point compared to 
the normalized control. There are no significant changes in whole cell lysate ENaC levels 
consistent with cell surface biotinylation assay results (section 3.1.3). 
 It is possible that COMMD10 KD delays ENaC endocytosis over a 2 min time course, 
but increases endocytosis over 10 min. However, it is more likely that COMMD10 KD 
delays recycling of ENaC after internalization, resulting in an increase of biotin-bound 
ENaC in endosomes and thereby in a decrease in cell surface population of the channel. 





3.3.2 Knockdown effect of COMMD10 on ENaC recycling 
 
It is well established that Na+ absorption through ENaC is stimulated by cAMP/PKA 
activation (Garty & Palmer, 1997; Morris & Schafer, 2002; Snyder et al., 2004; 
Butterworth et al., 2005a). It was also shown that constitutive ENaC recycling is distinct 
from the regulated ENaC recycling (Butterworth et al., 2005a; Butterworth et al., 2009; 
Butterworth et al., 2012; Edinger et al., 2012; Klemens et al., 2017). The regulated 
recycling differs from constitutive recycling by sorting cargos depending on their tail 
sequences (therefore called sequence-dependent sorting) and by being regulated by 
extracellular signals through cAMP/PKA axis (Cao et al., 1999; Hanyaloglu et al., 2005; 
Millman et al., 2008). For GPCRs such as β2AR, precise investigations showed that cAMP-
mediated phosphorylation of β2AR on its cytoplasmic tail, restricts the β2AR to spatially 
defined PDZ- and actin-dependent endosomal microdomains and that such a flexible 
switch allows cells to modulate responses rapidly to extracellular signaling (Vistein & 
Puthenveedu, 2013; Bowman et al., 2016). Butterworth et al.  showed that newly 
synthesized ENaC is not essential for the forskolin (FSK) response but, as expected, 
depolymerization of F-actin stimulated by LatA before FSK stimulation diminished the 





indicate the result of diminished actin-stabilization of recycling tubules on endosomal 
ASRT domains. 
 However, these previous investigations have not answered the question of 
whether cAMP stimulation induces only the translocation of subapical or perinuclear 
vesicles carrying membrane proteins to the PM, or whether cAMP induces the sequence-
dependent sorting of these proteins on endosomal tubules, or both. In the case of ENaC, 
does cAMP stimulation restrict ENaC to ASRT domains as it does for β2AR? Forskolin is a 
substance that stimulates the synthesis of cAMP by the enzyme adenylyl cyclase (AC) 
(Pfeuffer & Pfeuffer, 1989; Sievert et al., 2002) which activates PKA also known as cAMP-
dependent protein kinase. However, as the exact mechanism of AQP2 channel insertion 
into the apical membrane by vasopressin through the cAMP pathway is not fully 
understood, it is not known for other cAMP-mediated cargos as well, including the well-
studied β2AR. The putative PKA sites on ENaC are thought to be unlikely to contribute to 
the effect of FSK, which is in agreement with the absence of convincing evidence in the 
literature for direct PKA-mediated ENaC phosphorylation (Yang et al., 2006). Recently it 
was shown that phosphorylation at -5 (also -6), -3 upstream PDZbm promotes interaction 
of cargos with SNX27 whereas phosphorylation of Ser (-2) abolished this interaction 
(Clairfeuille et al., 2016). This suggests the G protein-coupled receptor kinase 2 (Grk2), an 
upregulator of ENaC activity through phosphorylating the C-terminal domain of β-ENaC 
at Ser-633(Dinudom et al., 2004) cannot involve SNX27-mediated ENaC upregulation 
(Dinudom et al., 2004).  
 In a recent investigation, Xie and coworkers showed that sorting occurs only in 
early/sorting endosomes and the cargo remains segregated in the ERC (Xie et al., 2016). 
This suggests that, either the cAMP directly induces ENaC sorting or translocation from 
the intracellular pool (if not from the EE, then from the ERC) to the apical membrane or 
both. In addition, the level of cAMP-mediated delivery of membrane proteins including 
ENaC will depend on the sequence-dependent sorting on ASRT domains that is also the 
focus of this study. As the CCC complex is a crucial part of sequence-dependent sorting 
(Harbour et al., 2012; Phillips-Krawczak et al., 2015; Bartuzi et al., 2016; McNally et al., 
2017), depletion of its subunit COMMD10 is predicted to affect cAMP-mediated recycling.
 Furthermore, the ENaC endocytosis assay showed that, after internalization, more 
ENaC was accumulated intracellularly in COMMD10 KD cells compared to control KD cells 
(Figure 3.6 B), suggesting that recycling of ENaC is impaired with COMMD10 KD, and 





reveal this. Given this, electrophysiological studies were performed with COMMD10 KD 
epithelia under FSK stimulation.  
 
 
3.3.2.1 COMMD10 KD reduces endogenous cAMP-induced ENaC recycling 
 
To assess the cAMP-mediated delivery of ENaC to PM in COMMD10 KD epithelia 
compared to control KD epithelia, ENaC Isc was measured in mCCD epithelia with FSK 
stimulation. mCCDcl1 cells were transiently transfected with siControl or siCOMMD10 as 
described in section 2.6.3.2 and the current was measured after 120 h as described in 
section 2.8.2.  
 Following the protocol of Klemens et al. (2017), in the initial protocol, the ENaC 
irreversible blocker phenamil (25 μM; final concentration) was added into Ussing 
chamber apically, then chambers were washed and the experiment continued with 
forskolin addition. However, the washing step disrupted the current in some of 
experiments and therefore the results were excluded. Therefore, the experiment was 
redesigned and optimized by adding 5 μM forskolin (final concentration) to the 
basolateral side of cells when the current stabilized. Upon FSK addition, usually the 
current started to increase immediately after 30-50 seconds and followed an “S”-shaped 
blue line (Figure 3.7, A). Due to increased ENaC insertion into the PM by FSK stimulation, 
the increase in Isc was accompanied by simultaneous reduction in trans-epithelial 
resistance (Figure 3.7 A). As the current reached to its peak of “S” (approximately 10 
minutes after adding FSK) (which was followed by a continuous but slight decline after 
the peak), amiloride was added to dissect the ENaC Isc from other currents. The basal Isc 
value was subtracted from the value at the peak of “S” to identify FSK-stimulated ENaC 
Isc.  
 Figure 3.7 B demonstrates relative average traces of FSK-stimulated ENaC Isc in 
control and COMMD10 KD epithelia across five experiments. FSK-stimulated ENaC Isc in 
control KD epithelia was normalized to 1 and current in COMMD10 KD epithelia was 
compared to the normalized control KD epithelia. 
 The results showed that FSK-stimulated ENaC Isc in COMMD10 KD epithelia was 





mCCD cells were transiently transfected with control siRNA or COMMD10 siRNA. 120-hours post-
transfection, the Isc was measured with addition of 5 μM forskolin basolaterally. A, A representative trace 
of ENaC Isc and transepithelial resistance that demonstrate changes with FSK stimulation and amiloride 
addition. B, Trace of relative average ENaC Isc in control and COMMD10 KD epithelia (N=3, n=5, mean ± 
SEM). C, Pooled results showing that FSK stimulated ENaC Isc was reduced significantly. Isc in control KD 
epithelia was normalized to 1 and that in COMMD10 KD epithelia was compared to the normalized control. 
One-sample t-test, *P<0.05, mean ± SD. N=3, n=5. D, Isc traces from two individual experiment sets showing 
that when ENaC channels were permanently inhibited by phenamil, forskolin could still slightly increase 
the current, however, this current was amiloride-sensitive but not a current generated by other ion 










for COMMD10 KD epithelia, One-sample t-test, *P˂0.05, N=3, n=5, Figure 3.7 C) where 
COMMD10 protein was knocked down by 55% (Figure 3.4 B). To identify if COMMD10 KD 
alters other currents during FSK stimulation, another set of experiments was performed 
where upon stabilization of basal ENaC Isc, 25 μM phenamil was added apically and after 
which 5 μM FSK was added basolaterally. Forskolin slightly increased the current in both 
the control and COMMD10 KD epithelia, however, upon addition of amiloride 5 min after 
forskolin addition, most of the FSK-induced current was reduced, suggesting that most of 
the FSK-stimulated current is produced by ENaC newly inserted into apical membrane 
but not blocked yet by phenamil (N=1, n=2, Figure 3.7 D). 
 This experiment could be repeated with longer FSK-stimulation time (up to 10 
min) as the FSK-stimulated ENaC Isc reaches its pick after around 10 min, however, 
because firstly, regardless in 5 or 10 min, COMMD10 KD-mediated change in other 
currents should not affect the amiloride (or phenamil)-sensitive current. Secondly, as the 
Figure 3.7 B demonstrates, the average FSK-stimulated ENaC Isc trace has slid down in 
COMMD10 KD epithelia compared to control KD epithelia suggesting that COMMD10 KD 
reduces other currents as well, however, this reduction is negligible as the analysis of 
ENaC Isc at 3 min after adding amiloride at the peak of the current (the last series of traces 
in Figure 3.7 B) confirms that reduction in other currents in COMMD10 KD is not 
significant (0.64 ± 1.8 for control KD vs -1.1 ± 2.6 μA/cm2 for COMMD10 KD epithelia, 
P>0.05, N=3, n=5). 
 The results provide evidence that reducing COMMD10 protein level disrupts FSK-
stimulated apical delivery of ENaC. Forskolin-stimulation was shown to restrict β2ARs 
(from constitutive recycling) to the endosomal sequence-dependent sorting tubules via 
PKA phosphorylation (Vistein & Puthenveedu, 2013; Bowman et al., 2016), given this, it 
is possible that forskolin regulates endosomal sorting of ENaC in the same way. 
 Interestingly, the relative reduction in basal Isc in mCCD COMMD10 KD epithelia 
(compared to control epithelia) (1 : 0.74, Figure 3.5 C) is very similar to the relative 
reduction in FSK-stimulated Isc (1 : 0.74, Figure 3.7 B) in this epithelia. This suggests that 
impairment in FSK- stimulated ENaC apical delivery, is alone responsible for the decrease 
in basal Isc in COMMD10 KD epithelia. The similar relative reduction also excludes 
involvement of COMMD10 in other pathways. Thus, if COMMD10 would be a part of, for 
example, constitutive recycling, then the relative reduction in basal Isc in COMMD10 KD 
epithelia should not be as same as (probably would be more than) the relative reduction 





the CCC), the results confirm possible role for FSK stimulation in sequence-dependent 
sorting of ENaC like for β2ARs, however, COMMD proteins were also shown to be involved 
in trafficking of recycling endosomes (Campion et al., 2018).  
 Based on previous literature that ENaCs, trafficking from biosynthetic pathway, 
from TGN (Butterworth et al., 2005a), and from constitutive recycling (Butterworth et al., 
2005a; Butterworth et al., 2009; Butterworth et al., 2012; Edinger et al., 2012; Klemens et 
al., 2017) are not involved in the FSK-stimulated ENaC apical delivery, a model for FSK 
stimulation and proposed involvement of COMMD10 in FSK-targeted regulated recycling 
pathway is described in Figure 3.8 C.  
 It was hypothesized that if FSK stimulation would function only on translocation 
of ENaC vesicles to the PM, then FSK-stimulated ENaC Isc should reach the peak in the 
same time in both control and COMMD10 KD epithelia. Therefore, to obtain further 
evidence, FSK stimulation duration for control and COMMD10 KD epithelia was analyzed. 
FSK stimulation duration in control KD epithelia was normalized to 1 and that in 
COMMD10 KD epithelia was compared to the normalized control of the same set of 
experiment. The stimulation duration was seen to be increased significantly in COMMD10 
KD epithelia (1 for control, 1.15±0.08 for COMMD10 KD epithelia; One-sample t-test 
*P<0.05, mean ± SD; N=3, n=5, Figure 3.8 A). This is an evidence for slowed delivery of 








A, Relative normalized FSK stimulated ENaC delivery durations.  One-sample t-test *P<0.05, mean ± SD; 
N=3, n=5. B, A model for FSK stimulation and its target - regulated recycling pathway. Impaired FSK 
stimulation of ENaC in COMMD10 KD epithelia suggests that COMMD10 KD slows down the regulated 
recycling, however, it is not known if this is through slowing sequence-dependent sorting of ENaC or 
through blunting translocation of ENaC carrying tubules/vesicles. The recycling of TfR and C6-NBD-SM are 
shown as examples of constitutively recycled membrane proteins. TfR=transferrin receptor, C6-NBD-
SM=C6-NBD-sphingomyelin, ERC=endosomal recycling compartment, AC=adenylyl cyclase, FSK=forskolin 
  
  
However, the slowed FSK-stimulated ENaC insertion to PM in COMMD10 KD epithelia still 
does not indicate whether COMMD10 functions in endosomal sorting or in translocation 
of recycling vesicles. This is because COMMD proteins were shown to be involved in both 
of these processes (Drevillon et al., 2011; Li et al., 2015; Campion et al., 2018; Fedoseienko 
et al., 2018; Stewart et al., 2019b) and COMMD10 can slow down either endosomal sorting 
or translocation of recycling vesicles.  






 So far there are no reports showing a role for the retromer heterotrimer in 
translocation of vesicles/tubules to PM after endosomal sorting, but it is well known that 
retromer is an important part of endosomal sorting machinery  (Seaman, 2012; Seaman 
et al., 2013; Burd & Cullen, 2014; Zhang et al., 2018). Therefore, it is hypothesized that 
retromer can mediate ENaC sorting as well and one of the retromer subunits, VPS35, was 





3.3.3 Knockdown effect of VPS35 on ENaC recycling  
 
To interrogate the role of retromer in ENaC recycling, the McDonald laboratory have 
measured endogenous ENaC current in FRT and mCCDcl1 epithelia using transient KD of 
retromer proteins to test the effect of this KD on ENaC cell surface activity. Results showed 
that current was decreased in VPS35 KD in both of FRT and mCCDcl1 epithelia (Cheung 
et. al., paper in revision).  
 Conversely, other studies provided evidence that VPS35 protein level was 
stabilized and thereby ENaC Isc was increased in FRT and mCCDcl1 epithelia by treating 
the cells with retromer stabilizer R55 (Cheung et. al., paper in revision). Based on this 
evidence, it was hypothesized that the possible role for VPS35 in regulated recycling of 
ENaC can be confirmed by FSK stimulation. Thus, measuring Isc in transient VPS35 KD or 
VPS35- stabilized mCCDcl1 epithelia under FSK stimulation should provide important 
evidence about ENaC endosomal sorting and the results can confirm the role of COMMD10 
in regulated recycling of ENaC. 
 
 
3.3.3.1 Endogenous ENaC Isc was reduced by VPS35 KD but was not changed by 
R55 treatment 
 
mCCDcl1 were transiently transfected in suspension with siControl or siVPS35 as 





maintained and the current was measured after 120 h post-transfection as described in 
section 2.8.2. Considering that Ussing chamber settings may influence the results, every 
Control-VPS35 KD pair of plates that the current was measured with on the same day 
were mounted, set, or referenced to the Ussing chamber settings separately. The cells 
were lysed immediate after Ussing experiment to identify VPS35 protein level to confirm 
the siRNA effect.   
 Densitometry analysis of the Western blot results (Figure 3.9 A) showed a ~35% 
mean decrease in VPS35 protein level. VPS35 protein level in control KD cells was 
normalized to 1 and VPS35 protein level in VPS35 KD cells was compared to the 
normalized control (1 for control KD, 0.65 ± 0.13 for VPS35 KD cells, One-sample t-test, 
***P<0.001, mean ± SD; N=4, n=5 for control KD, n=8 for VPS35 KD, Figure 3.9 B).  
 
 
mCCD cells were transfected with either control siRNA or VPS35 siRNA in suspension and grown for 
electrophysiological studies. 120-hours post-transfection, the epithelia were used in Ussing assays 
following which they were immediately lysed. The proteins were separated by 12% SDS-PAGE and the 
samples were western blotted with anti-VPS35 antibody (Abcam, Ab0099). A, Representative western blots 
of four individual experiments reflecting VPS35 protein levels in siControl and siVPS35 transfected cells. B, 
Pooled results showing VPS35 fold change in VPS35 KD cells relative to control KD cells. VPS35 protein level 
in control KD cells was normalized to 1 and that in VPS35 KD cells was compared to the normalized control. 












 For each epithelium mounted in the Ussing apparatus current measurement was 
initiated and the current decrease upon amiloride addition from stabilized point to the 
farthest decrease was taken as the basal current. Average traces of basal current and 
transepithelial resistance for control and VPS35 KD epithelia from 4 individual 
experiments and 6 samples are shown in Figure 3.10 A and B. Analysis of results for mCCD 
epithelia with control or VPS35 KD showed up to a ~12% reduction in Isc with VPS35 KD 
(1 for control KD and 0.88 ± 0.07 for VPS35 KD epithelia; One-sample t-test; *P<0.05, 
mean ± SD relative to Isc in control KD epithelia. N=4, n=6) (Figure 3.10 C).  
 To evaluate the effect of R55 on basal ENaC Isc, on the fifth day of seeding, the 
mCCD cells were treated with 5 µM R55 (from a 2 mM stock of R55 solubilized in 1:1 
DMSO/water) or vehicle (1:1 DMSO /water) in filter cup medium and incubated for 48 
hours. At a concentration of 5 µM of R55 is nontoxic and corresponds to the in vitro 
dissociation constant (Kd) of compound R55 to the retromer complex (Mecozzi et al., 
2014). However, inconsistent basal ENaC currents were measured (Figure 3.10 D). 
 Although the reduction in endogenous ENaC Isc in VPS35 KD epithelia was slight 
(~12%) with ~35% mean decrease in VPS35 protein level (Figure 3.9 B), it confirms once 
more that VPS35 plays a role in cell surface activity of ENaC, consistent with previous 

































A, Trace of relative average ENaC Isc over the last 20 minute across 6 experiments (mean ± SEM).  B, Trace 
of relative average transepithelial resistance over the last 20 minute across 6 experiments (mean ± SEM). 
C, Basal ENaC Isc was reduced significantly in VPS35 KD epithelia. Isc in control KD epithelia was normalized 
to 1 and that in VPS35 KD epithelia was compared to the normalized control. One-sample t-test; *P<0.05, 
mean ± SD relative to Isc in control KD epithelia. N=4, n=6. D, R55 did not alter basal ENaC Isc compared to 
vehicle control epithelia. mCCD epithelia were treated with vehicle (DMSO /water (1:1)) or with R55 
(solubilized in 1:1 DMSO/water). One-sample t-test; P>0.05, mean ± SD; N=6, n=6. 
 
 
 According to the current model for retromer-mediated cargo sorting, retromer 
functions in sequence-dependent cargo sorting at actin/sorting nexin/retromer tubular 
endosomal microdomains (Arighi et al., 2004; Strochlic et al., 2007; Harterink et al., 2011; 
Temkin et al., 2011; Steinberg et al., 2013; Lucas et al., 2016) and this type of sorting is a 
target for cAMP-mediated stimulation (Temkin et al., 2011; Vistein & Puthenveedu, 2013; 
Bowman et al., 2016). However, no report could be found investigating cargo trafficking 
to the PM in retromer subunit VPS35 depleted cells under FSK stimulation, therefore, 
evaluation of ENaC delivery to the PM by FSK stimulation should confirm the role of 













3.3.3.2 VPS35 KD reduces endogenous cAMP-mediated ENaC recycling 
 
Previous results showed that VPS35 KD reduces ENaC Isc, therefore it was hypothesized 
that VPS35 is involved in ENaC endosomal sorting like in endosomal sorting of many other 
cargos and measuring FSK-stimulated ENaC current in VPS35 KD epithelia should confirm 
this hypothesis together with confirming the FSK stimulation to function in endosomal 
sorting. As the FSK stimulation is used to understand where COMMD10 functions, 
confirming the functional site of the FSK stimulation in recycling pathway should also 
support the COMMD10-related results. 
 mCCDcl1 cells were transiently transfected with siControl or siVPS35 as described 
in section 2.6.3.2, the current was measured after 120 h as described in section 2.8.2. Upon 
the current stabilization, 5 μM forskolin (final concentration) was added to the basolateral 
side of epithelia and results were analyzed as described in section 3.3.2.1. The basal Isc 
value was subtracted from the value at the peak of “S” to identify FSK-stimulated ENaC 
Isc. Figure 3.11 A, demonstrates relative average traces of FSK-stimulated ENaC Isc in 
control and VPS35 KD epithelia across four experiments (N=4, n=6, mean ± SEM).  
 FSK-stimulated ENaC Isc in control KD epithelia was normalized to 1 and that in 
VPS35 KD epithelia was compared to the normalized control KD epithelia. With ~35% 
mean decrease in VPS35 protein level (Figure 3.9 B), the results showed that FSK-
stimulated ENaC Isc in VPS35 KD epithelia was significantly (~ 15%) reduced compared 
to that in control KD epithelia (1 for control vs 0.85±0.11, One-sample t-test, *P˂0.05, 
mean ± SD; N=4, n=6, Figure 3.11 B). 
 Although the relative reduction in basal Isc in VPS35 KD epithelia (compared to 
control epithelia) (1 : 0.88, Figure 3.5 C) is not the same as the relative reduction in FSK-
stimulated Isc (1 : 0.85, Figure 3.7 B), it is very close to that in VPS35 KD epithelia. This 
suggests that impairment in FSK-stimulated ENaC apical delivery is alone responsible for 
the decrease in basal Isc in VPS35 KD epithelia. The similar relative reduction also 
excludes the involvement of VPS35 in other pathways delivering cargos to PM.  
 The slowed FSK-stimulated ENaC insertion to PM in COMMD10 KD epithelia 
provided evidence that FSK stimulation can function on endosomal sorting of ENaC 
(Figure 3.8 B) together with accepting the possibility of its function on translocation of 





of ENaC vesicles to PM, then FSK-stimulated ENaC Isc should reach the peak in the same 
time in control and VPS35 KD.  
 
 
mCCDcl1 cells were transiently transfected with control siRNA or VPS35 siRNA. At 120 h post-transfection, 
the Isc was measured with addition of 5 μM forskolin basolaterally. A, Trace of relative average ENaC Isc in 
control and VPS35 KD epithelia demonstrating changes with FSK stimulation (N=4, n=6, mean ± SEM). B, 
Pooled results show that FSK stimulated ENaC Isc was reduced significantly. Isc in control KD epithelia was 
normalized to 1 and that in VPS35 KD epithelia was compared to the normalized control. One-sample t-test, 
*P<0.05, mean ± SD, N=4, n=6. C, Pooled relative normalized FSK stimulation durations.  Data shown as 
mean ± SD relative to normalized FSK-stimulated ENaC Isc level of control KD epithelia. One-sample t-test, 









Therefore, FSK stimulation duration for control and VPS35 KD epithelia was analyzed 
which revealed that the duration showed a trend towards an increase in VPS35 KD 
epithelia (the FSK stimulation duration in control KD epithelia was normalized to 1 and 
that in VPS35 KD epithelia was compared to the normalized control of the same set of 
experiment (1 for control, 1.10± 0.17 for VPS35 KD epithelia; One-sample t-test, P>0.05, 
N=4, n=6, Figure 3.11 C). 
 As VPS35 is known to function in endosomal cargo sorting, the similar results in 
VPS35 KD and COMMD10 KD under FSK stimulation suggest that VPS35 and COMMD10 
function in the same regulated ENaC recycling pathway and possibly at the endosomal 
sorting step. However, as COMMD proteins were also shown to be involved in the delivery 
of recycling endosomes to the PM by hooking them to and changing the cytoskeleton 
(Campion et al., 2018), it was hypothesized that COMMD10 could also regulate ENaC 




3.4 Does COMMD10 KD reduce ENaC recycling by changing the 
microfilament organization of the cell? 
 
 
CCC and WASH complexes associate with both retromer and retriever complexes to 
facilitate tubular entry and recycling of cargo to the cell surface. Despite such a necessary 
function of CCC complex in endosomal sorting, a distinct biochemical or adaptor activity 
that may underlie this activity is currently unknown. 
 The WASH complex was identified as an actin nucleation-promoting factor (NPF) 
that activates the Arp2/3 complex promoting actin polymerization (Linardopoulou et al., 
2007). However, no report was found linking WASH activity with microfilament 
organization of the cell. In a recent paper it was reported that COMMD5 suppression 
resulted in enlarged static Rab5-positive endosomes that accumulated underneath the 
PM (Campion et al., 2018). Further analysis of the cytoskeleton distribution showed that 
COMMD5 silencing leads to a major re-organization of actin filaments with enrichment of 
cortical actin stress fibers near the PM. Campion and coworkers have also shown that 





WASH1 and its partner Arp2/3 supporting the hypothesis that COMMD5 is involved in 
actin polymerization. Moreover, COMMD5 depletion severely decreased RhoA activity 
(Campion et al., 2018). RhoA is a Rho GTPase that binds to a variety of effectors once 
activated, including protein kinases (Zhao & Manser, 2005) and some actin-binding 
proteins that change the organization and dynamics of F-actin (Hall & Nobes, 2000b; 
Spiering & Hodgson, 2011). 
 Given this information it was hypothesized that COMMD10 knockdown could also 
change cytoskeletal organization and thereby downregulate ENaC activity since 
COMMD10 is an upregulator of ENaC cell surface population just as COMMD5 is an 




3.4.1 COMMD10 KD doesn’t change microfilament organization in FRT and U2OS 
cells 
 
 To test whether KD of COMMD10 affected actin filament organization or amount, 
fluorescent phallotoxin staining assay was performed as described in section 2.12.2. 
Briefly, cells were fixed in 3.7% formaldehyde for 10 min and permeabilized with 0.1% 
Triton X-100 in PBS for 5 min. After blocking with PBS + 1% BSA, the cells were stained 
with phalloidin conjugated with Alexa Fluor 488 for 20 min and mounted and imaged.
 Qualitative comparison by unblinded visual comparison of microfilaments in FRT 
control KD (272 cells) and COMMD10 KD (253 cells) cells suggested that there was no 
consistent difference in F-actin distribution (Figure 3.12 A) where COMMD10 was 
knocked down by 80% in FRT cells (Figure 3.1 B). Also no difference was observed in the 
actin-covered endosome distribution between control and COMMD10 KD cells.  
 To analyze the exact filament organization, a number of ImageJ plugins were tested 
but none of them gave convincing results because of the variety of actin filament forms, 
sizes and directions in the cells although more clear images and z-stack image series were 
taken to improve actin visualization. Therefore, intensity of actin filaments by quantifying 
fluorescence intensity was analyzed. The quantification results showed no significant 





(n=272) vs 1870±380 for COMMD10 KD cells (n=253), paired t-test, P=0.62, mean ± SD. 































FRT control and COMMD10 KD cells were fixed with 3.7% formaldehyde and permeabilized with 0.1% 
Triton X-100. Then the cells were mounted with VECTASHIELD® HardSet™ Mounting Medium with DAPI 
followed by staining with phalloidin conjugated to Alexa Fluor™ 488. A, Representative images of stained 
F-actin in FRT control and COMMD10 KD cells. Scale bar = 10 μM. B, Quantitative analysis of fluorescence 
intensity of actin filaments showing actin intensity in control and COMMD10 KD FRT cells. Paired t-test, 































 To further confirm no effect of COMMD10 KD on actin filament structure, a second 
cell line was used. U2OS cell lines with stable control or COMMD10 KD were stained for 
F-actin. This cell line is more amenable to F-actin analysis because of their widened cell 
shape. Western blot analysis with two different samples of U2OS cells showed an average 
of a 76% COMMD10 KD compared to control KD (1 for control KD vs 0.24±0.13 for C10 
KD cells, One-sample t-test, P>0.05, mean ± SD; n=2. Figure 3.13 A and B).  
 Qualitative comparison of microfilaments in U2OS control KD (153 cells) and 
COMMD10 KD (117 cells) cells suggested that actin filaments are less organized in 
COMMD10 KD cells compared to control KD cells (Figure 3.13 C). Then, the intensity of 
actin filaments by quantifying fluorescence intensity was analyzed which, like in FRT cells, 
revealed no significant difference in control and COMMD10 KD U2OS cells (1173±482.9 
for control KD cells (n=117) vs 1007±359.7 for COMMD10 KD cells (n=153). Paired t-test, 




















































A, Representative western blot for COMMD10. B, Pooled results showing 76% decreased COMMD10 level 
in U2OS COMMD10 KD cells relative to control KD cells. COMMD10 protein level in control KD cells was 
normalized to 1 and that in COMMD10 KD cells was compared to the normalized control (1 for control KD 
vs 0.24±0.13 for COMMD10 KD cells, One-sample t-test, P>0.05, mean ± SD; n=2. C, Representative images 
of stained F-actin in U2OS control and COMMD10 KD cells. Scale bar = 10 μM. D, Quantitative analysis of 
fluorescence intensity of actin filaments showing actin intensity in control and COMMD10 KD U2OS cells. 

































 The results suggest that intensity representing expression of F-actin is not changed 
by silencing COMMD10 in FRT and U2OS cells, however, the organization/pattern does 
look different. This means that while the amount of F-actin is unchanged how it organizes 
the microfilaments may be different. More studies would be needed to confirm this. 
However, these results do not exclude a role for COMMD10 in endosomal F-actin 
formation in concert with the WASH complex and do not exclude a role in hooking 
recycling endosomes to the cytoskeleton like its COMMD5 partner. To further investigate 
the role of COMMD10 in endosomal sorting, more precise investigations were needed 

























































4.1 Which endosomal domain does COMMD10 localize to? 
 
 
The endosomal sorting complex retromer is recruited to the EE through the coordinate 
action of Rab5 and Rab7 (Rojas et al., 2008). Once the active Rab5 associates with the EE, 
numerous effectors are recruited, including a class III PtdIns(3)-kinase (PI3-kinase) that 
generates PI(3)P at these membranes (Jovic et al., 2010). Subsequently the enrichment of 
EE membranes with P(3)P results in the increased recruitment of the SNX subcomplex 
(Rojas et al., 2008). A recent study shows that the CCC complex regulates the 
phosphorylation and endosomal recruitment of the PI(3)P phosphatase MTMR2, and 
depletion of CCC complex proteins leads to elevated PI(3)P levels, enhanced recruitment 
and activation of WASH complex, excess endosomal F-actin and cargo trapping in the 
endosomes (Singla et al., 2019). Previous investigations determined the precise 
endosomal localization of WASH, Arp2/3 complex, cortactin (an Arp2/3 activator), 
endosomal F-actin, and coronin (an F-actin binding protein) during endosomal tubulation 
whereby the mechanism of sequence-dependent endosomal sorting was established 
((Puthenveedu et al., 2010) Figures 3, 4). However, the localization of CCC complex 
subunits during dynamic endosomal tubulation has not been reported and this data 
would give a clearer idea about their function. 
 Hereto, the results described in chapter 3 showed that COMMD10 depletion 
reduces ENaC cell surface population (Figure 3.3) through regulated recycling (Figure 
3.7) like VPS35 (Figure 3.11), suggesting that COMMD10 normally contributes to 
increasing ENaC cell surface population. Visualization of COMMD10 protein on 
endosomes should provide evidence on whether COMMD10 upregulates ENaC through 
only regulating endosomal F-actin formation together with the WASH complex (as the 
CCC complex is recruited onto endosomes by the WASH complex, (Phillips-Krawczak et 
al., 2015)), or if COMMD10 is involved at a later step in the recycling pathway as well, like 
its COMMD5 partner (Campion et al., 2018).  
 It was hypothesized that COMMD10 localizes to Rab5- and Rab7-positive 
endosomes as a functioning part of the endosomal sorting complex CCC, and also localizes 
to Rab11-positive endosomes if COMMD10 is involved in a later step in the recycling 





membrane compartments, where Rab5 and Rab7 mark the early endosome, and Rab11 
marks the recycling endosome.  
   
 
 
4.1.1 COMMD10 localizes on Rab5-positive endosomes in U2OS and in FRT cells 
 
Rink and coworkers observed the frequent outgrowth of Tf-containing Rab4-positive 
tubules from Rab5-positive endosomes (Rink et al., 2005b). Both constitutive (van der 
Sluijs et al., 1992; de Wit et al., 2001) and regulated recycling was shown to be Rab4-
dependent (Temkin et al., 2011; Li et al., 2012) and occurring on Rab5-positive 
endosomes. Furthermore, COMMD5, a subunit of the sequence-dependent endosomal 
sorting complex CCC, was reported to bind with Rab5 through its N-terminal end and to 
colocalize with endosomal F-actin on the Rab5 effector EEA1-positive endosomes 
(Campion et al., 2018). 
 To discover if COMMD10 could also be visualized on Rab5-positive endosomes, 
Rab5a-mCherry and COMMD10-GFP plasmids were coexpressed in U2OS and FRT 
COMMD10 stable knockdown cells. Live-cell imaging and image analysis using FiJi 
software was performed as described in section 2.12.3 and in a previous report 
(Puthenveedu et al., 2010). The purpose of this analysis was to identify if COMMD10 
localizes on the base of recycling tubules like the WASH, and Arp2/3 complexes, cortactin, 
endosomal F-actin, and coronin (Puthenveedu et al., 2010) or if COMMD10 coats the 
whole tubule like VPS35 (Kovtun et al., 2018). 
 
U2OS cells. In the U2OS cells, the size of Rab5-positive endosomes ranged from 0.5 to 1.4 
μm in diameter, probably depending on maturation stage of the endosome, which is 
consistent with previous reports showing the diameter of the endosomes ranging from 
0.3–1 μm (Skjeldal et al., 2012) or very similar sizes ((Bowman et al., 2016), Figures 1, 2).  
 As seen in Figure 4.1 A, COMMD10-GFP proteins are mostly concentrated on 
tubule-like structures emanating from endosomes rather than on the membrane of Rab5-
positive endosomes. This localization profile of COMMD10 is very similar to that 
described for EGF labelled tubules on EEA1-positive endosomes (Skjeldal et al., 2012). 





al. (2012).  The localized punctate labelling of COMMD10 is similar to that described 
previously for endosomal F-actin, coronin, and the WASH complex which all localize to 
the base of tubules emanating from endosomes ((Puthenveedu et al., 2010), Figure 3,A&B 
and 4,G).  
The video sequence in Figure 4.1 B shows that COMMD10-positive structures bud 
off from the endosome after 4.5 minutes instead of disappearing gradually suggesting that 
COMMD10 migrates together with the budded tubules regardless of whether COMMD10 
localizes on the base of the tubule or coating the tubule (Figure 4.1 B).  
 Linear pixel analysis of fluorescence intensity along the endosome (Figure 4.1 C) 
also shows that COMMD10 is not recruited onto the whole Rab5-positive endosome but 
only to the tubular structure emanating from the endosome (Figure 4.1 C and D). The 
fluorescence intensity trace in Figure 4.1 C was obtained from the same endosome shown 
in Figure 4.1 A and C, while the average trace in Figure 4.1 D is from 12 endosomes (Linear 


































A, Representative image of U2OS cell with stable COMMD10 KD co-expressing Rab5a-mCherry and 
COMMD10-GFP, imaged by Nikon A1R, 60× PlanApo (1.49 NA, oil immersion). Boxed areas are enlarged in 
the inset where the arrows indicate concentration of COMMD10 on endosomal tubular domains. B, Time 
lapse series from the example endosome with Rab5a-mCherry and COMMD10-GFP where the endosomal 
tubule-like structure buds off the endosome. C, An example endosome showing the location of linear pixel 
frequency analysis, together with a pictorial model for the tubulated endosome. D, Trace of linear pixel 
values for Rab5 (red) and COMMD10 (green) across the same endosome given in panel C, which confirms 
that COMMD10 localizes to tubule-like structures emanating from Rab5-positive endosomes. E, Trace of 
linear pixel values for Rab5 (red) and COMMD10 (green) of endosomal tubules averaged across 12 
endosomes, normalized to the maximum, supporting the visualizations showing specific enrichment of 
COMMD10 on tubule-like structures. Linear regression, mean ± SEM. N=3, n=12.  
 
 
FRT cells. To test whether the COMMD10-positive tubular structures emanating from 
Rab5-positive endosomes in U2OS cells could be visualized in a different cell line, FRT 
cells with stable knockdown of COMMD10 were co-transfected with COMMD10-GFP and 
Rab5a-mCherry, and live cell imaging was carried out as described above for U2OS cells.  
 The results in FRT cells showed that COMMD10 localizes to the Rab5-positive 
endosomes which was consistent with the results observed in U2OS cells (Figure 4.2 A). 
Linear pixel analysis of fluorescence intensity along the endosome also shows that 
COMMD10 is concentrated onto a structure distinct to, but attached to the endosomes 
(Figure 4.2 B and C). The fluorescence intensity trace in Figure 4.2 B was obtained from 
the same endosome shown in Figure 4.2 A, while the average trace in Figure 4.2 C is from 
16 endosomes (Linear regression, diameters of endosomes were normalized to the 
maximum, mean ± SEM. N=3, n=16).  
D E 
Figure 4. 1. COMMD10 localizes to tubule-like structures emanating from Rab5-positive endosomes 





 The results from both the U2OS and FRT cell lines show that COMMD10 localizes 
on special domains associated with Rab5-positive endosomes supporting the possibility 
of these domains being sequence-dependent endosomal sorting microdomains consistent 
with COMMD10 and the CCC complex having a role in sorting at this location. 
A, Representative image of FRT cell with stable COMMD10 KD coexpressing Rab5a-mCherry and 
COMMD10-GFP, imaged by Olympus FV3000, 60x (1.49 NA). The boxed area is enlarged in the images on 
the right panel where the arrows indicate concentration of COMMD10 on endosomal tubular domains. B, 
Trace of linear pixel values for Rab5 (red) and COMMD10 (green) across the same endosome, confirming 
that a specific domain on Rab5-positive endosomes is enriched with COMMD10. C, Trace of linear pixel 
values for Rab5 (red) and COMMD10 (green) on endosomal tubules averaged across 16 endosomes, 
normalized to the maximum, which supports the specific enrichment of COMMD10 on endosomal domains. 
Linear regression, mean ± SEM. N=3, n=16.  
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Figure 4. 2. COMMD10 concentrates on short tubule-like structures around Rab5-positive 







The linear pixel analysis of COMMD10 fluorescence in U2OS and FRT cells gave very 
similar results to WASH, coronin, cortactin localization (Puthenveedu et al., 2010) 
supporting the hypothesis that COMMD10 performs its function at the base of endosomal 
tubules. To compare the results reported here with the results of Puthenveedu and 
coworker’s, an adapted figure from their published paper is provided below (Figure 4.3 
adapted from Puthenveedu and coworker’s report, where the endosomes were marked 
with β2AR, analyzed against Arp2/3 (Fig.4.3 A and B), cortactin, WASH (Fig.4.3 C) and 
coronin (Fig.4.3 D and E) (Puthenveedu et al., 2010)). At the start of the report they have 
shown that the β2AR enters endosomes marked by Rab5 from where the β2AR enters into 
tubules containing Rab4 or Rab11 ((Puthenveedu et al., 2010), Figure S1B)). 
 
An adapted figure from a published paper providing a comparative view for localization of endosomal 
sorting complexes (Puthenveedu et al., 2010). In all images, the endosomes were marked with β2AR and 
analyzed against the localization of Arp2/3 (A and B), cortactin (C), WASH (C) and coronin (D and E) which 
are very similar to the localization of COMMD10 onto Rab5 positive endosomes (see Figures 4.1 and 4.2). 
 
During analysis of the U2OS stable COMMD10 KD cells co-expressing COMMD10-
GFP and Rab5-mCherry, there were numerous COMMD10 labelled tubule-like 
structures/domains that were found emanating from Rab5-negative endosomes, as 
expected (Figure 4.4 A and B).   
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A, Representative image of U2OS cell with stable COMMD10 KD coexpressing Rab5a-mCherry and 
COMMD10-GFP, imaged by Nikon A1R, 60× PlanApo (1.49 NA, oil immersion). Boxed areas are enlarged in 
the images on the right panel where the arrows indicate concentration of COMMD10 on endosomal tubular 
domain. B, Trace of linear pixel values for Rab5 (red) and COMMD10 (green) across the same endosome, 
confirms that the special domain on Rab5-negative endosome is enriched with COMMD10.  
 
It is possible that these structures are Rab7 positive endosomes that have matured from 
Rab5 positive endosomes, therefore in the next set of experiments, localization of 
COMMD10 on Rab7-positive endosomes was investigated. This is important, because 
COMMD proteins may have a role in promoting the exit of recycling cargo from 
endosomes after retromer-mediated cargo sorting and Rab7a was shown to regulate the 




4.1.2 COMMD10 localizes on Rab7a positive endosomes in U2OS and in FRT cells 
 
During the conversion of early endosomes to late endosome Rab5 is gradually lost from 
the endosome while in parallel Rab7 is recruited to the endosome (Rink et al., 2005a). 
Although Rab7a was shown to regulate the transport of cargo to lysosomes (Bucci et al., 
2000; Rink et al., 2005a), later Rab7a was found to be required for the constitutive 
B A U2OS cells 
COMMD10-GFP 
Rab5-mCherry 






recycling of unliganded EGFRs (Rush & Ceresa, 2013), and to be necessary for retromer 
recruitment to endosomes thereby regulating recycling in the regulated pathway (Rojas 
et al., 2008; Seaman et al., 2009; Balderhaar et al., 2010; Liu et al., 2012b; Priya et al., 
2015). A recent report explained these contradictory results, by hypothesizing a dual 
function for endosomal Rab7 (Purushothaman et al., 2017). Purushothaman and 
coworkers demonstrated that retromer complex recruitment onto endosomal 
membranes releases Rab7, which separates endosomal recycling from Rab7-dependent 
lysosomal fusion (Purushothaman et al., 2017). On the surface of endosomal tubules, 
binding to cargo is likely an important factor for retromer recruitment and as cargo 
recycles or involutes into the endosome, Rab7 induces lysosome fusion (Purushothaman 
et al., 2017). 
Although it was reported that Rab7a does not associate with the CCC complex 
(McNally et al., 2017) and COMMD5 had no affinity for late Rab7-positive endolysosomes 
located in the perinuclear region, this doesn’t exclude the possibility of CCC complex 
localization on retromer-coated tubules emanating from Rab7-positive endosomes.  
To identify, if the CCC complex and particularly COMMD10 functions on 
microdomains of Rab7-positive endosomes, again COMMD10-GFP and Rab7a-DsRed 
were coexpressed in U2OS and FRT control and COMMD10 stable knockdown cells. Cells 
were grown and transfected as described in sections 2.6.1 and 2.6.3.1, respectively. After 
no more than 20 hours, images were acquired with living cells and analyzed as described 
in section 2.12.3.  
 
U2OS cells. As seen in the Figure 4.5 A, COMMD10 localized on microdomains of Rab7-
positive endosomes, which is similar to the results for Rab5-positive endosomes (Figure 
4.1 A, C) were the predominant structures observed. They were analyzed as described 
above for COMMD10 localization onto Rab5-positive endosomes. Thus, linear pixel 
analysis of fluorescence intensity along the endosome shows that COMMD10 is recruited 
onto specific tubule-like structures emanating from Rab7-positive endosomes (Figure 4.5 
B). The fluorescence intensity trace in Figure 4.5 B was obtained from the same endosome 
shown in the Figure 4.5 A, while the average trace in Figure 4.5 C is from 11 endosomes 
(Linear regression, diameters of endosomes were normalized to the maximum, mean ± 







A, Representative image of U2OS cell with stable COMMD10 KD co-expressing Rab7a-DsRed and 
COMMD10-GFP, imaged by Nikon A1R, 60× PlanApo (1.49 NA, oil immersion). The boxed area is enlarged 
in the images on the right panel where the arrows indicate concentration of COMMD10 on a Rab7-positive 
endosomal tubular domain. B, Trace of linear pixel values for Rab7 (red) and COMMD10 (green) across the 
same endosome, confirming that the specific domain on the Rab7-positive endosome is enriched with 
COMMD10. C, Trace of linear pixel values for Rab7 (red) and COMMD10 (green) of endosomal tubules 
averaged across 11 endosomes, normalized to the maximum, which supports the specific enrichment of 








Figure 4. 5. COMMD10 concentrates on short tubule-like structures around Rab7-positive 





However, despite optimization, COMMD10 was more concentrated around the Rab7-
positive endosomes or in distinct structures (Figure 4.6 A), compared to COMMD10 
localization in Rab5 overexpressed cells. This suggests that overexpression of Rab7 not 
only triggers aggregation of Rab7-positive endosomes alone as reported previously 
(Bucci et al., 2000), but also that Rab7 triggers concentration of COMMD10 on distinct 
structures. Interestingly, COMMD10 aggregation was mostly observed on structures 
distinct from the Rab7-positive endosomes (red arrows in the left side, Figure 4.6 A). 
However, distinct COMMD10 concentrations, similar to those observed in Rab5-positive 
endosomes were also often observed (Figure 4.6 A, white arrows in the right side). 
Furthermore, COMMD10 concentrations were seen on some Rab7-negative endosomes 
(Figure 4.6 B). This was confirmed using linear pixel values Figure 4.6 C. The latter 
indicates COMMD10 localization on endosomes that are not marked with Rab7, but 





























A, Representative image of U2OS cell with stable COMMD10 KD co-expressing Rab7a-DsRed and 
COMMD10-GFP, imaged by Nikon A1R, 60× PlanApo (1.49 NA, oil immersion). Boxed areas are enlarged in 
the right panel where the arrows indicate concentration of COMMD10 on distinct structures (red arrows on 
the left side) or on Rab7-positive endosomal tubular domains (white arrows on the right side). B, Rab7-
DsRed and COMMD10-GFP co-expressing U2OS stable COMMD10 KD cells. Boxed areas are enlarged in the 
right hand panel where the arrows indicate concentration of COMMD10 on a Rab7-negative endosomal 
tubular domain. C, Trace of linear pixel values for Rab7 (red) and COMMD10 (green) across the same 
endosome, confirms that the special domain on Rab7-positive endosome is enriched with COMMD10.  
 
FRT cells. To test whether the COMMD10-positive tubular structures emanating from 
Rab7-positive endosomes in U2OS cells could be visualized in a different cell line, FRT 
cells with stable knockdown of COMMD10 was co-transfected with COMMD10-GFP and 
Rab7a-DsRed, and live cell imaging was carried out as described above for U2OS cells.  
 As shown in Figure 4.7 A, COMMD10-GFP proteins are mostly concentrated on 
tubule-like structures emanating from endosomes rather than on the whole membrane of 
Rab7-positive endosome itself (indicated with arrows). Linear pixel analysis of 
fluorescence intensity along the given endosome also confirms this (Figure 4.7 B). The 
average fluorescence intensity trace in Figure 4.7 C is from 16 endosomes (Linear 
regression, diameters of endosomes were normalized to the maximum, mean ± SEM. N=2, 











A, Representative image of an FRT cell with stable COMMD10 KD coexpressing Rab7a-DsRed and 
COMMD10-GFP, imaged by Olympus FV3000, 60× (1.49 NA). The boxed area is enlarged in the images on 
the right panel where the arrows indicate concentration of COMMD10 on endosomal tubular domains. B, 
Trace of linear pixel values for Rab7 (red) and COMMD10 (green) across the same endosome, confirming 
that the special domain on Rab5-positive endosome is enriched with COMMD10. C, Trace of linear pixel 
values for Rab7 (red) and COMMD10 (green) of endosomal tubules averaged across 16 endosomes, 
normalized to the maximum, which supports the specific enrichment of COMMD10 on endosomal domains. 







Figure 4. 7. COMMD10 concentrates on short tubule-like structures around Rab7-positive 





The results from U2OS and FRT cell lines suggest that during endosomal maturation, 
COMMD10 is still involved in tubule formation or endosomal sorting, which is 
inconsistent with a report where the co-localization experiment showed that COMMD5 
does not co-localize with Rab7 (Campion et al., 2018). But the results suggest that 
COMMD10 is localized to the cargo loaded tubules/base of tubules, on which domain, the 
Rab7 was released (Purushothaman et al., 2017). Overall the results show that the 
localization of COMMD10 on Rab7-positive endosomal domains is also very similar to that 
of endosomal actin, coronin, and the WASH complex which localize to the base of tubules 
emanating from Rab5-positive endosomes (Puthenveedu et al., 2010).  
 Although the results showed that COMMD10 localizes on Rab5- and Rab7-positive 
endosomal domains, based on these overall results, it is not possible to speculate whether 
COMMD10 is involved only in the release of stabilized tubules from endosomes 
disassembling the WASH complex  (Singla et al., 2019) or also further in the translocation 
of recycling endosomes to the PM. COMMD5 was shown to hook endosomes to the 
cytoskeleton through its COMM domain that serves as a platform for direct interaction 
with G- and F-actin and with polymerized tubulin (Campion et al., 2018). These findings 
suggest that COMMD proteins may have a role in the transport of cargos from endosomes 
to the cell surface. Campion et al. (2018) have also shown that COMMD5 has high affinity 
for Rab11-positive recycling vesicles (Campion et al., 2018). Therefore, analyzing 




4.1.3 COMMD10 localizes on Rab11-positive recycling endosomes in U2OS and FRT 
cells 
 
Endocytosed Tf was shown to move sequentially through compartments that were 
immunostained first with anti-Rab5 and then with anti-Rab11, consistent with the theory 
that Rab5 and Rab11 localize to sorting and recycling endosomes, respectively (Trischler 
et al., 1999). Subsequently, the Tf–TfR complex is returned to the PM either directly 
(constitutive recycling) (Mayor et al., 1993; Maxfield & McGraw, 2004) or indirectly via 
slow recycling endosomes (REs) (Maxfield & McGraw, 2004; Takahashi et al., 2012). The 





al., 2012), and Rab11 is believed to tether recycling endosomes with the PM (Takahashi 
et al., 2012), with this role being consistent with the function of Rab GTPases in membrane 
tethering and fusion (Zerial & McBride, 2001b). However, the fast recycling of cargos 
through both the constitutive and sequence-dependent (regulated) recycling occurs via 
Rab4-positive tubules/recycling endosomes (Zerial & McBride, 2001a; Maxfield & 
McGraw, 2004; Li et al., 2008; Puthenveedu et al., 2010; Temkin et al., 2011; MacDonald 
et al., 2018). How then can COMMD5, a subunit of sequence-dependent recycling complex 
CCC, have an affinity for Rab11-positive recycling endosomes, as previously reported 
(Campion et al., 2018)?  
 Firstly, it should be considered that Rab11a is involved in the transport of material 
from peripheral sorting endosomes to the perinuclear RE/ERC (Horgan et al., 2010) and 
from there to the PM. Secondly, it was demonstrated that the WASH complex co-localizes 
with both Rab4 and Rab11, markers of fast and slow recycling, respectively (Derivery et 
al., 2009; Duleh & Welch, 2010). As another evidence linking sequence-dependent 
endosomal sorting with Rab11-positive slow recycling, it was found that the SNX27-
regulated CFTR resides in a perinuclear compartment co-localizing with Rab11 (Holleran 
et al., 2013). These data suggest that after endosomal sorting cargo can either be delivered 
to the cell surface via Rab4-positive recycling vesicles, or transported to the perinuclear 
area for later Rab11-mediated slow recycling. It is possible therefore, that both types of 
REs carry some endosomal sorting “markers” like WASH and COMMD proteins on them. 
Brefeldin A, an inhibitor of intracellular protein translocation, blocked the 
stimulatory action of Rab11a on ENaC activity, demonstrating that ENaC, present on the 
apical plasma membrane, is being exchanged with channels from the intracellular pool in 
a Rab11-dependent manner (Karpushev et al., 2008). Taken together, investigating 
COMMD10 protein localization on Rab11-positive REs in different cell lines should clarify 
the hypothesis that after sequence-dependent sorting, COMMD proteins migrate together 
with cargo and thereby may contribute to the translocation of recycling endosomes to the 
PM. The results may also support the previous results on COMMD10-mediated ENaC 
recycling (see section 3.3.2.1). 
To identify, if COMMD10 localizes on Rab11-positive recycling endosomes, 
COMMD10-GFP and Rab11a-DsRed were coexpressed in U2OS and FRT stable COMMD10 
knockdown cells. Cells were grown and transfected as described in sections 2.6.1 and 
2.6.3.1, respectively. After no more than 20 hours, images were acquired with living cells 





 In U2OS cells, Rab11-positive (recycling) endosomes were observed in the 
peripheral regions, particularly around the cellular tips (edges) of U2OS cells (Figure 4.8 
A, lower left panel), consistent with previous reports (Bruce et al., 2012; Takahashi et al., 
2012), but inconsistent with many other reports showing the Rab11-positive structures 
concentrated to the perinuclear region as a ERC (Horgan et al., 2010; Amorim et al., 2011; 
Mölleken & Hegemann, 2017). As seen in the Figure 4.8 A (top left panel), COMMD10-GFP 
was observed in puncta of varying sizes also peripheral to the nucleus. The bottom right 
panel in Figure 4.8 A shows that COMMD10 has concentrated on most of the Rab11-
positive endosomes, but in an asymmetric pattern, with occasional areas of overlap (blue 
arrows). These images were generally acquired as a time-lapse series which revealed that 
the Rab11-positive vesicular structures move in an intermittent manner suggestive of 
microtubule-based transport consistent with previous reports (Amorim et al., 
2011)((Takahashi et al., 2012) Fig. 1B and supplementary material Movie 1).  
 Figure 4.8 B shows the merged image of boxed areas in Figure 4.8 A and provides 
higher resolution evidence of structure and relative location of Rab11 and COMMD10. 
Linear pixel analysis of fluorescence intensity along the Rab11-positive recycling 
endosomes (Figure 4.8 C), obtained from the same row of recycling endosomes shown in 
the Figure 4.8 B, shows that COMMD10 is not recruited onto the whole Rab11-positive 
endosome but localizes to specific structures on the endosomes (Figure 4.8 C). Thus, the 
time-lapse series show these structures are attached to the Rab11-positive recycling 
endosomes and move together. However, there are also separate COMMD10-positive 
structures (white arrows in the right panel) that maybe are the structures localized to the 






































A, Representative image of a U2OS cell with stable COMMD10 KD coexpressing Rab11a-DsRed and 
COMMD10-GFP, imaged by Nikon A1R, 60× PlanApo (1.49 NA, oil immersion). Boxed areas are enlarged in 
the inset where the arrows indicate concentration of COMMD10 on endosomal tubular domains. B, Merged 
image of boxed areas from image A, showing a row of endosomes and how they were analyzed. C, Trace of 
linear pixel values across the same row of endosomes, confirms that COMMD10 is enriched as special 
structures on Rab11-positive recycling endosomes. N=3. 
 
FRT cells. To test whether the COMMD10-positive structures localizing onto the Rab11-
positive endosomes in U2OS cells could be visualized in a different cell line, FRT cell line 
with stable knockdown of COMMD10 was co-transfected with COMMD10-GFP and 




Figure 4. 8. COMMD10 concentrates on specific structures on Rab11-positive recycling endosomes 





Rab11a-DsRed, and live cell imaging was carried out as described above for U2OS cells. 
The results showed that COMMD10 has concentrated on most of the Rab11-positive 
endosomes, but in an asymmetric pattern, with occasional areas of overlap, which is 
consistent with the COMMD10 localization pattern in U2OS cells (Figure 4.9 A). However, 
some of the COMMD10 dotted concentrations are seen around larger endosomes 
(possibly early or maturing endosomes) in the time-lapse movie. Rab11 is also observed 
on the PM or directly beneath the PM in FRT cells, confirming previous reports that Rab11 
not only associates with perinuclear REs, but also participates in exocytosis of recycling 
vesicles at the PM (Vossenkämper et al., 2007; Takahashi et al., 2012).  
 Figure 4.9 B provides the merged image of boxed areas in Figure 4.8 A and 
provides higher resolution evidence of structure and relative location of Rab11 and 
COMMD10.  Linear pixel analysis of fluorescence intensity along the same row of Rab11-
positive recycling endosomes also confirms that COMMD10 localizes on the endosomes 





























A, Representative image of FRT cells with stable COMMD10 KD coexpressing Rab11a-DsRed and 
COMMD10-GFP, imaged by Olympus FV3000, 60x (1.49 NA). Boxed areas are enlarged in the inset where 
the arrows indicate concentration of COMMD10 on endosomal tubular domains. B, Merged image of boxed 
areas from image A, showing a row of endosomes and how they were analyzed. C, Trace of linear pixel 
values across the same row of endosomes, confirms that COMMD10 is enriched as special structures on 
Rab11-positive recycling endosomes. N=2. 
 
 The results are consistent with the report showing that COMMD5 co-localizes with 
Rab11 with similar confocal images of COMMD5 on Rab11-positive endosomes 
((Campion et al., 2018), Fig. 1 E). The overall results support the previous results in 
chapter 3 and the hypothesis that COMMD10 is an important part of endosomal recycling 
as well as endosomal sorting. However, the results do not reveal the role that COMMD10 
plays on Rab-11 positive endosomes in the recycling pathway. Further, these results do 










Figure 4. 9. COMMD10 concentrates on specific structures on Rab11-positive recycling endosomes 





To identify ENaC localization pattern 
on Rab5, 7 and 11-positive 
endosomes, co-expression of HA-
tagged ENaC (immunostaining with 
anti-rabbit conjugated AF-488) and 
Rab5a-mCherry, Rab7a- or Rab11a-
DsRed was evaluated in fixed FRT 
cells. Although ENaC was observed 
on tubules emanating from 
endosomes (Figure 4.10), in all 
cases, it was not possible to find any 
Rab GTP expressing cells, suggesting 
Rab proteins were degraded in the 
fixed cells during preparation with 
this protocol. To identify if ENaC co-
localizes with COMMD10 in fixed 
FRT cells coexpressing HA-tagged 
ENaC (immunostaining with anti-HA HRP and Tyramide conjugated AF-546) and 
COMMD10-GFP, were analyzed but there was no distinct staining above background.  
 Identifying ENaC colocalization with VPS35 should also give a clue about ENaC 
recycling, hypothesizing that ENaC should colocalize with VPS35 on Rab5- and Rab7-
positive endosomes, as the results showed that regulated recycling of ENaC was impaired 




4.2 Evaluation of ENaC and retromer (VPS35) colocalization  
 
Previous studies showed that knockdown of the retromer core VPS35 protein reduced 
ENaC current while increasing VPS35 level by stabilizing it with R55 increased ENaC 
current (Cheung et al., manuscript submitted). The results above (section 3.3.3.2) also 
showed that FSK-stimulated ENaC current was reduced in VPS35-depleted mCCD 








FRT cells co-expressing HA-tagged ENaC (immunostained 
with anti-rabbit conjugated AF-488) and Rab7a-DsRed in 
fixed cells. ENaC is observed on endosome-shaped and -
sized compartment having tubule-like structures, however, 
Rab proteins were not detected 
 





surface, probably through endosomal sorting. Therefore, ENaC is likely co-localized with 
VPS35. To investigate ENaC-retromer colocalization, an immunocytochemistry (ICC) 
assay was performed with mCCDcl1 cells that express both endogenous ENaC and VPS35. 
A protocol for this study was developed based on Abcam’s ICC protocols and, based on 
published protocols (Li et al., 2016; Assmus et al., 2017) providing ENaC-special 
immunostaining in mCCDcl1 cells. It was expected that VPS35 and ENaC would colocalize 
in the cytoplasm, especially around the early endosomes since ENaC is recycled through 
endosomes retromer-dependent manner (section 3.3.3.2). 
  
 
4.2.1 Is ENaC co-localized with VPS35? 
 
mCCD cells for immunostaining was prepared as described in section 2.12.1. To detect 
ENaC rabbit anti-αENaC antibody (pAb) and then anti-rabbit conjugated with AF-488 
(sAb) was used while for VPS35, goat anti-VPS35 (pAb) and then anti-goat conjugated 
with AF-546 (sAb) was used, before confocal imaging.  ‘Lookup Table’ function was 
increased to remove background colors in the NIS-Elements viewer software (Nikon, 
v5.21). 
 Representative images provided in Appendix E, Figure E.1 A and z-stack images in 
Figure E.1 B shows that ENaC (green) and VPS35 (red) staining mostly occurs on vesicular 
and tubule-like structures. Quantification of the colocalization between ENaC and VPS35 
revealed the Pearson correlation coefficient to be 0.72 (PCC, 0.723 ± 0.109, Figure IV.1 C), 
which means that there is 72% pixel-by-pixel covariance in the signal levels of two 
images. Because the calculation subtracts the mean intensity from each pixel's intensity 
value, the PCC is independent of signal levels and signal offset (background). Therefore, 
Mander’s overlap co-efficient (MOC) was also used to overcome this problem using 
absolute intensities but not the deviation from the mean (PCC). Two Mander’s overlap co-
effcients were calculated giving values of: M1, 0.8394 ±0.128, and M2, 0.7923±0.139, 
Figure IV.1 C. The MOC-M1 results, given in Figure IV.1 C, means that 83.9% of all green 
pixels co-occur with red pixels in the images, MOC-M2 means that 79.2% of all red pixels 
co-occur with green pixels. 
 However, later it was realized that this type of fluorescence is autofluorescence 





expressed FRT cells immunostained with the same anti-αENaC pAb and AF-488 sAb. 
These results showed that all FRT cells were in the similar level of fluorescence suggesting 
that anti-αENaC Ab does not bind to ENaC, and the fluorescence is cellular 
autofluorescence that is detected by other channels where there is also staining failed.  
Further experiments are needed to clarify the role of COMMD10, VPS35, and other 
subunits of endosomal sorting complexes specifically in ENaC regulation through triple 
labelling of ENaC, Rab and COMMD10, VPS35-positive sorting and recycling endosomes 
























































5.1 Are COMMDs regulated by aldosterone? 
 
 Endosomal sorting mechanisms allow regulation of the cell surface populations of many 
membrane proteins, however it is not known if endosomal sorting complexes are 
themselves regulated. The ENaC cell surface population is altered in the presence of 
various hormones, and it is possible that those hormones alter the activity, expression or 
stability of endosomal sorting complex proteins. To identify, firstly, whether the subunits 
of endosomal sorting complexes (retromer, SNXs, WASH, retriever and CCC ) are the 
targets for any hormonal regulation, a thorough search through Renal Epithelial 
Transcriptome and Proteome Databases, 
https://hpcwebapps.cit.nih.gov/ESBL/Database/) and through the PubMed database 
was performed. Vasopressin, aldosterone, insulin, and insulin-like growth factor-1 (IGF-
1) hormones upregulate ENaC in kidney principal cells (Reif et al., 1986; Marunaka et al., 
1992; Verrey, 1999; Ecelbarger et al., 2001; Ilatovskaya et al., 2015) and the literature 
was searched to identify if these hormones have been reported to regulate mRNA and/or 
protein levels of endosomal sorting complex subunits including COMMDs (see Table 5.1). 
 









The search showed that only a few subunits of these complexes were reported to be 
regulated by some hormones in the kidney. The search results for collecting duct cells are 
as follows: 
Vasopressin. In response to vasopressin Commd7 mRNA was increased significantly 
(P<0.05) by 200% (Sandoval et al., 2016). The mRNA abundance for Cdc53, a subunit of 
the WASH complex, was increased by 250% percent in response to 24 h of dDAVP (1nM) 
treatment in mouse mpkCCD cells (Sandoval et al., 2016). Of the SNXs only SNX1 mRNA 
Complex Subunits 
Retromer Vps26, Vps29, Vps35 
SNXs SNX1,2,5,6 and SNX3,17,27 
WASH 
WASHC1,  WASHC2, WASHC3, 
WASHC4, WASHC5, 
Retriever Vps26, VPS35L, DSCR3 





level was increased significantly (P<0.05) by 200% in response to the same concentration 
of dDAVP (1nM) for 24h (Sandoval et al., 2016). 
Aldosterone. Single-cell transcriptome analysis showed that long-term aldosterone 
treatment (6 days) doesn’t change the mRNA level of any of the subunits given in Table 
5.1, but as expected aldosterone increases αENaC mRNA by 1.4 fold in mouse 
DCT2/CNT/iCCD cells (Poulsen et al., 2018).  
In another transcriptome analysis of a mouse kidney cortical collecting duct cell 
line treated with either aldosterone or vasopressin for 4 h, no changes for any of the 
subunits in Table 5.1 were reported (Robert-Nicoud et al., 2001), although other genes 
were found to be regulated by these hormones.  
Insulin and IGF-1. No reports were found that recorded changes in mRNA level for any 
of the subunits in Table 5.1 in response to insulin or IGF-1. However, it was shown that 
only the protein level of VPS35 among the subunits was decreased 30% (P=0.006) in the 
kidney of diabetic rats compared to controls (Al Hariri et al., 2017).  
 Taken together, it is seen that some of the subunits of endosomal sorting 
complexes are hormonally regulated while others are not or they are not studied yet. 
Similarly, no report was found showing the effect of aldosterone – the main regulator of 
ENaC – on COMMD1-10 mRNA and protein levels in 30 min as an early phase action and 
3 and 24 hours were not studied.  
 In the kidney collecting duct, aldosterone enhances the cell membrane abundance 
of ENaC within 30 min (in adrenalectomized rat), while the remaining total cellular 
expression of ENaC is unchanged (El Mernissi & Doucet, 1983; Horisberger & Diezi, 1983; 
Loffing et al., 2001; Summa et al., 2001). This early phase of aldosterone action is achieved 
through the SGK1 pathway (Chen et al., 1999). Thus, the aldosterone-mediated 
phosphorylation of SGK1 upregulates ENaC by phosphorylating Nedd4-2 and thereby 
preventing internalization of ENaC (Debonneville et al., 2001; Snyder et al., 2002; 
Balderhaar et al., 2010; Hallows et al., 2010; Lang & Stournaras, 2013). A new period of 
increase in Na+ absorption starts within 3 hours after exposure to aldosterone which is 
realized through transcription of the αENaC subunit (Girardet et al., 1986; Loffing et al., 
2001).  
Recently, ankyrin G (AnkG) – a protein involved in vesicular transport was 
identified as an aldosterone-induced protein which alters Na+ transport in mouse cortical 





insertion of ENaC from the constitutive recycling pathway. Although COMMD family 
proteins probably regulate ENaC through regulated recycling pathway (FSK stimulation 
results, section 3.3.2.1), it was hypothesized that aldosterone can adjust COMMD protein 
levels depending on requirements for Na+ homeostasis as it was also shown that 10 µM 
aldosterone causes a time-dependent reduction in COMMD10 (but not in COMMD1) 
protein levels in M1CCD cells ((Ware, 2017), PhD Thesis).  
 
 
5.1.1 Aldosterone increases endogenous ENaC current in mCCDcl1 epithelia 
 
To confirm the aldosterone effect on ENaC cell surface activity in mCCDcl1 epithelia at 0.5, 
3, and 24 hours, ENaC Isc was measured by Ussing assay. Briefly, the mCCDcl1 cells were 
cultured for electrophysiological studies as described in section 2.8.2. The epithelia were 
treated with 300 nM aldosterone as described in section 2.7 for three time periods: 0.5, 3, 
and 24 hours. The time periods of 30 min and 3 hours were taken to identify the 
aldosterone early phase action (El Mernissi & Doucet, 1983; Horisberger & Diezi, 1983; 
Loffing et al., 2001; Summa et al., 2001) and the start of late phase action (Girardet et al., 
1986; Loffing et al., 2001) on ENaC activity, respectively. However, the 24 hour treatment 
was taken for a long-term aldosterone effect. Although the concentration of 300 nM does 
not represent physiological plasma aldosterone concentration, this concentration has 
been used previously in many studies for ENaC physiology (Verrey et al., 1989; Olivera et 
al., 2000; Gaeggeler et al., 2005). 
 In the first experiment, aldosterone treatment of epithelia mounted in Ussing 
chamber was performed directly by adding aldosterone into the basolateral Ringer’s 
solution as described previously (Gaeggeler et al., 2005). Epithelia was incubated over 3 
hours with continuous measurement of the current to observe the effect of aldosterone 
in real-time. However, due to the continuous decrease in the Isc of both vehicle and aldo-
treated epithelia (possibly due to the cell death that was indicated by continuous decrease 
in resistance), no difference between vehicle and aldosterone-treated epithelia could be 
identified. The reason for failure may have been due to using mCCD-special Ringer’s 
solution in the Ussing chamber instead of growth medium as used in a previous study 
(Gaeggeler et al., 2005). It was then decided to change the technique to aldosterone-





the cell culture incubator before mounting the epithelia in the Ussing chamber for current 
measurement.  
 After incubation for various times with aldosterone, Isc of mCCD epithelia was 
measured. Table 5.2 summarizes the actual Isc and resistance mean values of all time 
periods performed in this experiment as vehicle versus aldosterone treated epithelia. To 
perform quantitative analysis, Isc and resistance values in control epithelia were 
normalized to 1 and those in aldo-treated epithelia were compared to that in the 
normalized control. The comparison of vehicle with aldo-treated epithelia for all time 
periods showed that aldosterone increases the Isc in a time-dependent manner (0.5 hour: 
1 for control epithelia vs 1.57 ± 0.22 for aldo-treated epithelia *P<0.05; 3 hours: 1 for 
control epithelia vs 1.34 ± 0.34 for aldo-treated epithelia, P=0.09; 24 hours: 1 for control 
epithelia vs 2.419 ± 0.652 for aldo-treated epithelia, *P<0.05. One-sample t-test for each 
veh-aldo pair separately, mean ± SD. N = 4.  Figure 5.1 A).  
 Analysis of normalized transepithelial resistances showed that resistances in 
aldosterone treated epithelia were increased with 0.5-hour treatment significantly when 
normalized, but with later time points not significantly (0.5 hour: 1 for control epithelia 
vs 1.55 ± 0.17 for aldo-treated epithelia, **P<0.01; 3 hours: 1 for control epithelia vs 1.9 
± 1.45 for aldo-treated epithelia, P>0.05; 24 hours: 1 for control epithelia vs 1.73 ± 0.98 
for aldo-treated epithelia, P>0.05. One-sample t-test for each veh-aldo pair separately, 
mean ± SD. N = 4. Figure 5.1 B and C). The increase in resistance by aldosterone is 
consistent with the results of previous studies showing that aldosterone increases tight 
junction formation through upregulating the expression of claudin-4 in the renal cortical 
collecting duct (Rajagopal & Yu, 2015). Claudin 4, one of the main tight junction (TJ) 
proteins, was shown to decrease Na+ paracellular permeability in MDCK cells (Van Itallie 
et al., 2001). 
 









































































































Mean 19 365 28 553 20 380 26 561 17 412 35 558 
   





mCCDcl1 cells were seeded on permeable Snapwell filters and incubated in growth medium. On the fifth 
day after seeding, the medium was changed to filter cup medium supplemented with less dexamethasone 
(3 nM). Medium was changed to sterile medium for last 24 h during treatment period before measuring the 
current. Aldosterone (Aldo, 300 nM) and Vehicle (Veh, 100% DMSO) were dissolved in new sterile medium 
and added onto cells after removing the sterile medium). After each treatment period, currents were 
measured after mounting the epithelia in an Ussing chamber. Isc and resistance values in control epithelia 
were normalized to 1 and those in aldo-treated epithelia were compared to that in normalized control. A, 
Pooled relative ENaC Isc results showing significant increase in 0.5 and 24 hours. One-sample t-test for each 
veh-aldo pair separately. *P<0.05; N=4.  B and C, Pooled relative transepithelial resistance results across 
the same experiments showing significant increase at 0.5 and 24 hours. One-sample t-test for each veh-aldo 
pair separately. *P<0.05,  **P<0.01; N=4.  
 
As the Isc results show that 300 nM aldosterone increases Isc, representing ENaC activity, 
in mCCD epithelia, this concentration was used to investigate the mRNA levels of 









5.1.2 mRNA levels of COMMD1-10 are not regulated by aldosterone 
 
 
To study the effect of aldosterone on mRNA expression levels of COMMD1-10, RT-qPCR 
assay was carried out with mCCDcl1 epithelia.  Cells were grown on 24 mm Transwells to 
obtain polar epithelia and incubated with vehicle (100% DMSO) or 300 nM (final 
concentration) aldosterone (dissolved in 100% DMSO) for 0, 0.5, 3, or 24 hours in serum 
and drug free medium as described in section 2.7. After each aldosterone/vehicle 
treatment period, RNA was extracted as described in section 2.4.1 and cDNAs were 
synthesized using the PrimeScript RT Reagent Kit as described in section 2.4.3.  
COMMD1-10, SGK1 and β-actin primers were amplified from cDNAs of 0 min aldosterone treated cells by 
RT-qPCR and then the PCR products obtained were analyzed on a 3% agarose gel after adding loading dye. 
PCR fragments are observed at their expected sizes compared with 500 bp band of the 1 kb DNA ladder 
loaded in lanes labelled Ladder suggesting that primers are specific and amplifying a single product except 
for the COMMD3 primers that produced primer dimers.  
 
mRNA level of COMMD1-10 proteins in mCCD epithelia was quantified by RT-qPCR as 
described in section 2.4.4 and amplicon sizes were confirmed by analysis on a 3% agarose 
gel (Figure 5.2). Annealing temperature for COMMD1-10 and SGK1 was tested with 60°C, 
55°C and 58°C to identify the optimal point for most efficient DNA amplification. However, 
no significant difference in cycle numbers for COMMD1-10 and SGK1 was observed, 
therefore a middle point (58°C) was chosen for further experiments.  
 In the PCR experiments, amplification cycle numbers for COMMD1-10 ranged from 
21 to 23 cycles, for β-actin from 15 to 17 cycles, however for SGK1 from cycle number 
ranged from 15 to 31 cycles depending on the aldosterone treatment period. Very rarely, 
137 kb 96 kb 159 kb 104 195 196 90 kb 154 kb 77 kb  173 kb 83 kb 165 kb 
500 bp- 





DNA amplification with cycle number 36-39 were observed in some of the negative 
(water) control triplets, and primer dimerization was observed at high cycle numbers 
only with COMMD3 primers (as seen in Figure 5.2 above). However, the PCR efficiency for 
COMMD3 as well as for other COMMDs was in acceptable ranges. Thus, to create a 
standard curve, the PCR efficiency control experiments were performed with a 4-fold 
dilution series of cDNA starting with an undiluted cDNA sample and with standard primer 
concentration (2 pmol) of all COMMDs, reference gene β-actin and SGK1. Ct values 
(number of cycles) were plotted as the function of log (base 4) of dilution factor. The slope 
was around -1.9, R-squared (the coefficient of multiple determination for multiple 
regression) values were very close to 1 (100%, (100% indicates that the model explains 
all the variability of the response data around its mean)) and PCR efficiencies were ranged 
between 95-110% (see, Appendix B) which is the acceptable range (Bustin et al., 2009). 
 Before evaluating the effect of aldosterone, mRNA levels of COMMDs from non-
treated samples (0 min) were compared and the results showed that mCCDcl1 epithelia 
express COMMD1-10 genes at a variety of levels (Figure 5.3 A). The mRNA levels (given 
in ΔC value) of COMMD4 (7.38±0.12, **P<0.01), COMMD5 (7.13±0.28, *P<0.05), and 
COMMD9 (7.70±0.83, ***P<0.001) were found to be significantly higher than COMMD10 
mRNA (5.85±0.23, One-way ANOVA (multiple comparisons). N=4) – the main focus of this 
project. Like the mRNAs of COMMD1-10, protein abundance (log10) also were shown to 
vary in mouse mpkCCD cells (https://hpcwebapps.cit.nih.gov/ESBL/Database) (Yang et 
al., 2015), however, the difference in mRNA levels and in protein abundances of COMMD1-
10 do not overlap (Figure 5.3 B). This variety suggests that although all COMMD1-10 
proteins are involved in the CCC complex (Phillips-Krawczak et al., 2015), they may exist 
in this complex in various ratios or they may function in cells separate from the CCC 





A, mRNA levels of COMMD1-10 (given in ΔC value – Ct value of a COMMD minus Ct value of β-actin of the 
same sample) in mCCDcl1 epithelia. The results show uneven levels of COMMD1-10 mRNAs and significant 
difference when compared to COMMD10 mRNA ΔC value. One-way ANOVA (multiple comparisons), 
*P<0.05, **P<0.01, ***P<0.001, mean ± SD. N=4. B, comparison of mRNA ΔC values in mCCDcl1 epithelia and 
logarithmic(10) protein abundance of COMMD1-10 in mpkCCD epithelia (Yang et al., 2015).  
 
For aldo-treatment time course analysis, as a relative quantification (RQ) strategy, the 2-
ΔΔCT method was used to quantify expression levels of COMMD1-10. Results were analyzed 
by one-way ANOVA for each COMMD separately. Transcripts detected for each target 
were normalized to that of β-actin which was taken as a reference gene. It was previously 
shown that β-actin is not regulated by aldosterone (Náray-Fejes-Tóth et al., 1999) 
suggesting that it is a reliable reference gene for this study.  
The analysis showed that aldosterone does not significantly change the mRNA 
levels of any COMMD1-10 (RQ values were not beyond 0.5 and 2) at any time period 
(Figure 5.4 A). Table 1 in Appendix C provides the RQ values of all COMMD1-10 together 
with standard deviation (SD) values, P values and experiment numbers (N) for 
aldosterone-treated epithelia compared to vehicle-treated epithelia.  
To test whether aldosterone was able to regulate mRNA levels of a known 
aldosterone-sensitive gene in mCCDcl1 epithelia, qPCR was used to amplify SGK1 mRNA 
in parallel, as a positive control for aldosterone treatment. The results showed SGK1 
mRNA was significantly increased at each time period (30 min: 1 for vehicle vs 3.82±2.45 
for aldo-treated epithelia, *P< 0.05, N=7; 3 hours: 1 for vehicle vs 33.58±10.28 for aldo-
treated epithelia, **P<0.01, N=4; 24 hours: 1 for vehicle vs 48.12±11.23 for aldo-treated 
epithelia, **P<0.01, N=4. One-sample t-test for each pair of time period separately. Figure 
A B 





5.4 B) as expected which is consistent with the results of others (Náray-Fejes-Tóth et al., 
1999; Jacobs et al., 2016; Welch et al., 2016).  
 
mCCDcl1 cells were grown on permeable membranes, treated with DMSO or 300 nM aldosterone (in DMSO) 
for 0, 0.5, 3, and 24 hours in serum and drug free medium 6 days after seeding. Cells were lysed in Trizol 
and cDNA was synthesized with a PrimeScript RT Reagent Kit. PCR assays were performed with 10 ng of 
cDNA in 10 μl reactions. mRNA levels of COMMD1-10 and SGK1 were quantified by RT-qPCR. A, Column 
statistics of mRNA levels (in RQ values) of COMMD1-10 showed that they are not changed significantly 
(clinically (RQ values were not beyond 0.5 and 2)) by aldosterone at any time period. One-way ANOVA, 
mean ± SD; N=7 for 30 min, N=4 for 3 and 24 hour periods. B, mRNA levels of SGK1 were measured as a 
positive control for aldosterone treatment, and were increased significantly at all three time periods. Veh-
vehicle (DMSO), Aldo-aldosterone (in DMSO). One-sample t-test, mean ± SD; N=7 for 30 min, N=4 for 3 and 









The results suggest that although COMMD proteins are involved in the 
upregulation of ENaC ((Ware et al., 2018) and sections 3.1.2, 3.1.3 and 3.2.2), the mRNA 
expression of these genes are not a target for aldosterone. However, as mentioned above, 
previous studies in McDonald laboratory had shown that aldosterone downregulates 
COMMD10 protein levels, but not COMMD1, time-dependently in M1-CCD cells (Ware, 
2017). Therefore, it was hypothesized that aldosterone should change COMMD protein 




5.1.3 COMMD1 and COMMD10 protein levels were decreased by aldosterone in 
mCCDcl1 cell line  
 
 
To evaluate the effect of aldosterone on COMMD protein levels, Western blot 
analysis was performed.  For that purpose, firstly, protein samples were precipitated (by 
isopropanol precipitation method) from the same TRizol lysates that were used for RNA 
extraction for qPCR (section 5.1.2). However, when analyzed by 10% SDS-PAGE gel, 
proteins aggregated and did not migrate into the gel from the wells. Therefore, new cells 
were grown and treated with aldosterone in the same way as for the PCR assay (or as 
described in section 2.7), and proteins were extracted for Western blot analysis as 
described in section 2.5. Samples were separated using 10% SDS-PAGE gel and the 
membranes were blotted with anti-COMMD1, 3, 9 (Raised in McDonald lab, (Ke et al., 
2010; Liu et al., 2013)) and COMMD10 (GeneTex) antibodies. However, COMMD bands 
were only detected with the COMMD1 and -10 antibodies. Representative Western blot 
images for COMMD1 and 10 are given in Figure 5.5 A, with pooled results shown in Figure 
5.5 B and C.  
 COMMD1 and -10 protein levels were significantly decreased after 300 nM 
aldosterone treatment for 30 min (COMMD1: 1 for vehicle vs 0.63±0.09 for aldo; 
COMMD10: 1 for vehicle vs 0.76 ±0.09 for aldo, One-sample t test for each veh-aldo-
treated cells separately, *P˂0.05, N=4 for COMMD1, N=3 for COMMD10), however there 
were no significant differences at the 3- and 24-hour treatment periods (Figure 5.5 B and 





  Since many studies of aldosterone regulation of gene expression is carried out with 
a higher dose of aldosterone (Godfrey et al., 2011; Yoshika et al., 2011), another two 
experiments were performed with 10 µM aldosterone. Only COMMD10 protein levels 
were measured, to identify if a higher concentration of aldosterone decreases COMMD 
protein levels. However, the results showed no reduction in COMMD10 at any time point 
(data not shown). Higher levels of aldosterone possibly start the transcription of ENaC in 
a very short time and thereby the SGK1/Nedd4-2 pathway may not be needed as the 
endocytosis blockage should be the main reason for slowing the recycling pathway 
through reducing COMMD levels. 
mCCDcl1 cells were grown on permeable membranes, treated with 300 nM aldosterone for 0, 0.5, 3, and 24 
h in serum and drug free medium. Protein levels of COMMD1 and 10 were identified by Western blot. 
Vehicle-treated epithelia COMMD protein levels were normalized to 1 while aldo-treated epithelia protein 
levels were compared to that of vehicle epithelia. Veh-vehicle (100% DMSO), Aldo—aldosterone (in 100% 
DMSO). A, Representative blots for COMMD1 and -10 protein levels in mCCDcl1 cells. B and C, Pooled 
relative protein levels of COMMD1 and -10 that were significantly decreased only with 30 min aldo-
treatment. Mean ± SD relative to COMMD1 or -10 level in vehicle treated epithelia. All Western blot 
densitometry results were analyzed in aldo-vehicle pairs separately using a One-sample t test. *P˂0.05; N=4 
for COMMD1, N=3 for COMMD10. 
B 
A 






 To test whether aldosterone was able to regulate protein levels of a known 
aldosterone-regulated protein in mCCDcl1 epithelia, Western blot was used to determine 
SGK1 and phosphorylated SGK1 (pSGK1) as a positive control for aldosterone treatment. 
It was shown that aldosterone induces mRNA expression of (SGK1) at 15 min and reaches 
a significant level of change at 30 min (Náray-Fejes-Tóth et al., 1999) in rabbit CCD cells 
which also increases the protein level of SGK1 at 30 min. Furthermore, aldosterone 
mediates phosphorylation of SGK1 at its Ser422 amino acid through which cell surface 
ENaC is upregulated as an early phase impact of aldosterone (Debonneville et al., 2001; 
Snyder et al., 2002).  
 Aldosterone-mediated induction of SGK1 protein levels and indirect 
phosphorylation has been studied in native kidney distal tubule and in many cell lines 
including amphibian collecting duct like cells (A6)(Chen et al., 1999) and mesangium 
(Terada et al., 2008). However, no report was found on the aldosterone effect on SGK1 
protein levels and its SGK1-phosphorylation in the mCCDcl1 cell line.  
To evaluate SGK1 and pSGK1 protein levels, the same mCCDcl1 cell lysates that 
were used for COMMD protein levels (Figure 5.5) were analyzed. To detect pSGK1(S422) 
protein, firstly an antibody from Abcam (ab55281) was used, but it didn’t detect any 
protein, although it was tested in two experiments. Then, another anti–pSGK1(S422) 
antibody from Santa Cruz Biotechnology (sc-16745) was used which specifically 
recognized endogenous pSGK1(S422). This antibody detected the pSGK1 at ~69-70 kD as 
expected (https://datasheets.scbt.com/sc-16745.pdf) which is also consistent with the 
results of Lu and coworkers (Lu et al., 2010).  
A second anti-SGK1 antibody (Abcam ab59337) detected SGK1 at ~ 60 kD (mainly; 
consistent with manufacturer’s indication), at ~69 kD, and a few other bands (data not 
shown) with less signal while anti-pSGK1(422) antibody detected SGK1 as a single band 
at ~69 kD. Representative Western blot images are given in Figure 5.6 A. All Western blot 
densitometry results were analyzed in aldo-vehicle pairs separately by unpaired t-test.  
Positive controls SGK1 and phospho-SGK1 protein levels showed a trend towards 
an increase by aldosterone at all time periods as seen in the Figure 5.6 B and C (and data 







mCCDcl1 cells were grown on permeable membranes, treated with 300 nM aldosterone for 0, 0.5, 3, and 24 
h in serum and drug free medium. Protein levels of SGK1 and pSGK1 were identified by Western blot. Vehicle 
epithelia SGK1 protein levels were normalized to 1 and aldo-treated cell protein levels were compared to 
that of vehicle epithelia. Veh-vehicle (DMSO), Aldo—aldosterone (in DMSO). A, Representative blots for 
SGK1 and phospho-SGK1(S422) protein levels in mCCDcl1 cells. B and C, Pooled relative protein levels for 
SGK1 and phospho-SGK1(S422) that showed a trend towards an increase. One-sample t-test for each veh-
aldo pair. Mean ± SD relative to SGK1 or pSGK1 level in vehicle treated epithelia. *P˂0.05; N=3 for SGK1 and 














The results confirmed that aldosterone upregulated ENaC Isc at 30 min probably 
preventing ENaC internalization possibly through pSGK1 phosphorylating Nedd4-2 
reducing ENaC ubiquitination and endocytosis (Debonneville et al., 2001; Snyder et al., 
2002). However, aldosterone was expected to upregulate COMMD protein levels, as the 
COMMD family proteins are thought to function in a regulated recycling pathway ((Vistein 
& Puthenveedu, 2013; Bowman et al., 2016) and forskolin results – sections 3.3.2.1 , 
3.3.3.2). One possible reason for the decrease in COMMD protein levels at 30 min could 
be due to the need to maintain a constant amount of the plasma membrane. Thus, as ENaC 
internalization is prevented by aldosterone, new vesicle fusions from recycling pathways 
are required to be prevented at that time period, however, at the later time periods, as 
ENaC is upregulated through biosynthetic pathway, prevention of membrane 
internalization is not required and therefore possibly recycling pathway also “opened” 
that does not require COMMD1 and -10 protein levels to be reduced. This possible 

























5.2 COMMD10 protein stabilizes COMMD1 and VPS35 proteins 
 
Many studies have shown that some of the subunits of the CCC, WASH and retromer 
complexes stabilize each other, and that interaction between the individual proteins are 
required for complex stability. Thus, for example, knocking down one of the core retromer 
proteins (Vps35–Vps29–Vps26) decreases other retromer protein levels (Arighi et al., 
2004; Seaman, 2004; Verges et al., 2004; Small et al., 2005). Similarly, CCC subunits also 
stabilize other components of the complex. Thus, silencing of CCDC22 or CCDC93 was 
shown to reduce each other significantly, but not COMMD1 (Phillips-Krawczak et al., 
2015; Fedoseienko et al., 2018). However, knockout of Commd1 in mouse embryo 
fibroblasts (MEFs) also decreased Ccdc22 and Ccdc93 protein levels (Phillips-Krawczak 
et al., 2015). Furthermore, hepatic COMMD1, -6, or -9 knockout was shown to reduce the 
protein levels of all 10 COMMDs, CCDC22, CCDC93, and the retriever subunit VPS35L 
(Fedoseienko et al., 2018). COMMD10 deficiency in the liver has been shown to also 
reduce CCC complex stabilization (Ben Shlomo et al., 2019). Finally, COMMD8 and 
COMMD3 protein stability was recently shown to be interdependent in mouse B cells 
(Nakai et al., 2019). Previous studies showed that COMMD10 protein knockdown 
decreased the protein levels of COMMD1 and Vps35 in FRT cells suggesting loss of CCC 
complex destabilizes the retromer complex as well (Cheung et al, paper in revision).  
 To extend these findings, the effect of COMMD10 knockdown in mCCDcl1 cells on 
the protein levels of COMMD1 and VPS35 was tested. mCCDcl1 cells were transfected with 
siRNA for COMMD10 or with control siRNA in suspension. On the fifth day after 
transfection, cells were lysed and the lysates were analyzed by SDS-PAGE gel, and western 
blot analysis was performed with COMMD10, COMMD1 and VPS35 antibodies. 
Representative Western blot images are given in Figure 5.7 A.  
 The analysis showed that COMMD10 was significantly knocked down by 45% (see 
section 3.2.1 above) and that the COMMD1 protein level was similarly reduced by 45% (1 
for control KD cells vs 0.555±0.18 for COMMD KD cells; One-sample t-test, ***P<0.001; 
N=4, n=7.  Figure 5.7 B), suggesting that COMMD1 functions in concert with COMMD10. 
In contrast, the VPS35 protein level was significantly reduced by 21% (1 for control cells 
vs 0.79±0.15 for COMMD KD cells; One-sample t-test, *P=0.05; N=3, n=6. Figure 5.7 C), 






mCCDcl1 cells were transfected with control or COMMD10 siRNA in suspension and lysed on the fifth  day 
of seeding. Protein levels of COMMD1 and VPS35 were identified by Western blot. COMMD1 and VPS35 
protein levels in control cells were normalized to 1 while the protein levels in COMMD10 KD cells were 
compared to that of control cells. A, Representative blots for COMMD1 and VPS35 protein levels together 
with those for COMMD10 and β-actin. B and C, Pooled relative protein levels of COMMD1 and VPS35 that 
were decreased significantly. Mean ± SD relative to COMMD1 or VPS35 level in control cells. One-sample t-
test. *P˂0.05, ***P˂0.001; N=3. n=7 or n=6.  
 
To test whether knockdown of VPS35 also destabilizes the CCC complex, protein levels of 
COMMD1 and COMMD10 were analyzed in VPS35 KD cells. However, Western blot 
analysis showed that none of these proteins were decreased consistently in VPS35 KD 




















mCCDcl1 cells were transfected with control or VPS35 siRNA in suspension and lysed on the fifth  day of 
seeding. Protein levels of COMMD1 and COMMD10 were identified by Western blot. COMMD1 and 
COMMD10 protein levels in control cells were normalized to 1 and the protein levels in VPS35 KD cells were 
compared to that of control cells. A, Representative blots for COMMD1 and COMMD10 protein levels 
together with for VPS35 and β-actin. B, and C, Pooled relative protein levels of COMMD1 and COMMD10 
that were not changed by VPS35 KD. Mean ± SD relative to COMMD1 or COMMD10 level in control cells. 




5.3 Calcium treatment upregulates COMMD protein levels without 
changing their mRNA level 
 
Ca2+ as an important second messenger, and has been shown to inhibit ENaC (Wang & 
Chan, 2000) where an increase in cytoplasmic Ca2+ results in decrease of apical 
















1990; Frindt et al., 1993). However, it is still unclear whether this inhibition is due to a 
direct effect on ENaC or through its other regulation pathways. Some investigations 
showed that cytoplasmic Ca2+ inhibits ENaC by direct interaction (Ismailov et al., 1997) 
whereas others using A6 cells (Ling et al., 1997) and rat CCD cells (Palmer & Frindt, 1987) 
suggested that cytoplasmic Ca2+ inhibits ENaC by indirect interaction and through other 
second messengers. Another study reported that Ca2+ directly interacts with endogenous 
ENaC and negatively regulates ENaC open probability without alteration in channel 
conductance (Gu, 2008). However, the contribution of recycling pathways to ENaC 
activity regulated by Ca2+ has not been considered. The original report on COMMD5, 
described this protein as a hypertension-related, calcium-regulated gene (HCaRG) that was 
highly expressed in kidney tubules and more highly expressed in kidneys from 




5.3.1 Calcium treatment doesn’t change mRNA levels of COMMDs in mCCD epithelia 
 
COMMD5 was shown to be negatively regulated by extracellular calcium concentration, 
and its basal mRNA and protein levels were found to be higher in hypertensive animals 
(Solban et al., 2000). Therefore, it was hypothesized that COMMDs in mCCDcl1 cells can 
be regulated by extracellular calcium and thereby can modulate ENaC cell surface activity. 
To test this hypothesis mCCDcl1 cells were treated with CaCl2 and mRNA levels of 
COMMD1, COMMD10, and as a positive control COMMD5 were evaluated. 
Since calcium concentration in the basal culture medium for mCCD cells is 1.05 mM 
and because calcium content in FBS ranges from 3.5–4 mM (Blankenship & Heitman, 
2005), and considering that in the media, there is 10% of FBS, the final concentration of 
calcium in the media is 1.45 mM of Ca2+. Therefore, for Ca2+ stimulation, mCCD cells were 
treated with an extra 2 and 4 mM CaCl2, with the final concentrations between 2.45-7.45 
mM. These concentrations are similar to those used in many previous investigations 
(Crilly et al., 1999) (Sakaguchi et al., 2003; Robben et al., 2006) with up to 20 mM Ca2+ 
being used (Lorget et al., 2000; Lee et al., 2018) where the free, physiologically active 
calcium (often called ionized calcium) concentration in the plasma is approximately 1.1 





were grown on permeable Transwells, treated with 2 or 4 mM CaCl2 in complete medium 
24 hours after seeding, for a total of 72 hours. The cells were lysed by TRizol, RNA was 
extracted as described in section 2.4.2, cDNA was synthesized using 750 ng of RNA and 
PCR was performed in 10 μL reactions as described in sections 2.4.3 and 2.4.4, 
respectively. 
The 2-ΔΔCT method was used to quantify the mRNA levels of COMMD1, 5, and 10.  
Analysis of the results by column statistics showed that the mRNA levels of COMMD1, 5, 
and 10 remained stable after Ca2+ treatment in mCCD cells (Figure 5.9), and this result 
was confirmed by two-way ANOVA (Dunnett's multiple comparisons test, P>0.05, N=3). 
β-actin was used as a control housekeeping gene, and mRNA levels of β-actin were 
evaluated by normalizing Ct values (cycle numbers) of β-actin in control cells to one and 
comparing the Ct values of β-actin in treated cells to the normalized control. Thus, 
although the mRNA levels of β-actin were not adjusted with any control housekeeping 
gene (as β-actin itself was used as a control housekeeping gene), the Ct values of β-actin 
in control and treated cells were very similar (which is seen in the Figure 5.9, right) 
suggesting that the mRNA levels of β-actin are not controlled by extracellular Ca2+.  
mCCDcl1 cells were grown on permeable membranes, treated with 2 or 4 mM CaCl2 in complete medium 
24 hours after seeding the cells, for a total of 72 hours. cDNA was synthesized with PrimeScript RT Reagent 
Kit. RT-qPCR assay was performed with 10 ng of cDNA in 10 μL reactions. mRNA levels of COMMD1, 5 and 
10 and β-actin were not changed by 2 mM and 4 mM concentrations of extracellular Ca2+. β-actin mRNA 
levels were evaluated by normalizing Ct values of β-actin in control cells to one and comparing the Ct values 
of β-actin in treated cells to the normalized control.  Two-way ANOVA (Dunnett's multiple comparisons 
test). P>0.05, N=3.  





5.3.2 Calcium treatment upregulates COMMD protein levels in mCCD cells  
 
Although the previous study above showed that Ca2+ doesn’t change mRNA levels of 
COMMD1, 5 and 10, it was hypothesized that Ca2+ can change the protein levels of 
COMMDs as it was reported in parathyroid cells (Solban et al., 2000). To identify if Ca2+ 
regulates the protein levels of COMMDs, Western blot experiments were performed with 
anti-COMMD1 and 10 antibodies, however, a COMMD5 antibody was not available. 
Furthermore, as the previous results showed that COMMD10 KD destabilizes COMMD1 
and VPS35, the protein levels of COMMD1 and VPS35 also were analyzed, hypothesizing 
that increase in COMMD10 protein level may enhance the protein levels of COMMD1 and 
VPS35, through stabilizing them. 
 mCCDcl1 cells were treated with an extra 1, 2, 4, or 6 mM CaCl2 in complete 
medium 24 hours after seeding, for a total of 72 hours. The cells were lysed and prepared 
as described in section 2.5.1, and samples were analyzed on a 10% SDS-PAGE gel. β-actin 
protein levels were found decreased by Ca2+ treatment, therefore, GAPDH protein levels 
were used as a loading control. Representative Western blot images are shown in Figure 
5.10 A. Densitometry results were analyzed by one-way ANOVA.  
The one-way ANOVA analysis showed that Ca2+ treatment increased COMMD10 
protein levels overall (*P<0.05; after 1 mM (1 for control vs 1.42±1.19 for 1 mM Ca2+ tr.), 
after 2 mM (1 for control vs 2.20±1.00 for 2 mM Ca2+ tr.), after 4 mM (1 for control vs 
1.43±0.37 for 4 mM Ca2+ tr.), and after 6 mM (1 for control vs 1.2±0.43 for 6 mM Ca2+ tr.), 
Figure 5.10 B).    
COMMD1 protein levels also followed a similar pattern of increase to COMM10, 
protein levels, however, one-way ANOVA analysis showed that these increases are not 
significant, suggesting that the increase is possibly mediated through stabilization by 
COMMD10 protein (P> 0.05; after 1 mM (1 for control vs 1.70±0.84 for 1 mM Ca2+ tr.), 
after 2 mM (1 for control vs 1.74±0.76 for 2 mM Ca2+ tr.), after 4 mM (1 for control vs 
1.41±0.58 for 4 mM Ca2+ tr.), and after 6 mM (1 for control vs 0.97±0.46 for 6 mM Ca2+ tr.), 





   
mCCDcl1 cells were treated with extra 1, 2, 4, or 6 mM CaCl2 in complete medium 24 h after seeding, for a 
total of 72 hours. Protein levels of COMMD1, 10, and VPS35 were analyzed by Western blot. COMMD1, 10, 
and VPS35 protein levels in control cells were normalized to 1 while the protein levels in treated cells were 
compared to that of control cells. A, Representative blots including GAPDH blots as loading control. B, C, 
and D, Pooled relative protein levels of COMMD1, 10, and VPS35. COMMD10 protein levels were increased 
by Ca2+ treatment dose-dependently, and COMMD1 and VPS35 protein levels showed similar pattern of 





















It was hypothesized that COMMD10 stabilized by Ca2+ would increase VPS35 
protein levels (section 5.2). Although overall one-way ANOVA not to be significant (1 for 
control vs 1.56±0.25, vs 1.91±0.62, vs 1.65±1.14, vs 1.90±1.04), analysis using unpaired 
t-test of each control-treated pair showed that VPS35 protein levels were increased with 
1 mM and 2 mM Ca2+ treatment significantly (1 for control vs 1.71±0.84 for 1 mM Ca2+ tr, 
***P<0.001, N=4 or N=3), while with 4 mM and 6 mM Ca2+ there was no significant change 
(Figure 5.10 D). 
 The pathway of Ca2+ stimulation of COMMD10 and VPS35 proteins is not known. It 
is also not known if this regulation is direct or indirect. Based on previous reports that 
COMMD5 is a calcium regulated protein and contains a mutated EF-hand in its protein 
sequence (Solban et al., 2000), the protein sequences of all COMMDs including COMMD1 
and COMMD10 were analyzed against EF-hand sequence and there is no whole EF-hand 
sequence present, suggesting that possibly the increase in protein levels is mediated 
through a pathway that does not depend on Ca2+ binding directly to COMMD10/VPS35. It 
is possible that Ca2+ blocks the function of these proteins and as a compensation reaction, 
protein levels of COMMD10/VPS35 are increased. However, to understand how Ca2+ can 
stimulate the endosomal sorting machine subunits and how it results in ENaC cell surface 
activity, further investigations were required on the dynamics of COMMD-mediated 
protein sorting and protein trafficking under Ca2+ treatment. Therefore, it was 
hypothesized that analyzing F-actin distribution and measuring ENaC Isc under 




5.3.3 Calcium treatment changes microfilament organization in U2OS cells 
 
A study demonstrated that 5 mM extracellular calcium strongly inhibited FSK-stimulated 
increase in AQP2 in the apical plasma membrane of AQP2-transfected collecting duct CD8 
cells. One of the pathways activated by the extracellular calcium found to contribute to 
this effect was a twofold increase in F-actin content compared with basal conditions 
(Procino et al., 2004). It was previously shown that gelsolin (a calcium-binding protein)-
Ca2+ complex increases the rate of nucleation of actin which precedes polymerization, but 





by plastin isoforms was found to be negatively regulated by Ca2+ as all plastin isoforms 
contain two N-terminal Ca2+-binding sites and two C-terminal actin-binding sites (Namba 
et al., 1992). It was also shown that Ca2+ influx during excitatory synaptic activity induces 
F–actin depolymerization and causes a ∼53 % reduction in the intensity of phalloidin 
staining (Akopian & Cristofanilli, 2006). COMMDs have also been linked to microfilament 
reorganization (Campion et al., 2018). 
 Therefore, it was hypothesized that Ca2+ can regulate COMMD proteins through 
affecting their recruitment onto endosomes that occurs through the actin-nucleation 
stimulator WASH complex, and therefore, the F-actin distribution was analyzed by 
phalloidin staining.  
Briefly, U2OS cells were grown and stained with phalloidin as described in sections 
2.6.1.3 and 2.13, respectively. Images were taken using the same microscope settings (For 
CH2 - 488.0: Laser Power = 1.2, PMT HV = 22-25, PMT Offset = -127, Pinhole Size: 38.31 
μm and software (with default LUT) for control and Ca2+ treated cells.  
Representative images are given in the Figure 5.11 A, where the upper panel 
represents non-treated control and lower panel represents Ca2+ treated U2OS cells 
showing microfilaments stained with phalloidin (Alexa Flour 488) and nucleus stained 
with DAPI.  Qualitative analysis showed that there are no or very few parallel bundles of 
F-actin in the Ca2+ treated cells. Thus, the F-actin stress fibers demonstrate a more 
disordered distribution compared to control cells. Then, intensity of actin filaments by 
quantifying fluorescence intensity was analyzed. Unpaired t-test was used to compare the 
integrated density of fluorescence relative to area in Ca2+ treated cells to that in control 
cells. The analysis showed that F-actin intensity was significantly reduced in Ca2+ treated 
cells compared to the control cells (1170±408 for control cells vs 780±250 for Ca2+ treated 
cells. Paired t-test, *P<0.05., mean ± SD; N=2, n=8, representing 110 (control) and 92 (Ca2+ 
















































































Cells were treated with CaCl2 to bring its final concentration to ~4 mM (2 mM extra) while control cell were 
grown in normal medium containing ~2 mM Ca2+. Cells were fixed with 3.7% formaldehyde and 
permeabilized with 0.1% Triton X-100. Then the cells were mounted with VECTASHIELD® HardSet™ 
Mounting Medium with DAPI followed by staining with phalloidin conjugated to Alexa Fluor™ 488. A. 
Representative images showing relatively disordered F-actin filaments in Ca2+ treated cells compared to 
control cells qualitatively; B. Quantitative analysis results showing less F-actin intensity Ca2+ treated cells 
compared to control cells. Scale - 10μm; Paired t-test, *P<0.05, mean ± SD; -N=2, n=8, representing 110 
(control) and 92 (Ca2+ treated) cells. 
 
The results showed that Ca2+ treatment changes actin organization and decreases its 
intensity which is inconsistent with the previous report (Procino et al., 2004) mentioned 
above. However, the results suggest that this decrease is not through blocked 
COMMD10/VPS35 function because actin intensity was found not to be changed in 
COMMD10 KD cells (section 3.4.1) but possibly is through increased COMMD10/VPS35 
activity or there is no relationship between COMMD10 and microfilament distribution. 





5.3.4 Calcium treatment leads to actin-coated vesicle enlargement in U2OS cells 
 
 
It has previously been shown that direct elevation of cytoplasmic Ca2+ downregulates 
RhoA, in cultured cerebellar granule cells and HEK293T cells (Jin et al., 2005) where RhoA 
is known as a key regulators of the actin cytoskeleton (Ridley & Hall, 1992; Hall, 1998; 
Girouard et al., 2016). It was also shown that in contrast to RhoA, RhoB recruits 
Diaphanous-related formin, Dia1, to endosomes which is required for the formation of the 
actin coat around EEA1-positive endosomes and delays epidermal growth factor receptor 
trafficking (Fernandez-Borja et al., 2005). Later, an investigation on the role of WASH / 
Arp2/3 in endosomal actin formation revealed that an actin meshwork is a requirement 
for endosomal sorting and trafficking (Duleh & Welch, 2010). Only one report on Ca2+-
RhoB interaction was found. This report showed that hypoxia-induced intracellular 
calcium levels have no effect on RhoB activation or inhibition (Wojciak-Stothard et al., 
2012). A recent investigation showed that CCC depletion results in F-actin accumulation 





on endosomes through increasing WASH complex activity (Singla et al., 2019). Thus, their 
studies revealed that knocking out CCDC93, COMMD3, or VPS35L, causes an accumulation 
of F-actin on WASH-positive endosomal foci together with the accumulation of cortactin 
(an ARP2/3 complex and F-actin-stabilizing protein). Furthermore, Singla and coworkers 
showed that in Commd1-deficient mouse embryonic fibroblasts and CCDC22 mutant 
human fibroblasts F-actin on endosomes was increased (Singla et al., 2019). 
Upon more detailed analysis of the phalloidin staining microscopy experiment 
described above in both FRT and U2OS cells, some special types of vesicles were stained 
together with actin filaments (see sections 3.4.1 and 5.3.3). Very interestingly, in the Ca2+ 
treated cells U2OS cells, actin-coated vesicles were drastically enlarged compared to that 
of control cells (Figure 5.12) suggesting actin nucleation activity was increased. 
 
 
Cells were treated with CaCl2 to bring the final concentration to ~4 mM (2 mM extra) while control cells 
were grown in normal medium containing ~2 mM Ca2+. Cells were fixed with 3.7% formaldehyde and 
permeabilized with 0.1% Triton X-100. Then the cells were mounted with VECTASHIELD® HardSet™ 
Mounting Medium with DAPI followed staining with phalloidin conjugated to Alexa Fluor™ 488. 
Representative images showing enlarged and actin accumulated endosomes in Ca2+ treated cells compared 
to control cells. 
 
 
As described above, Ca2+ treatment increases protein levels of COMMD10 and 




























accumulation, however, it was expected that activated COMMDs (or CCC) should decrease 
endosomal actin accumulation through dissembling WASH complex from endosomes, as 
CCC negatively regulates the WASH complex (Singla et al., 2019) although CCC is recruited 
to endosomes by the WASH complex (Phillips-Krawczak et al., 2015). But most possibly, 
these results suggest that Ca2+ treatment induces endosomal actin accumulation through 
increasing endosomal WASH activity and WASH complex, in turn, recruits and thereby 
stabilizes more CCC (including COMMD1 and -10). Another possibility is that Ca2+ 
treatment changes the actin cytoskeleton and thereby recycling is blocked causing 
endosomal actin accumulation together with cargo accumulation. Evaluating the ENaC 




5.3.5 Calcium induces basal ENaC Isc but FSK-stimulated ENaC recycling is reduced 
 
With a recent study it was reported that COMMD1 promotes ATP7B exit from the early 
endosomes as part of the CCC complex showing attenuated COMMD1 increases ATP7B 
accumulation with VPS35 (Stewart et al., 2019b). Furthermore, CCC complex depletion 
was shown to lead to trapping of internalized receptors on endosomal actin accumulated 
endosomes (Singla et al., 2019). Therefore, it was hypothesized that ENaC Isc should be 
increased in Ca2+ treated epithelia if Ca2+ treatment induces COMMDs due to increased 
endosomal WASH activity (as negative regulator of WASH) or should be decreased if 
COMMDs are induced due to their functional blockage by Ca2+. 
 To test this hypothesis, endogenous ENaC Isc was measured after treating the 
epithelia with 2 mM excess Ca2+ (a total of 3.5 – 4 mM Ca2+). In the first experiment, ENaC 
Isc was measured after adding 3.2 mM of Ca2+ directly into the Ringer’s solution (without 
CaCl2) in the Ussing chamber and ENaC current was slightly decreased compared to 
control epithelia (data not shown) suggesting that ENaC cell surface activity does not 
react to extracellular excess Ca2+ for short time. Then the treatment was performed 
similar to previous Ca2+ treatment assays above (sections 5.3.2 and 5.3.3) to replicate the 
same Ca2+ treatment period. Thus, 24 hours after seeding cells, medium was changed to 
fresh complete medium with 2 mM excess Ca2+ dissolved in it and incubated for a total of 





 Furthermore, to understand the effect of Ca2+ treatment on ENaC recycling, upon 
the Isc stabilization, 5 μM (final concentration) FSK was added basolaterally and the 
measurement was continued. Figure 5.13 A demonstrates relative average traces of basal 
and FSK-stimulated ENaC Isc in control and Ca2+ treated epithelia across four individual 
experiments. The basal Isc value was subtracted from the value at the peak of “S” to 
identify FSK-stimulated ENaC Isc while the basal Isc was calculated subtracting the lowest 
value upon amiloride addition from the value before FSK addition. Basal and FSK-
stimulated ENaC Isc in control epithelia was normalized to 1 and then these currents in 
Ca2+ treated epithelia were compared to the normalized control epithelia. 
 Analysis of results showed that basal ENaC Isc in Ca2+ treated mCCD epithelia was 
increased up to a 31% compared to control epithelia (1 for control and 1.31 ± 0.17 for 
Ca2+ treated epithelia; One-sample t-test, ***P<0.001, mean ± SD; N=4, n=8, Figure 5.13 
B). Interestingly, the results also showed that FSK-stimulated ENaC Isc in Ca2+ treated 
epithelia was significantly (15%) less than that in control epithelia (1 for control vs 
0.85±0.07 for Ca2+ treated epithelia; One-sample t-test, ***P˂0.001, mean ± SD; N=4, n=8, 
Figure 5.13 C) suggesting that either regulated recycling of ENaC was blocked or Ca2+ 
treatment was depleting ENaC from endosomes through enhanced recycling (by 
increased CCC (Fig. 5.10)/WASH/endosomal actin (Fig. 5.12)). 
 It was hypothesized that if reduction in FSK-stimulated ENaC Isc is due to blocked 
recycling under Ca2+ treatment, then FSK-stimulated ENaC Isc should reach the peak later 
in Ca2+ treated epithelia than in control epithelia like in COMMD KD and VPS35 KD 
epithelia (Figure 3.8 and 3.11). Therefore, FSK stimulation duration for control and Ca2+ 
treated epithelia was analyzed. The FSK stimulation duration in control epithelia was 
normalized to 1 and that in Ca2+ treated epithelia was compared to the normalized control 
of the same set of experiment. Interestingly, the FSK stimulation duration was 
significantly decreased (which means recycling fastened) in Ca2+ treated epithelia 
compared to control epithelia (1 for control, 0.87±0.12 for Ca2+ treated epithelia; One-
sample t-test, *P<0.05, mean ± SD; N=4, n=8, Figure 3.8 D). This suggests that there is no 
functional blockage of COMMDs (unlike COMMD10 KD which slowed the stimulation 
duration, Figure 3.8) on endosomal sorting or on the translocation of ENaC vesicles to the 


































mCCDcl1 cells were treated with excess CaCl2 to bring its final concentration to ~4 mM (2 mM extra) while 
control cells were grown in normal medium containing ~2 mM Ca2+. After a total of 96-hours Ca2+ treatment, 
the Isc was measured and upon Isc-stabilization, the measurement was continued with addition of 5 μM 
forskolin basolaterally. A, Trace of relative average ENaC Isc in control and Ca2+ treated epithelia 
demonstrating changes with FSK stimulation (N=4, n=8, mean ± SEM). B, Basal ENaC Isc was increased by 
Ca2+ treatment significantly. One-sample t-test, ***P<0.001, mean ± SD; N=4, n=8. C, FSK stimulated ENaC 
Isc was reduced significantly. Isc in control epithelia was normalized to 1 and that in Ca2+ treated epithelia 
was compared to the normalized control. One-sample t-test, ***P<0.001, mean ± SD; N=4, n=8. D, Pooled 
relative normalized FSK stimulation durations.  Data shown as mean ± SD relative to normalized FSK-










The overall results of Ca2+ treatment suggests that extracellular Ca2+ increases endosomal 
actin nucleation (Figure 5.12) probably through increased WASH activity that possibly 
recruits more CCC complex and thereby stabilizes and increases COMMD1 and -10 protein 
levels (Figure 5.10). The enhanced endosomal WASH/CCC activity leads to more ENaC 
activity at the cell surface (Figure 5.13 B) probably through recycling that can be 
confirmed by decreased regulated ENaC recycling (under FSK stimulation, Figure 5.13 C) 
and by fast finishing of FSK stimulation (Figure 5.13 D). As known from previous results, 
the impaired endosomal sorting leads to lower basal ENaC activity (Figure 3.2, 3.5 and 
3.10), lower FSK stimulated ENaC recycling and longer FSK stimulation duration (slowed 
recycling, Figure 3.8 and 3.11), the results also suggest that Ca2+ treatment does not 












































6.1 Endosomal recycling of ENaC and role of COMMD10 
 
 
ENaC transports Na+ across tight epithelia, including the distal nephron (Garty & Palmer, 
1997; Hamm et al., 2010) therefore, controlling ENaC at the cell surface is the major 
determinant of extracellular fluid volume and consequently blood pressure (Pratt, 2005; 
Rotin & Schild, 2008). The surface density of active ENaC is regulated by channel open 
probability, changes in transcription, translation, and trafficking including ubiquitin 
stimulated endocytosis and recycling, etc. (Debonneville et al., 2001; Abriel & Staub, 2005; 
Butterworth et al., 2005a; Butterworth, 2010). 
 As described in the introduction chapter of the thesis (section 1.2.4.3), internalized 
membrane proteins have two main fates after reaching the endosomes. Thus, some of the 
membrane proteins are left in maturing endosomes that fuse with lysosomes to degrade 
its contents, while many others are sorted and recycled back to the cell surface. This 
project aimed to further our understanding of recycling pathways and ENaC-specific 
recycling. 
According to recent reviews (including (Cullen & Steinberg, 2018; Simonetti & 
Cullen, 2019)) three recycling pathways from endosomes to the plasma membrane have 
been classified: constitutive, regulated, and slow recycling. The constitutive and regulated 
recycling comprise the fast recycling pathway, while the recycling through the endosomal 
recycling compartment (ERC) is known as the slow recycling pathway (Rea & James, 
1997; Pessin et al., 1999; Lampson et al., 2001).  
 The constitutive recycling pathway (also called bulk recycling (Mayor et al., 1993; 
Maxfield & McGraw, 2004)) provides a mechanism for nutrient receptors, TfR, C6-NBD- 
sphingomyelin, -phosphatidylcholine and -galactosylceramide to be recycled leaving 
soluble nutrients behind for utilization in the cell (Mayor et al., 1993).  
However, a number of membrane proteins, such as many ion channels and 
signaling receptors, escape the bulk recycling and degradation pathways, and are instead 
recycled in a regulated manner (Hanyaloglu & Zastrow, 2008; Yudowski et al., 2009). 
Regulated recycling requires the interaction of a specific cis-acting sorting sequence 
present on the receptor's cytoplasmic tail with specific endocytic sorting machinery (Cao 
et al., 1999; Hanyaloglu et al., 2005; Millman et al., 2008). von Zastrow’s group also 





2009). The mechanism of how cargos escape the degradation pathway and bulk recycling 
is a fundamental cell biological question that is still unanswered. This project was mainly 
focused on the regulated recycling of ENaC, however, the role of the endosomal sorting 




6.1.1 COMMD10-mediated ENaC sorting and recycling 
 
Previous studies demonstrated that all of COMMD1-10 proteins interact with ENaC (Ke et 
al., 2010; Liu et al., 2013) and COMMD10 depletion reduces ENaC current in FRT epithelia 
(Ware et al., 2018). Other unpublished studies revealed that knockdown of Fam21, a 
subunit of the WASH complex, significantly decreased ENaC current in FRT cells. 
However, overexpression of another subunit of WASH complex - WASH1 decreased ENaC 
Isc (Cheung et al, 2020; paper in revision) suggesting that the WASH complex is 
responsible for stabilization of ENaC-loaded tubules. ENaC was also co-
immunoprecipitated with the CCC complex subunit CCDC22 and knockdown of CCDC22 
decreased ENaC current reducing cell surface population of ENaC which was confirmed 
by a cell surface biotinylation assay (Cheung et al, 2020; paper in revision).  
 To determine whether COMMD10 also regulates endogenous ENaC current and to 
develop the findings of the preliminary data, COMMD10 was transiently knocked down in 
mCCD epithelia and the ENaC Isc was measured. The results showed that ENaC current 
was significantly reduced (by an average of 26%) when COMMD10 was depleted (average 
knockdown of 45%) confirming a role for COMDM10 in endogenous ENaC regulation 
(section 3.2.2, Figures 3.4 and 3.5).  
 Then, to identify if this reduction in ENaC current is due to a decrease in cell surface 
population of ENaC, cell surface ENaC was quantified by biotinylation assay. The results 
confirmed the hypothesis showing that the cell surface population of ENaC was 
significantly reduced by 32% (section 3.1.3, Figure 3.3)(Ware et al., 2018) in the FRT 
stable COMMD10 knockdown epithelia. In this cell line COMMD10 protein level was 
reduced by an average of 79% (Figure 3.1) and ENaC current was also decreased 
significantly by an average of 43% (section 3.1.2, Figure 3.2). But the pathway by which 





 Previous studies have identified that the CCC complex (containing COMMD1-10, 
CCDC22 and CCDC53) is required for retromer- and retriever-dependent protein 
trafficking (Burstein et al., 2005; Phillips-Krawczak et al., 2015; Bartuzi et al., 2016; 
McNally et al., 2017). Campion et al., 2018 showed that COMMD5 interacts with WASH1 
and partially co-localizes with it and its partner Arp2/3 suggesting that COMMD5 is 
involved in actin polymerization (Campion et al., 2018). However, the mechanism was not 
known, until recently it was discovered that depletion of the CCC complex causes 
endosomal actin accumulation, excluding the possibility of a stimulatory role for the CCC 
complex in endosomal F-actin polymerization (Singla et al., 2019). Singla et al (2019) also 
showed that the CCC complex functions as a negative regulator of WASH complex 
recruitment to endosomes (Singla et al., 2019). Thus, CCC deficiency results in endosomal 
accumulation of PI(3)P and this is due to lack of PI(3)P- phosphatase MTMR2 recruitment 
by CCC (Singla et al., 2019). Taken together, the WASH complex recruits the CCC complex 
which phosphorylates MTMR2. MTMR2 then converts PI(3)P to PI, as CCC deficiency 
causes endosomal PI(3)P accumulation, which leads to more WASH recruitment or 
possibly long-lasting localization to the endosome through binding to the PI(3)P and 
thereby to endosomal F-actin accumulation.  
 These data strongly suggest that COMMD10, as a subunit of the CCC complex, also 
plays a role in endosomal sorting of ENaC and that regulation of ENaC by COMMD10 
should be through a similar pathway as VPS35 regulates the ENaC. Therefore, endogenous 
ENaC current was measured in VPS35 knockdown epithelia and the results showed that 
with 35% VPS35 knockdown (Figure 3.9) ENaC current was significantly reduced by 12% 
(see section 3.3.3.1, Figure 3.6), consistent with previous results (Cheung et al, 2020; 
paper in revision). As both the CCC and retromer complexes are known to function in 
endosomal sorting, the effect of VPS35 knockdown on ENaC current similar to COMMD10 
knockdown, supports the hypothesis that COMMD10 is involved in ENaC endosomal 
sorting.  
 The CCC complex has also been linked with the retriever complex that also 
requires the WASH complex for endosomal localization. It was reported that suppression 
of the CCC complex perturbs the recruiting of retriever to endosomes (McNally et al., 
2017) and leads to retriever-dependent recycling defects (Singla et al., 2019) which 
suggests that COMMD10 can regulate ENaC cell surface level through a retriever-
dependent manner as well. Retriever-mediated cargo selection is realized by SNX17 





SNX17 binding motifs (ΦxNPxY/F or ΦxNxxY/F (Ghai et al., 2013; Stiegler et al., 2014)) 
in human and mouse αβγENaC subunits showed that the subunits possess ΦxNxxY/F 
sequence motifs in their cytoplasmic domains but not the most common motif ΦxNPxY/F. 
So, it remains still elusive if retriever regulates ENaC recycling. To answer this question 
attempts were made to knockout the retriever subunit VPS35L using CRISPR (see section 
5.4), but unfortunately, this approach was not successful. The results would provide 
evidence for ENaC regulation by retriever. However, to answer this question, ENaC 
regulation should be evaluated with transient knockdown of VPS35L. 
 As all data discussed hereto suggests that COMMD10 functions in endosomal 
recycling, as a confirmation step, to identify if downregulation of ENaC cell surface activity 
in COMMD10 depleted cells is not due to decreased ENaC internalization, an endocytosis 
assay was performed. Interestingly, the results showed that at the start of incubation (at 
2 mins) ENaC internalization in control FRT cells was higher than that in FRT COMMD10 
KD cells, then at 5 min, the internalized ENaC levels were similar, however, more 
internalized ENaC level was seen at 10 min in COMMD10 KD cells compared to control KD 
cells (section 3.3.1.1, Figure 3.6). However, this result still does not clarify whether the 
higher level of internalized ENaC at 10 min was due to increased endocytosis or delayed 
recycling. In many studies, suppression of endosomal sorting machinery subunits 
revealed accumulation of cargos on endosomes (Liu et al., 2012a; Liu & Grant, 2015; 
Norris et al., 2017; Singla et al., 2019). However, the mechanism of cargo trapping in 
endosomes is not known. It would be interesting to overexpress COMMD10 to assess if 
this enhances cargo exit from endosomes. 
 For that purpose, COMMD10 was overexpressed in mCCDcl1 epithelia and the 
ENaC Isc was measured (section 3.2.2, data of results was not shown). Interestingly, the 
resistance and ENaC Isc measured was lower than that in control epithelia, possibly due 
to cell death. Similar results of lower current and resistance were observed with the OE 
of COMMD1 and WASH1 (data not shown). 
 However, based on the model that the CCC complex releases the WASH complex 
(Singla et al., 2019) and possibly thereby also releases actin-stabilized recycling tubules, 
it was expected that the ENaC current should be decreased consistent with previous 
studies showing that transient overexpression (OE) of COMMD1, -3 and -9 down regulates 
ENaC cell surface activity in FRT epithelia (Ke et al., 2010; Liu et al., 2013). This is also 





overexpression also resulted in accumulation of ATP7B on VPS35-positive EEs instead of 
trafficking to the TGN (Stewart et al., 2019a).  
 Cells can die for many reasons, but here the most possible reason can be 
downregulation of cell surface proteins including cell adhesion receptors, growth factor 
receptors, etc. needed for cell survival, due to the intensive loss of PI(3)P by MTMR2 
(activated by CCC) (Singla et al., 2019), and thereby more WASH complex disassembly 
leading to the less endosomal F-actin (Singla et al., 2019).  As a result, lack of stabilization 
of recycling tubules may result in less cargo entry into tubules and less recycling to the 
cell surface that can lead to cell death. As an example, loss of integrin leads to cell death 
as it was shown that integrin-mediated adhesion to extracellular matrix proteins is 
required for survival of many cell types (Meredith & Schwartz, 1997; Iseri et al., 2010; 
Aoudjit & Vuori, 2012). Similarly, increased WASH activity by overexpression of Flag-
WASH1 (which is expected to be more than an increase of endogenous WASH through 
CCC depletion) also possibly led to longer stabilization of tubules thereby trapping cell 
surface proteins resulting in cell death that was observed in the experiments to measure 
ENaC current in mCCD epithelia.  
 
 
6.1.2 COMMD10 functions on exit of ENaC from endosomes and further recycling 
 
The localization of WASH, Arp2/3, cortactin and coronin on endosomal domains was 
investigated previously (Puthenveedu et al., 2010), however, no studies have investigated 
the localization of the CCC complex or COMMD proteins on endosomal domains. Although 
COMMD5 colocalization with endosomal markers Rab5, -7 and -11 has been reported 
(Campion et al., 2018), the exact localization of COMMD5 on endosomal domains was also 
not evaluated. In this thesis, the endosomal domain that COMMD10 localizes to was 
studied hypothesizing that localization pattern of COMMD10 on endosomal domains 
should look like WASH, Arp2/3, cortactin etc. as reported (Puthenveedu et al., 2010). For 
that purpose, COMMD10-GFP and Rab5a-mCherry, Rab7-DsRed, or Rab11-DsRed 
plasmids were coexpressed in U2OS and FRT COMMD10 stable knockdown cells and the 
localization pattern of COMMD10 on endosomes marked by Rab5, -7 or -11 in living cells 
was evaluated. The microscopy results showed that COMMD10 localizes on Rab5- and 





section 4.1.1 and 4.1.2, Figures 4.1, 4.2 and 4.5, 4.6, respectively). This type of localization 
is similar to localization of WASH, coronin, cortactin, etc. (Puthenveedu et al., 2010), and 
supports a recent model where CCC complex regulates WASH complex localization on 
endosomes (Singla et al., 2019).  
 How can COMMD10 localize on both early endosomes (Rab5 positive) and late 
endosomes (Rab7 positive)? Do these indicate a role for COMMD10 in distinct recycling 
pathways? Probably not. It has been shown in a well-established study that the 
conversion of Rab5 positive endosomes to Rab7 positive ones is a gradual process (Rink 
et al., 2005b). Rab7 is required for retromer recruitment onto endosomes (Rojas et al., 
2008; Seaman et al., 2009; Balderhaar et al., 2010; Liu et al., 2012b; Priya et al., 2015). 
These data suggest that where COMMD10 localized on Rab5 positive endosomes they are 
also probably Rab7 positive endosomes or for the retromer recruitment and function in 
endosomal cargo sorting, the Rab5-to-Rab7 conversion will be required. Upon 
recruitment onto tubules, the retromer releases Rab7 on this domain, which separates 
endosomal recycling from Rab7-dependent lysosomal fusion (Purushothaman et al., 
2017). That should be the reason that COMMD5 was found to have no affinity to Rab7 
(Campion et al., 2018). Thus, probably COMMD5 also localizes onto specific structures/ 
domains of Rab7 positive endosomes like COMMD10, where retromer released Rab7, 
thereby do not co-localize with Rab7. 
COMMD10 localization on Rab11-positive recycling endosomes was distinct from 
that on Rab5- and Rab7-positive endosomes suggesting another role for COMMD10 in the 
recycling pathway after a role in WASH regulation on endosomes (section 4.1.3, Figures 
4.8, 4.9). This role for COMMD10 is possibly similar to the role shown for COMMD5 to 
hook endosomes to cytoskeleton, but this hypothesis needs further investigation 
(Campion et al., 2018). Although over-expression of Rab11 resulted in an inhibition of 
ENaC, knockdown of Rab11 also reduced ENaC cell surface activity suggesting ENaC is 
recycled through Rab11-endsomes (Butterworth, 2010; Butterworth et al., 2012) 
supporting the results that COMMD10 can regulate ENaC through Rab11-positive 
recycling endosomes. Furthermore, Rab4 and Rab11, which function in endosome-to-
plasma membrane recycling (Zerial & McBride, 2001a; Maxfield & McGraw, 2004), were 
localized to domains containing β2AR (Puthenveedu et al., 2010) suggesting that after 
endosomal sorting, cargos utilize both Rab4- and Rab11-mediated recycling pathways 





 However, COMMD5, appears to have another distinct function at the endosome 
where depletion of COMMD5 induces cytoskeleton re-organization resulting in formation 
of larger endosomes clustered in the center of the cells (Campion et al., 2018), thus 
impacting on the trafficking of recycling vesicles. Does this indicate a different function 
for the CCC complex or does cytoskeleton re-organization still occur through the CCC-
PI(3)P-WASH axis? Although no reports in the literature show a direct link between 
endosomal F-actin and microfilament growth, cytoskeleton re-organization from a 
diagonal distribution to a periferal location in COMMD5-depleted cells likely indicates this 
link (Campion et al., 2018). Taken together, the CCC complex possibly induces actin 
polymerization from the branches of endosomal tubule-stabilizing actin network at the 
end of the sorting process and forces the tubules/vesicles to start moving by hooking 
them to and stimulating the further development of actin filaments towards the cell 
surface. 
 To identify if COMMD10 silencing also changes microfilament organization, F-actin 
was stained with phalloidin in FRT and U2OS COMMD10 knockdown cells. However, the 
results revealed no difference in microfilament organization between control and 
COMMD10 knockdown cells (see section 3.4.1, Figure 3.12), suggesting no role for 
COMMD10 in microfilament organization. Although endosomal F-actin was also stained, 
in these microscopy images, they were not a focus during these experiments and further 
precise investigation is needed to analyze endosomal F-actin as it is expected to be 
accumulated in COMMD10 KD cells. Co-staining of F-actin with COMMD10 could also be 
performed. In addition, further co-staining experiments should be carried out using 
antibodies against endogenous proteins to confirm the location of COMMD10 on Rab5,7, 




6.1.3 Future Directions 
 
To further investigate the role of sorting complexes in ENC regulation, several avenues 
could be investigated. For example, although overexpression of COMMD10 caused cell 
death preventing the direct measurement of the impact of overexpressed COMMD10 on 





biotinylation assay in COMMD10 overexpressed cells (preferably mCCD cells). This 
experiment will allow the reduction of the post-transfection time from 5 days (at least) to 
three days, as in longer post-transfection times more COMMD10 is expressed and more 
cells die (this was confirmed in several experiments). 
To visually confirm the role of COMMD10 in ENaC recycling, colocalization of 
fluorophore-tagged ENaC and COMMD10 could be evaluated in living or fixed U2OS and 
FRT cells. Despite many trials during this study, no colocalization of ENaC together with 
COMMD10 was observed on an endosome or on a tubule emanating from an endosome 
which would better demonstrate the exact localization of COMMD10 relative to ENaC. As 
a best candidate for marking the endosome together with a tubule emanating from it, 
endogenous ENaC was tested in mCCDcl1 cells, however the available antibody was non-
specific for immunostaining. None of the available plasmids encoding GFP-tagged ENaC 
subunits were successfully expressed. Then, αβ-HA-γENaC and COMMD10-GFP were 
cotransfected into FRT cells, and β-HA-ENaC was immunostained with anti-HA then AF-
633-conjugated secondary antibody or with tyramide, however, the immunostaining for 
ENaC failed in fixed FRT cells. Similarly, in experiments where Rab5, -7 and -11 were co-
transfected together with αHA-βγENaC and then later immunostained with anti-HA and 
AF-488-conjugated secondary antibody, Rab proteins were found to be degraded in fixed 
FRT cells (in all three experiment replicates). To prevent aggregation, it is strongly 
recommended that in future microscopy experiments, expression period of COMMD10 
and Rab5,-7, or -11 is reduced to a maximum 24 hours. 
As explained in section 4.2.1, ENaC and VPS35 colocalization was also 
unsuccessful. This was unfortunate because this experiment would answer the question 
of whether COMMD10 regulates ENaC through retromer. In this project a number of other 
recycling proteins were tested for co-expression and immunostaining including HA- and 
Flag-tagged DSCR3 (retriever subunit), Flag-tagged Wash1 (WASH complex subunit), HA-
tagged CCDC22 (CCC complex subunit) and HA-tagged SNX27 together with HA-tagged 
ENaC, however, some of those plasmids did not produce protein (confirmed by Western 
blot) or immunostaining failed. In future, anti-HA/FLAG antibodies conjugated to 
AlexaFluor could be used to develop an experiment to visualize and confirm the role of 
subunits of sorting complexes listed above in ENaC sorting and recycling. Otherwise, new 






 The following experiments could be performed if CRISPR-mediated gene 
modification was successful: 
1) Measuring the knockout effect of COMMD10, VPS35, and VPS35L on endogenous ENaC 
current. 2) Evaluating the colocalization of ENaC with COMMD10, VPS35, VPS35L, and 
Clta. 3) Furthermore, cytoskeleton organization, cell shape of mCCDcl1 cells, could be 




6.2 ENaC recycling under forskolin stimulation 
 
Like many cell surface receptors and ion channels, ENaC is also stimulated by cAMP/PKA 
activation and forskolin is used to stimulate this pathway (Garty & Palmer, 1997; Morris 
& Schafer, 2002; Snyder et al., 2004; Butterworth et al., 2005a). Mutation of the PY motifs 
or deletion of the C terminal domains of all three ENaC subunits was shown to abolish the 
stimulatory effect of cAMP (Snyder, 2000; Yang et al., 2006; Lu et al., 2007). Although it 
was thought that cAMP affects ENaC internalization, later findings contradicted this. Lu et 
al. (2007) reported that mutation in the PY motif doesn’t completely disrupt ENaC 
internalization, and it was found that cAMP-dependent enhancement of recycling is seen 
with wildtype ENaC and also with internalized ENaC with a mutant PY motif after 
prolonged exposure to cAMP (Lu et al., 2007), suggesting that cAMP does not affect the 
ENaC internalization. It is possible that the abolished stimulatory effect of cAMP on ENaC 
with a mutant PY motif is due to less internalized ENaC on endosomes which leads to less 
ENaC to be sorted and recycled back to the cell surface by cAMP. Moreover, it was 
reported that IBMX/FSK stimulates ENaC Isc by increasing the surface expression and the 
open probability (PO) of the channel (Snyder, 2002; Yang et al., 2006). However, it is also 
possible that recycling of internalized ENaC is stimulated by cAMP and the cell surface 
accepts more “open” ENaC compared to non-stimulated cells for which the channel source 
is mostly from the biosynthetic pathway where some of the channels need to be cleaved 








6.2.1 COMMD10 knockdown impairs Forskolin-stimulated ENaC recycling  
 
 
To confirm the hypothesis that ENaC cell surface population was reduced in COMMD10 
KD cells due to impaired endosomal recycling an ENaC recycling assay was performed.  
 The ENaC endocytosis assay showed that despite less ENaC internalization at the 
start, at 10 minutes of incubation for endocytosis, ENaC was accumulated intracellularly 
in COMMD10 KD cells (section 3.3.1.1). This result suggested that the role of COMMD10 
could be in ENaC endosomal sorting or recycling. Due to difficulty in controlling cell 
membrane damage allowing biotin to enter cells and bind intracellular proteins, a 
recycling assay using cAMP stimulation was designed. The results discussed above also 
showed that COMMD10 acts on sorting endosomes (Rab5- and Rab7-positive) and 
recycling endosomes (Rab11-positive) (section 5.1) together with having a role in 
regulating ENaC cell surface activity and population (sections 3.1.2, 3.1.3, 3.2.2). 
Therefore, studying FSK-stimulated ENaC activity in COMMD10 depleted epithelia should 
provide better evidence about the role of COMMD10 in ENaC endosomal sorting or 
recycling. To confirm whether COMMD10 KD delays regulated ENaC recycling, an ENaC 
electrophysiological study was performed under FSK stimulation (see section 3.3.2.1).  
 The results showed that, firstly, transient COMMD10 knockdown (45%, Figure 3.4) 
significantly reduced FSK-stimulated endogenous ENaC Isc in mCCD epithelia (section 
3.3.2.1) which confirms that COMMD10 KD impairs ENaC recycling. However, the role of 
COMMD10 could be through endosomal sorting (through regulation of WASH complex 
recruitment) or in translocation of recycling vesicles (through hooking endosomes to 
cytoskeleton). Secondly, the relative reduction in basal Isc in COMMD10 KD epithelia 
(compared to control epithelia) (1 : 0.74, Figure 3.5 C) is very similar to the relative 
reduction in FSK-stimulated Isc (1 : 0.74, Figure 3.7 B) in this epithelia suggesting that 
impairment in FSK- stimulated ENaC apical delivery, is alone responsible for the decrease 
in basal Isc in COMMD10 KD epithelia. The similar relative reduction leaves less 
possibility for COMMD10 to be involved in other pathways. Thus, if COMMD10 would be 
a part of, for example, constitutive recycling, then the relative reduction in basal Isc in 
COMMD10 KD epithelia would probably be more than the relative reduction in FSK-
stimulated Isc.  
 This result is insufficient to conclude that impaired FSK stimulation of ENaC 





sorting. However, it has been shown that ENaC is recycled to the cell surface via 
constitutive recycling and separately via a cAMP-regulated recycling pathway 
(Butterworth et al., 2009; Butterworth et al., 2012; Edinger et al., 2012; Klemens et al., 
2017) like β2AR (Puthenveedu et al., 2010; Bowman et al., 2016) and upon cAMP 
stimulation, ENaC is recruited from intracellular stores and inserted into the apical 
membrane (Kleyman et al., 1994; Snyder, 2000; Morris & Schafer, 2002), while further 
investigation showed that this insertion is through translocation of subapical vesicles 
(Butterworth et al., 2005a; Edinger et al., 2012). Translocation of subapical vesicles was 
found by measuring the apical membrane capacitance, however, the type of vesicles was 
not investigated or shown. This does not exclude the possibility that these vesicles may 
be recycling vesicles deriving from endosomal tubules. Butterworth et al. (2005) also 
identified that the initial FSK response of ENaC Isc in CCD epithelium treated with BFA 
was not impaired, however the subsequent repetitive ENaC stimulations were 
significantly reduced. Thereby they identified the initial FSK response as an effect of FSK 
on ENaC recycling while the subsequent defective response was presumed to be due to 
disrupted trafficking from the TGN to an intracellular pool of ENaC (Butterworth et al., 
2005a). Furthermore, Butterworth et al. (2005) showed that newly synthesized ENaC is 
not essential for the FSK response but interestingly depolymerization of F-actin in mCCD 
epithelia using LatA before FSK stimulation diminished the ENaC Isc (Butterworth et al., 
2005a). Thus, as it is known that movement of recycling ENaC to the PM is microtubule 
dependent (Pochynyuk et al., 2007a), then most possibly, the LatA abolished endosomal 
F-actin and thereby endosomal tubules were not stabilized on endosomes which reduced 
ENaC entry into tubules. 
 Given that, however, it is not known whether cAMP stimulation induces the 
endosomal sorting of ENaC. More precisely, does cAMP stimulation restrict ENaC to ASRT 
domains as it does the β2AR (Vistein & Puthenveedu, 2013; Bowman et al., 2016)? Further 
analysis of results showed that FSK-stimulation duration was increased significantly in 
COMMD10 knockdown epithelia compared to FSK-stimulated current duration in control 
epithelia (section 3.3.2.1). As the same concentration of FSK (10 μM, final) was applied to 
both epithelia, this suggests that the increased duration is not limited by FSK but by the 
amount of ENaC available to be delivered to the cell surface. If COMMD10 knockdown 
leads to trapping of ENaC in the endosome or recycling pool of vesicles, this extra ENaC is 
available to be delivered to the cell surface. Secondly, it reveals that COMMD10 possibly 





ENaC-carrying vesicles to the cell surface, despite late arrival of the vesicles, the FSK-
stimulated ENaC level in COMMD10 knockdown epithelia should be similar to that in 
control knockdown epithelia. But because COMMD10 knockdown leads to trapping of 
ENaC and as long as the effect of FSK is there, ENaC is rescued from the “trap”, but over a 
longer time period. 
 Knockdown of the retromer subunit VPS35 also reduced FSK-stimulated current 
(section 3.3.3.2, Figure 3.11) suggesting retromer function is needed for ENaC recycling 
and thereby becoming a control for COMMD10 function in endosomal recycling.  
  A model summarizing COMMD10 (as part of the CCC complex) function in concert 
with the WASH complex in ENaC endosomal sorting and recycling is shown in Figure 6.1. 
The model describes ENaC regulated recycling which is distinct from the constitutive 
recycling pathway. Thus, the constitutive recycling pathway delivers membrane proteins 
including ENaC, TfR and N-[N-(7-nitro-2,1,3-benzoxadiazol-4-yl)- epsilon-
aminohexanoyl]-sphingosylphosphorylcholine (C6-NBD-SM) in a bulk flow manner 
(Mayor et al., 1993; Butterworth et al., 2009; Puthenveedu et al., 2010; Butterworth et al., 
2012), probably without sorting into actin-stabilized tubules. While the regulated 
recycling occurs through cargo loading into tubules stabilized by WASH/actin/CCC 























A, Continuous generation of 
endosomal recycling tubules. On the 
base of some of those tubules, 
endosomal Rab5 recruits PI3-K 
VPS34 which converts PI to PI(3)P 
through which the WASH complex is 
recruited onto endosomes. B, WASH 
complex promotes endosomal F-
actin polymerization which prevents 
tubules from quick budding off, 
stabilizing them for a longer time to 
enable sequence-dependent cargo 
entry. Some other tubules are 
released from endosomes 
immediately without actin-
stabilization conducting bulk 
membrane flow and carrying 
membrane proteins and lipids such 
as TfR, C6-NBD-SM, and ENaC. C, CCC 
complex (including COMMD10) is 
recruited onto the base of 
endosomes by WASH complex where 
the CCC complex negatively regulates 
WASH assembly through recruiting 
MTMR2 to dephosphorylate PI(3)P 
to PI. It is possible that as cargoes are 
loaded into actin-stabilized tubules, 
COMMD-cargo (including ENaC) 
interaction define the abundance of 
CCC recruitment onto endosomes 
and thereby release of tubules. 
TfR=transferrin receptor, C6-NBD-





Figure 6.1. A model for COMMD10 
function (involved in CCC complex) 





6.3. Regulators of COMMD proteins 
 
6.3.1 Aldosterone downregulates protein levels of COMMDs 
 
A previous study showed that aldosterone downregulates COMMD10 protein level in M1-
CCD cells ((Ware, 2017), PhD thesis). Since aldosterone is known to control transcription 
of a variety of ENaC regulators (Boulkroun et al., 2008; Butterworth et al., 2011; Edinger 
et al., 2014) it was hypothesized that aldosterone may regulate expression of COMMD 
genes, as the results showed that COMMD10 is an upregulator of ENaC. Therefore, mRNA 
levels of all COMMD1-10 and protein levels of COMMD1 and -10 were studied in mCCD 
epithelia.  
 Initially, ENaC Isc was measured in mCCD epithelia and confirmed that aldosterone 
(300 nM) increases endogenous ENaC current in mCCD epithelia with 0.5, 3, and 24 hours 
of treatment (see section 5.1.1). Then, RT-qPCR results showed that mRNA levels of 
COMMD1-10 are not regulated by aldosterone (300 nM) with any of the treatment periods 
of 0.5-, 3-, and 24-hours (see section 5.1.2). SGK1 was used as a positive control and was 
upregulated by aldosterone. Western blot analysis of COMMD1 and -10, SGK1 and 
phospho-SGK1 protein levels revealed that short-term aldosterone-stimulation (0.5 
hour) significantly decreased COMMD1 and -10 protein levels by ~35%, (see section 
5.13). But the results do not match the model of ENaC upregulation by COMMD10. 
However, considering the short-term effect of aldosterone on ENaC regulation may 
provide an answer. Thus, aldosterone prevents ENaC endocytosis through the 
SGK1/Nedd4-2 pathway (Balderhaar et al., 2010; Hallows et al., 2010; Lang & Stournaras, 
2013) which means it prevents compensatory membrane uptake following endocytosis 
(Houy et al., 2013; Liang et al., 2017) and this probably requires slowing down the 
recycling pathway to maintain the balance of surface membrane. As the long-term effect 
of aldosterone “arrives”, upregulation of ENaC switches to the biosynthetic pathway 
which eliminates endocytosis blockage, and conversely requires endocytosis due to new 
fusions of ENaC-carrying membrane vesicles from the biosynthetic pathway. As the 
endocytosis pathway “opens”, the reducing effect of aldosterone on COMMD protein 
levels at 3-hours and further are eliminated. This model may also explain why 
SGK1/Nedd4-2-mediated ENaC upregulation is for short time (Chen et al., 1999; Náray-





6.3.2 Calcium treatment upregulates COMMD10 protein level 
 
In the search for regulators of COMMD10, it was hypothesized that COMMD10 can be 
regulated by calcium as is the related COMMD5 which is known as the hypertension-
related, calcium-regulated gene (HCaRG) (Solban et al., 2000). COMMD5 was also shown 
to be highly expressed in the kidney tubules and more expressed in kidneys from 
hypertensive compared with normotensive animals (Solban et al., 2000). COMMD10, as 
an ENaC up-regulator, could also have a role in hypertension in the hypertensive animals. 
Therefore, mCCDcl1 cells were treated with calcium (2 mM (final) extra) and the mRNA 
and protein levels of a selection of COMMDs were analyzed. The results showed that 
mRNA levels of COMMD1 and COMMD10 and also COMMD5 as a control (based on 
previous data) was not regulated by calcium treatment (see section 5.3.1). Then, protein 
levels of COMMD10 were evaluated under various concentrations (1, 2, 4, and 6 mM 
(final) extra) of Ca+. The results showed that COMMD10 protein levels were upregulated 
significantly in a concentration dependent manner. Thus, at 2 mM Ca2+ treatment, 
COMMD10 protein level reached its peak and then the increase diminished by further 
increases in Ca2+ concentrations (see section 5.3.2). As previous results showed that 
COMMD10 KD destabilizes COMMD1 and VPS35, the protein levels of COMMD1 and 
VPS35 were also analyzed, hypothesizing that an increase in COMMD10 protein level may 
enhance the protein levels of COMMD1 and VPS35, through stabilizing them. The increase 
in protein levels of COMMD1 and VPS35 almost followed that of COMMD10 (section 5.3.2, 
Figure 5.10 B, C). However, the increase in protein levels of COMMD1 was non-significant 
while for VPS35 the increase was significant up to 2 mM Ca2+ treatment. VPS35 is 
increased possibly due to the increased WASH activity and thereby more cargo 
concentration at the endosomal ASRT domain. 
 Many investigations revealed that calcium downregulates microfilament intensity 
(Yin et al., 1981; Namba et al., 1992; Akopian & Cristofanilli, 2006). However, there is a 
report showing that 5 mM (~3 mM (final) extra) Ca2+ caused a nearly twofold increase in 
F-actin content in collecting duct CD8 cells (Procino et al., 2004). To identify whether Ca2+ 
changes the microfilament organization of mCCDcl1 cells as it was found to upregulate 
COMMD10 protein level, the F-actin distribution was analyzed by phalloidin staining. 
Results showed that Ca2+ treatment (2 mM (final) extra) significantly reduced 
microfilament intensity and by qualitative analysis a reduction in number of stress fibers 





 Further analysis revealed that endosomal F-actin accumulated on enlarged 
endosomes in Ca2+ treated cells compared to control cells (see section 5.3.4, Figure 5.12).  
In the literature, there are only reports of F-actin covering endosomes. No reports indicate 
that F-actin covers other types of trafficking vesicles or compartments. F-actin on 
endosomes is generated to stabilize recycling tubules budding from endosomes 
(Puthenveedu et al., 2010; MacDonald et al., 2018; Simonetti & Cullen, 2019) suggesting 
F-actin should exist only on Rab5- and Rab7-positive endosomes. However, Rab4- and 
Rab11-positive tubules could also be marked by F-actin as long as those tubules attach to 
Rab5/7- positive endosomes.  
According to previous data, endosomal F-actin accumulation occurs when the CCC 
complex was silenced or WASH activity was increased. However, Ca2+ treatment results 
showed that conversely, COMMD1 and -10 protein levels were increased (section 5.3.2). 
But as Ca2+ treatment reduced intensity of stress fibers similar to the results for COMMD5 
(Campion et al., 2018), it is possible that Ca2+ treatment blocked the function of the CCC 
complex. Therefore, ENaC cell surface activity was measured to identify whether CCC 
function was blocked by excess Ca2+ (and to compensate this blockage COMMD1 and -10 
level would be increased) and thereby ENaC recycling will be impaired and also whether 
changed microfilament organization affects the cargo trafficking.  
 Interestingly, the results demonstrated that basal ENaC Isc was increased by Ca2+ 
(see section 5.3.5, Figure 5.13) suggesting that CCC activity was not blocked. Then, 
possibly the endosomal F-actin accumulation under Ca2+ treatment is due to induced 
WASH/Arp2/3 activity and the increase in COMMD10 protein level is possibly due to 
increased CCC recruitment by WASH complex (Phillips-Krawczak et al., 2015) that is 
needed to overcome the endosomal F-actin accumulation, as a result, Ca2+ treatment 
increases ENaC cell surface activity. Thus, endosomal F-actin accumulation induces more 
cargo entry to the longer stabilized tubules and increased COMMD10 (also CCC) activity 
releases cargo tubules faster compared to that in nontreated cells. 
 Surprisingly, FSK-induced ENaC Isc was reduced in Ca2+ treated epithelia 
compared to nontreated epithelia (Figure 5.13 C). This is consistent with previous reports 
demonstrating that extracellular Ca2+ and its agonist GD3+ antagonizes forskolin-induced 
AQP2 trafficking in collecting duct CD8 cells (Procino et al., 2004) while not affecting the 
basal surface level of AQP2. However, in mCCD epithelia Ca2+ pretreatment upregulated 
basal ENaC Isc and this may be further evidence for increased COMMD10 function on 





by increased COMMD10 (and possibly CCC) activity before FSK stimulation in Ca2+ 
pretreated epithelia and when FSK was applied, less ENaC was available to be rescued 
compared to the ENaC level trapped in endosomal F-actin of control epithelial cells. This 
can be observed in the average relative trace of total ENaC levels at the peak FSK-
stimulated ENaC Isc that in Ca2+ treated epithelia, the total ENaC Isc is higher than control 
epithelia (Figure 5.13 A). This suggests that the function of the CCC complex and COMMDs 
was not blocked and all these COMMD10 regulatory results matches the proposed model 
for COMMD10-mediated ENaC regulation. Alternatively, it is possible that Ca2+ blocks the 
function of the CCC complex and this leads to compensatory increase in COMMD levels 
while ENaC is delivered to the PM through increased constitutive recycling pathway or 




6.3.3 Future directions  
 
In a search for additional regulators of COMMD protein levels, vasopressin treatment 
could be investigated in mCCD cells as it was shown that dDAVP treatment (1 nM) 
significantly increases mRNA abundance of Commd7 in mouse mpkCCD cells by 2-fold 
(Sandoval et al., 2016). As cAMP is on the downstream signalling pathway of vasopressin, 
this study may lead to clues of how COMMD protein levels are regulated under increased 
cAMP levels (under FSK stimulation). Furthermore, evaluating immunostained 
endogenous COMMD10 colocalization with endosomal F-actin would better reflect the 







In this study it was hypothesized that 1) COMMD10 regulates ENaC cell surface 
expression through the recycling pathway, 2) COMMD10 acts on endosomal sorting and 





extracellular calcium. In consideration of the conducted experiments and their results, the 
hypotheses were accepted. 
 From the results obtained during this project and that reported in the literature to 
date it is reasonable to propose that COMMD10, as a subunit of the CCC complex, regulates 
endosomal sorting and recycling of ENaC. According to a model of CCC-mediated 
endosomal sorting, Rab5 recruits VPS34, the class III PI3-K, onto early endosomes to 
generate endosomal PI(3)P (Christoforidis et al., 1999) through which the WASH complex 
is recruited (Singla et al., 2019) and it recruits the CCC complex in turn (Phillips-Krawczak 
et al., 2015). The CCC complex (including the COMMD10 protein) functions as a negative 
regulator of the WASH complex (Singla et al., 2019). Thus, through CCC complex activity, 
the WASH complex is disassembled from the endosomal domain and thereby endosomal 
F-actin formation is prevented which leads to the release of stabilized, ENaC-loaded 
tubules. CCC depletion (including COMMD10) leads to more WASH complex accumulation 
on endosomes which, in concert with Arp2/3, generates more endosomal F-actin on the 
sorting domains. Increased endosomal F-actin results in longer stabilization of recycling 
tubules and thereby trapping of ENaC on endosomes. Conversely, increased CCC complex 
activity (including COMMD10) impairs WASH/Arp2/3 function reducing endosomal F-
actin polymerization that prevents endosomal sequence-dependent ENaC sorting and 
thereby leads to reduced cell surface expression of ENaC.  
 
The results in this thesis support the hypothesized ENaC regulation through the 
WASH/CCC/F-actin axis, by providing further insights into the endosomal sorting and 
recycling of ENaC. Thus, the results have shown that extracellular Ca2+ led to endosomal 
F-actin accumulation while some others showed that Ca2+ treatment increases COMMD10 
protein level and the increased WASH activity leads to stabilization of the CCC complex 
leading to enhanced endogenous COMMD10 protein level. The increased endosomal 
actin-nucleation and endogenous COMMD10 protein level upregulated the cell surface 
expression of ENaC while COMMD10 overexpression alone and increase in WASH activity 
through COMMD10 knockdown alone impaired the cell surface expression of ENaC 
suggesting that COMMD10 protein level is required to be in a stable, original level for 
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A. Development of Crispr/Cas9-mediated knock-in/knock-outs 
 
 
Unsuccessful results from at least 16 attempts to knockdown COMMD10 in mCCDcl1 cells 
necessitated investigation of another method to silence this protein. Therefore, a 
knockout strategy was designed to evaluate the knockout effect of CCC complex subunit 
COMMD10, retromer subunit VPS35, and retriever subunit VPS35L on endogenous ENaC 
Isc in mCCDcl1 epithelia. Clathrin light chain gene (Clta) was also targeted for evaluation 
of ENaC endocytosis. The designed strategy allows fusion of the GFP gene to all of the 
target genes in parallel with introduction of nucleotide deletions to knock out gene 
expression. Stable knockdown of COMMD10 in FRT epithelia using lentiviral shRNA 
resulted in up to 90% knockdown (Ware et al., 2018), VPS35 KO in HeLa cells (McNally et 
al., 2017), VPS35-L KO in HAP1 cell line (commercially available) and Clta KO in B 
lymphocytes and in yeast cells (Wang et al., 2003; Wu et al., 2016) were shown not to be 
harmful for cell growth and proliferation suggesting that these KOs in mCCDcl1 cells also 
should not disturb general cell characteristics or cell proliferation. 
 
Crispr/Cas9 system. The Cas9 protein (CRISPR-associated protein 9), derived from Class 
2 CRISPR (clustered regularly interspaced short palindromic repeats) adaptive bacterial 
defence systems, is an RNA-guided DNA endonuclease that has become a very useful and 
precise tool for gene editing. In the Class 2 system, Cas9 participates in the processing of 
CRISPR RNA (crRNAs) (Deltcheva et al., 2011), and is responsible for the destruction of 
the inserted foreign DNA (Jinek et al., 2012a). Engineered CRISPR systems also contain 
two components: a guide RNA (gRNA or sgRNA) and a CRISPR-associated Cas protein. In 
order to recognize a target sequence (protospacer) and perform precise cleavage of the 
target DNA, the CRISPR system requires complementarity between the spacer of gRNA 
and the target sequence (protospacer) together with the presence of the protospacer-
adjacent motif (PAM) sequence at the 3′ end of the target sequence to be recognized by 
Cas9 nuclease (Jinek et al., 2012b; Cong et al., 2013; Mali et al., 2013). 
 An engineered gRNA is a short synthetic RNA composed of a scaffold sequence 
necessary for Cas-binding and a user-defined ∼20 nucleotide spacer that defines the 
genomic target to be modified. Thus, one can direct the genomic target of the Cas protein 





strand breaks (DSBs) in a target sequence. DSBs are then repaired by either the non-
homologous end joining (NHEJ) pathway (mostly) or the homology-directed repair (HDR) 
pathway. NHEJ can result in full repair without introducing a mutation or with indel or 
frameshift mutations (Rodgers & McVey, 2016). Due to this feature, NHEJ is an easy way 
to achieve gene knockout, however, it is a pathway of repair that is difficult to control. By 
contrast, the HDR pathway occurs less frequently but is a useful pathway to introduce 
knockins and knockouts (Zhang et al., 2017). 
 To perform CRISPR-mediated knockin/knockouts targeting four genes in mCCD 
and FRT cells, a sequence of experiments was performed as described in Appendix section 
A.1 below, where also the general workflow of experiments was provided. Despite many 


























A.1 Materials and methods used for Crispr/Cas9–mediated knockout /knockins 
 
Crispr/Cas9–mediated genetic modification experiments were performed under HSNO 
(Hazardous Substances and New Organisms) Act Approval APP201859 (development of 
new organisms), University of Otago.  
 
 A short workflow of the method for developing CRISPR/Cas9-mediated knockout/ 
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A.1.1 Designing guide RNA 
 
In this study, an area a few base pairs downstream of the start codon of the chosen genes 
was targeted to obtain full-sequence knockout and to obtain the full sequence of the target 
protein fused to a fluorophore tag after rescuing it from conditional knockout. Cas9 is 
guided by RNA to the targeted cut site. Therefore, to find the best sequence for guide-RNA 
(gRNA) in the intended site, the Sanger CRISPR Finder (CRISPR from gRNA) tool was used 
(www.sanger.ac.uk) which is a tool to analyze user-defined gRNA sequence specificity 
alongside the genome rather than finding the most specific gRNA sequence in the entire 
target gene. In order to recognize a target sequence (protospacer), the Cas9-gRNA 
complex requires complementarity between the spacer of gRNA and protospacer plus a 
protospacer-adjacent motif (PAM) sequence downstream of the target sequence to be 
recognized by Cas9 nuclease (Jinek et al., 2012b; Cong et al., 2013; Mali et al., 2013). The 
20-mer spacer sequence of gRNAs was designed for each target cut site while the scaffold 
sequence of gRNA was universal for all gRNA. The Cas9 protein used for this study was a 
chimera, therefore two gRNA sequences were designed for each target cut site. Both a T7 
promoter 5’-TAATACGACTCACTATA-3’ to the 5’ end of the spacer and tail annealing 
sequence 5’-GTTTTAGAGCTAGAA-3’ to the 3’ prime end of the spacer was added to allow 
in vitro synthesis of gRNAs (see Figure A.2 and Table A.1 for gRNA top sequences). As an 
important consideration for 20-mer spacer sequence, double G nucleotides at the 5’ end 
of the spacer was included which is necessary for the T7 polymerase to start the RNA 
synthesis (Figure A.8 and A.1.6). If there was no double G in the target sequence 
(protospacer), then in the target sequence, a protospacer sequence having at least the first 
nucleotide (5’) as G was chosen while the second nucleotide was changed to G if needed. 
Since the 5’ end of spacer is not in the seed sequence this means that some mismatches 
are tolerated when the gRNA bind to the protospacer and for activity of Cas9 nuclease. 
Both the top strand and the scaffold sequences were purchased from Integrated DNA 












Table A.1. List of gRNA top sequences. GRNA stands for guide-RNA, C10 for COMMD10, VPS-L for 
VPS35-L 
No Cat No name Oligo sequence 5’ to 3’ 
1 C10-GRNA1 TAATACGACTCACTATAGGCTCGGGCAGGATCAGCGCTGGTTTTAGAGCTAGAA            
2 C10-GRNA2 TAATACGACTCACTATAGGCGGCGAGACTTGGCCCTTGTTTTAGAGCTAGAA 
3 VPS35-GRNA1 TAATACGACTCACTATAGGTACAACACAGCAGTCACCCCGTTTTAGAGCTAGAA                   
4 VPS35-GRNA2 TAATACGACTCACTATAGGCTTACCAGGCATCTTTTCATCGTTTTAGAGCTAGAA 
5 VPS-L-GRNA1 TAATACGACTCACTATAGGCCTTCACAATCATGGCGTCTGTTTTAGAGCTAGAA 
6 VPS-L-GRNA2 TAATACGACTCACTATAGGAGCCCTCCCCGAAGCCTACTAGTTTTAGAGCTAGAA 
7 Clta-GRNA1 TAATACGACTCACTATAGGTGGGCTGTCATGGCCGAGTGTTTTAGAGCTAGAA 
8 Clta-GRNA2 TAATACGACTCACTATAGGTGCGCCAAGAAGGCCGCGGGTTTTAGAGCTAGAA 
 
 
A.1.2 Designing homology arms for donor DNA 
 
To engage the homology-directed repair (HDR), short homology arms (∼35 bases) were 
designed for donor DNAs targeting all four genes (COMMD10, VPS35, VPS35-L, and Clta). 
In the fine-tuning design of homology arms, to avoid a new break by Cas9 after HDR, a few 
"silent" mutations were included before (5') to the PAM sequence.  
 The oligonucleotides encoding homology arm sequences also contained a ~20-
mer sequence at the 3’ end of the homology arm sequence complementary to the edges of 
T7 promoter Spacer of gRNA Annealing sequence 
The sequence contains T7 promoter, spacer for gRNA, and tail sequence to enable annealing to 
the scaffold sequence during gRNA synthesis. 





the insertion sequences (Figure A.3). Through the synthesis of donor DNA by classic PCR 
(A.1.7), the ~20-mer sequence of this oligonucleotides served as primers while in later 
cycles of PCR, the whole oligonucleotide (55-60 bases) served as primers. The list of 
homology arm oligonucleotides is provided in Table A.2. The homology arm 





Table A.2. List of homology arm oligonucleotides. HA stands for homology arm, C10 for COMMD10, 
VPS-L for VPS35-L. 
No Cat No name Oligo sequence 5’ to 3’ 
1 C10-HA-1 GGGCGAGGGAGCTTCAAGGATGGCGGCGTCCGCAGATGGTAGCTCAGGTATAACTTC 
2 C10-HA-2 CCTGACCGCTACCTGGGGCTCTCGGGCAGGATCAGCGCCGATCCTCCACCACCAGAGC 
3 C10-HA-3 CCTGACCGCTACCTGGGGCTCTCGGGCAGGATCAGCGCAATAGGTCCAGGGTTCTCCTCC 
4 VPS35-HA-1 AAAATCTTCATTTTAGCCTACAACACAGCAGTCACTAGGTAGCTCAGGTATAACTTCG 
5 VPS35-HA-2 GGATGGCTTCATCCAAAAGTTTTTCCTGCTCATCCTGGGGCGATCCTCCACCACCAGAGC 
6 VPS35-HA-3 GATGGCTTCATCCAAAAGTTTTTCCTGCTCATCCTGGGGAATAGGTCCAGGGTTCTCCTC 
7 VPS-L-HA-1 CTTCAGAGCGGAAGCTGCCCTTCACAATCATGGCGAAAGGTAGCTCAGGTATAACTTCG 
8 VPS-L-HA-2 CTTTTCTCACATCCAGGGAAGCTCGGCCCCGCCCCAGACGATCCTCCACCACCAGAGC 
9 VPS-L-HA-3 CTTTTCTCACATCCAGGGAAGCTCGGCCCCGCCCCAGAAATAGGTCCAGGGTTCTCCTC 
10 Clta-HA-1 GGCGTCTCTGCGGTTGAGTTGGGCTGTCATGGCCAATGAAGGTAGCTCAGGTATAACTTC 
11 Clta-HA-2 CCGGGCGCACCGGCGGGAGCGCCGAATGGATCCAACTCCGATCCTCCACCACCAGAGC 








A.1.3 Designing insertion sequence for knockout/knockins 
 
Two insertion sequences were designed to both knockout the target gene and insert a 
blasticidin resistance gene flanked with 34bp loxP sites (locus of X-over P1, a Cre 
recombinase cut site) and GFP-tag (Figure A.3 A). Among the most used antibiotic 
resistance genes, the blasticidin resistance gene sequence (from Bacillus cereus) was 
chosen due to its short length (420 bp). This gene has low GC content compared to the 
puromycin resistance gene therefore correct PCR synthesis is more likely. Upon insertion 
of the artificial sequences into the targeted cut site, the blasticidin resistance protein 
should be expressed as split peptides (N-1-102 and 103-140-C) fused to split intein 
peptides from Nostoc punctiforme DnaE. The split inteins are trans-spliced from the fused 
peptides, attaching the peptides (N and C terminal blasticidin peptides) to each other 
(Figure A.3 B) (Oeemig et al., 2009; Stevens et al., 2017).  
 Translation of the selection marker gene should be terminated at a double stop 
codon. By 34 bp distal loxP site, the open reading frame (ORF) of the GFP-tag (1-10 or 11) 
and further the target gene, is shifted resulting in a frameshift mutation – knockout of the 
target gene. Following Cre-mediated excision of the blasticidin sequence, the GFP and 
target protein codons should be placed in-frame with the single remaining LoxP sequence 
and be consequently translated so the GFP11 DNA is fused to the target gene with a 
flexible GS-linker (GGGGS) while the GFP1-10 is cleaved from the target protein and 
recruited to the GFP11 fused to the target protein. Functional GFP protein would 
therefore allow later localization studies of the target proteins to track the target proteins 
using microscope while the Flag tag (DYKDDDDK) is a cost-effective tool for Western blot 
analysis (Figure A.3 A).  
 The design of the insertion sequence allows it to be used in any chromosomal locus 
of any eukaryotic organism as a universal knockin/knockout strategy. Target gene-
specific homology arms are the only requirement for any loci. The artificial DNA insertion 
sequence was purchased from GenScript cloned into the plasmid pcDNA3.1.   


























A, Two insertion sequences targeting both alleles of the target gene were designed to knockout the gene 
and to fuse GFP tag. Based on this strategy, only cells with both insertion sequences inserted into their 
targeted allele should be selected by antibiotic, resulting in homozygous knockout. The distal LoxP site 
causes a frame shift mutation, however, excision of the blasticidin sequence from LoxP sites should rescue 
the target gene, also resulting in GFP-tagging at the target gene's N-terminal. Abbreviations: HA-Homology 
Arm, Blast-Blasticidin (N and C terminal), DnaE-N or –C -Split intein (N and C terminal), STOP-Stop codon, 
Start-Start codon, Flag-Flag tag, GFP1-10 or 11-Split GFP1-10 and GFP11, GS-L- GS linker, P2A- 2A self-
cleaving peptide. B, Split blasticidin peptides fused to split inteins that upon cleaving (after translation), the 




A.1.4 Designing validation primers  
 
To validate insertions, a set of primers were designed external to the cut site (non-
insertion band) and another set of primers for the insertion sequence (insertion band; 
one set for the 5’ end, one set for the 3’ end of each insertion sequence).   
 The following criteria thought to be critical in validation primer design (Kumar & 
Chordia, 2015) were considered: 
1. Length - 18 and 24 bases. 
Complete blasticidin Complete intein 
Blast-N Intein-N Blast-C Intein-C 
B 
A 





2. GC content - about 45-55%. 
3. GC-lock (or GC "clamp") on the 3' end with the last 1 or 2 nucleotides being a G or 
C residue. 
4. Melting temperature (Tm) greater than 50°C but less than 65°C. 
5. No homopolymeric runs of more than 4-5 nucleotides.  
6. No secondary structures or the potential to self-hybridize. 
7. Specificity - lack of secondary priming site (using a NCBI BLAST search). 
8. Primer located at least 50-60 bases upstream and/or downstream of the sequence 
of interest. 
The criteria from 2. to 6. were confirmed with the Oligo Analyzer Tool v3.1 (Integrated 
DNA Technologies). The validation primers were purchased from Integrated DNA 
Technologies. The list of validation primers is shown in Table A.3 below. DonPrim primers 
(1 - 3) are for the ends of two insertion sequences, SeqPrim-In primers (4 - 7) are internal 
primers for two insertion sequences, and other SeqPrim primers (8 - 15) are genome 
specific and external primers to the cut site. 
 
 
Table A.3. List of validation primers for CRISPR-mediated modifications. F=forward, R=reverse, 
C10=COMMD10, VPS-L=VPS35-L. 
No Oligo name Oligo sequence 5’ to 3’ No Oligo name Oligo sequence 5’ to 3’ 
1 Don1Prim-F  GGTAGCTCAGGTATAACTTC   9 SeqPrimC10R AAGTTCCTCCGCAGCCTCAC 
2 Don1Prime-R  CGATCCTCCACCACCAGAGC 10 SeqPrimVPS35F GGAGAAAGTGCTTATGAGCC 
3 Don2Prime-R AATAGGTCCAGGGTTCTCCTCC 11 SeqPrimVPS35R TCATCTGGAATGACTGAACC 
4 SeqPrim-In1R CTTCTCTGTCGCTACTTCTAC      12 SeqPrimVPS-LF CACAATCATGGCGGATGACG 
5 SeqPrim-In1F ATTACATCAGGTGGTGGCGG 13 SeqPrimVPS-LR TTCCCAGTCACATGATCGCC 
6 SeqPrim-In2R TCAGAGCAAAGTTGTGATCG 14 SeqPrimCltaF TTTCCGCTTCCACCTTCTCC  
7 SeqPrim-In2F AGCTACTAACTTCAGCCTGC 15 SeqPrimCltaR TCTCTTGCTGCGCCAAGAAG 






A.1.5 Oligo maintenance 
 
A study by Integrated DNA Technologies reported that resuspending and storing oligos in 
1 x TE buffer (10 mM Tris, 0.1 mM EDTA, pH 8.0) ensures oligo stability (Speicher, 2017). 
Oligo stability in TE buffer at –20°C even with 30 freeze-thaw cycles was shown to be very 
stable and better compared to storage in nuclease-free water or dry, and compared to 
storage at 4°C, or 37°C (Speicher, 2017). 
 Therefore, all oligonucleotides used in this study were resuspended in TE buffer at 
a concentration of 100 mM for the stock solution and diluted to 10 mM working 




A.1.6 In Vitro synthesis of guide RNA (gRNA) using cloning-free methods 
 
The protocol for in vitro synthesis of gDNA was developed and optimized based on the 
method published in the paper (Varshney et al., 2016). Guide RNAs were designed as 
explained in section A.1.2 above. The method includes two sequential steps: oligo 
annealing and extending reaction and T7 RNA polymerase-mediated synthesis reaction. 
Oligo annealing and extending reaction. In this reaction, a target gene specific oligo 
named top strand consisting of T7 promoter, target-specific spacer sequence and 
annealing tail, was annealed to another oligo named bottom strand containing the scaffold 
sequence of gRNA (Figure A.4).  The annealed oligoes were then extended by Phusion® 
High-Fidelity DNA Polymerase (NEB, Cat. No: M0530S). 
 The oligo annealing reaction for gRNA synthesis in 20 μl volume was set up as 
follows:  
 
Component     Amount (μl)   Final concentration 
5× Phusion Buffer     4    1× 
10mM dNTP (2.5mM each)    0.8    0.4 mM 
Top Strand Oligo Mix (10μM)    0.8    0.4 μM 
Bottom Strand Ultramer (10μM)    0.8   0.4 μM 
Phusion DNA Polymerase    0.2 





Final       20 
 
The top strand consisting of T7 promoter, target-specific spacer sequence and annealing tail was annealed 
to the bottom strand containing the scaffold sequence of gRNA that was followed by extension of strands 
by Phusion® High-Fidelity DNA Polymerase. T7 RNA polymerase was used to synthesize RNA from the 
double stranded oligo starting with the T7 promoter sequence. The synthesized single stranded gRNA then 
automatically folds into its secondary structure.  
 
 
The oligo annealing and extending reaction conditions in a thermocycler were set up as 
follows: 
Cycle  Condition  Time 
1   98°C   2 min 
2   50°C   10 min 
3   72°C   10 min 
4   4°C  hold 
TAATACGACTCACTATAGGNNNNNNNNNNNNNNNNNNGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT 
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||            
ATTATGCTGAGTGATATCCNNNNNNNNNNNNNNNNNNCAAAATCTCGATCTTTATCGTTCAATTTTATTCCGATCAGGCAATAGTTGAACTTTTTCACCGTGGCTCAGCCACGAAAA 
Oligo annealing  
Oligo extension   
TAATACGACTCACTATAGGNNNNNNNNNNNNNNNNNNGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT 
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||            
ATTATGCTGAGTGATATCCNNNNNNNNNNNNNNNNNNCAAAATCTCGATCTTTATCGTTCAATTTTATTCCGATCAGGCAATAGTTGAACTTTTTCACCGTGGCTCAGCCACGAAAA 
T7 RNA polymerase 
GGNNNNNNNNNNNNNNNNNN 
guide RNA 
RNA synthesis  





A sample of 5 μl of the oligo assembly reaction products were analyzed on a 2.5 % agarose 
gel in TAE buffer along with 1Kb Plus DNA Ladder to confirm the double-strand oligo size. 
The expected size of a correctly assembled oligo is 117-120bp. 
 
Guide-RNA synthesis reaction. The set up for gRNA synthesis reaction using the NEB T7 
High yield RNA polymerase (NEB, E2040S) was as tabulated below: 
 
Component    Amount (μl)   Final concentration 
NTP Buffer Mix    5    1× 
Assembled oligo    4    unknown 
T7 RNA polymerase   1 
Final     10 
 
The reaction conditions for the thermocycler were as follows: 
Cycle  Condition  time  
1   37°C,   13 hours 
2   4°C,   hold 
 
Then 1μl DNAse was added to the reaction product, and incubated at 37°C for 15 minutes. 
RNA was precipitated using a standard method (section 2.4.2). The reaction gave a yield 
as high as ∼2 µg/μL in reactions where the concentrations were determined by 
MaestroNano® Spectrophotometer with a A260/280 ratio. A sample of 3 μL of the RNA 
product was analyzed on a 2.5% standard agarose gel in TAE buffer with addition of ~10 
mg of SDS to eliminate any possible contaminant RNAse activity in the TAE buffer or in 
the gel. RNA was visualized using Sybrsafe and was observed as two bands of ∼100 bp 




A.1.7 Synthesis of donor DNA for homology directed repair (HDR) 
 
According to the synthesis-dependent strand-annealing (SDSA) model for gene 
conversion, linear donors appear not to integrate at the double strand break (DSB), but 





2016; Mehta et al., 2017). Donors for SDSA can be single (single-stranded 
oligodeoxyribonucleotides (ssODNs)) or double stranded (PCR fragments) and require 
only short homology arms (∼35 bases) to engage the HDR (Paix et al., 2017). Based on 
this data, ∼35 bp homology arms were designed for each side of the DSB (section A.1.2 
and Table A.2). The insertion sequences were designed and purchased in plasmids as 
mentioned above (A.1.3).  
 The donor DNAs were synthesized by a classic PCR method directly from insertion 
sequences encoded in plasmids (4 ng) using homology arm oligonucleotides as tailed (at 
the start) primers (Figure A.4). During the later PCR cycles, the entire 58-60 nucleotide-
length homology arm oligonucleotides served as primers for the initial PCR amplicons.  
 
The donor DNAs were synthesized by a classic PCR method directly from insertion sequences encoded in 
plasmids (4 ng) using the 58-60 nucleotide-length homology arm oligonucleotides as tailed primers for the 
first 5 cycles and as entire primers during the later 35 PCR cycles.  
 
 
More precisely, for the first 5 cycles the homology arm oligonucleotides served as tailed 
primers and for the later cycles (6 to 35) they served as usual primers for amplification of 
homology arm-assembled amplicons. To avoid polymerase-dependent sequence errors in 
the donor DNA during the PCR amplification process, Phusion® and Q5® High-Fidelity 
DNA Polymerases (NEB, Cat. No: M0530S and M0491S, respectively) were used in this 
study, as they are extremely thermostable polymerases and are known with their high 
fidelity and robust performance (Chester & Marshak, 1993). The PCR reaction was set up 
as follows: 





Component     50 µl Reaction   Final 
Concentration 
5xPhusion GC Buffer    10 µl     1X 
10 mM dNTPs     1 µl     200 µM 
10 µM Forward Primer    2.5 µl     0.5 µM 
10 µM Reverse Primer    2.5 µl     0.5 µM 
Template DNA     variable    4 ng (plasmid) 
DMSO (optional)     (1.5 µl)    3% 
Phusion DNA Polymerase   0.5 µl     1.0 units/50 µl PCR 
Nuclease-free water    to 50 µl 
 
Because of the high complexity of the insertion sequences, GC Buffer supplied with the 
Phusion polymerase was used instead of HF Buffer in this reaction. All the reaction 
components were assembled on ice and quickly transferred to the CFX PCR equipment. 
For optimal performance, PCR conditions used for Phusion and Q5 DNA Polymerases 
were different from the conditions used for SYBR Premix Ex Taq standard polymerase.  
 As a result, both of the donor DNAs synthesized for each allele contained the same 
homology arms at the start of the insertion sequence and the same homology arms at the 
end of the insertion sequence that directed both donor DNAs into the same cut site of the 
same target gene but into different alleles.  
 
 
A.1.8 Transfecting CRISPR plasmids, gRNAs and donor DNAs into cells of interest  
 
The CRISPR/Cas9 plasmid, gRNA and donor DNA were delivered into cells by lipofection 
in suspension (see 2.6.3.2) or as described below. Briefly, 20 µl of Lipofectamine 3000 
reagent was added to one tube, and in another tube 20 µl P3000 reagent was mixed with 100 
µl of complete medium (for mCCDcl1 cells) or serum- and drug-free medium (for FRT cells). 
Then, 8 µg of large Cas9 chimera plasmid (Addgene, 107318) was added into the P3000 
reagent tube, followed by mixing the components of both tubes and incubating for 30 min at 
RT. At the end of 30 min, 2x106 trypsinized cells were resuspended directly into the 
Lipofectamine-nucleic acid mixture and incubated for 10 minutes at RT. After incubation, all 
of the suspended mCCDcl1 cells were placed into a 100 mm plate (Cat. No: S430293) and 
grown in complete growth medium overnight. The same amount of the suspended FRT cells 
were also seeded into 100 mm plates, however, FRT cells were incubated in serum- and drug-





growth period it was expected that cells would be expressing Cas9 proteins ready to function 
immediately when gRNA and donor DNA was transfected which is important to reduce gRNA 
degradation. 
  On the second day, 8 µg of gRNA and 8 µg of donor DNA as a PCR product (see 
A.1.7) was transfected into the cells through the usual transfection method by 
Lipofectamine as explained in section 2.6.3.1. After 4-5 hours of incubation of cells in the 
transfection mixture, the serum- and drug-free medium was replaced with complete 
growth medium for both cell lines. In later experiments, all of the three components - 
CRISPR/Cas9 plasmid, gRNA and donor DNA (4 μg of each) were transfected 
simultaneously by lipofection in suspension to overcome editing issues. 
 
 
A.1.9 Selection of modified cells  
 
Determining the Optimal Antibiotic Concentration. To assess the concentration of 
blasticidin needed to cause cell death, mCCDcl1 cells were grown in 35 mm plates, and 48 
hours after seeding, the cells were treated with blasticidin S reagent (Sigma, 
Cat.No:SBR00022) at 0, 2.5, 5, 10, and 20 µg/mL (final) concentrations. The medium was 
changed every second day and supplemented with blasticidin each time. Three 
treatments were required to achieve total cell death at 2.5 µg/mL (final) concentration. 
 
Treatment of CRISPR transfected cells. According to the designed biallelic insertion 
strategy, the antibiotic selection should select only homozygous edited cells. Therefore to 
select cells that had successfully undergone the CRISPR-Cas9 reactions, cells were 
incubated in blasticidin S reagent at 2.5 µg/mL as this was the lowest efficient 
concentration for selection. Although cell death began after the second treatment, 
massive cell death was seen after the third treatment, and this continued even after 
stopping antibiotic treatment for several days. If cells were then trypsinized another 








A.1.10 Validation of genetic modification  
 
In this study, for detection of CRISPR/Cas9-mediated insertions, several conformational 
sequential experiments were performed. Firstly, blasticidin-resistant cells were analyzed 
by Western blot to identify the target protein (using anti-COMMD10 and anti-VPS35 
antibodies to identify knockout) expression level (as described in section 2.5). Other 
samples of blasticidin-resistant cells were taken for PCR. For most cases, qPCR was 
performed as described in section 2.4.4 using the validation primers provided in the Table 
A.2. If more than one sample was tested in a PCR plate with primers having various 
melting temperatures (Tm), then touchdown PCR conditions were used. 
 
Touchdown PCR. In this PCR method, in the early cycles, the annealing temperature was 
set 3–5°C above the Tm of the primers used in the reaction, while in the later cycles it was 
reduced to 3–5°C below the Tm of the primers. The higher annealing temperature 
increased the specificity for primer binding, while the later lower temperature mediated 
efficient amplification. The reaction conditions were as follows:  
 
98°C for 3 min, 20 cycles of (95°C for 10 sec, 60°C for 30 sec), 10 cycles of (95°C for 10 sec, 
58°C for 30 sec), 5 cycles of (95°C for 10 sec, 55°C for 30 sec), 5 cycles of (95°C for 10 sec, 
52°C for 30 sec), and melting curve 65°C to 95°C (0.05°C). 
 
The PCR products were analyzed on a 2% agarose gel at 100 V/cm for 25 min (as 
described in section 2.4.5). Finally, the sequences of the PCR products were tested by 
Sanger sequencing. 
 
Sequencing reaction clean-up. For sequencing, PCR products for each sample were 
cleaned with ExoSAP-IT™ (ThermoFisher, Cat. No: 78200.200.UL). Briefly, 1 µl of ExoSAP-
IT and 1 µl of nuclease-free water were added into a tube containing 4 µl of PCR product 
to assemble clean-up reactions and run in a thermocycler with conditions given below: 
Cycle   Temperature  Time 
1   37°C,    15 min 
2   80°C,    15 min 





The first step (37°C for 15 min) degrades remaining primers and single nucleotides while 
the second step (80°C for 15 min) inactivates the ExoSAP-IT™ reagent. For sequencing, 





A.1.11 Removing the positive selection marker  
 
 According to the designed insertion sequence, rescuing the targeted proteins from 
conditional knockout should allow them to be expressed in GFP-tagged form which 
enables their localization to be studied using fluorescence microscopy. To excise 
the blasticidin gene, the Cre/Lox recombination system was used as the donor DNA was 
designed to include these components (section A.1.3). loxP is a site on the bacteriophage 
P1 consisting of 34bp (Sauer & Henderson, 1988). The two LoxP sites were designed to 
be in the same orientation in the donor DNA, enabling the Cre recombinase to excise the 
floxed sequence (sequence flanked by two LoxP sites) instead of inverting it (Sauer & 
Henderson, 1988). 
 Cre recombinase plasmid (https://www.addgene.org/31132/) was delivered 
using a standard Lipofectamine method and in suspension (sections 2.6.3.1 and 2.6.3.2). 
48 or 72 hours after the transfection, confocal microscopy and Western blot was 
performed with all four samples to identify the expression of GFP-tagged proteins and 














A.2 Results of Crispr system experiments 
 
 
A.2.1 Preparation of Crispr/Cas9 nuclease 
 
Modifications to various Cas enzymes have extended CRISPR protocols to selectively 
activate/repress target genes, purify specific regions of DNA, image DNA in living cells, and 
precisely edit DNA and RNA. To find the most efficient CRISPR-associated nuclease among 
Cas9 or its orthologues, their PAM sequence recognition, nuclease activity and genome-wide 
lesion specificities were considered. Ease of production and cost-effectiveness of the nuclease 
source were also factors to consider. A type of dual-nuclease Cas9-Cas9 chimera from 
Addgene (https://www.addgene.org/107318/) (Bolukbasi et al., 2018) was found that 
covers all of these criteria. The Cas9-Cas9 chimera consists of a Cas9 from Streptococcus 
pyogenes (SpCas9), which is one of the most widely used Cas9s, and Streptococcus aureus 
(SaCas9). A modified version of this chimera was used: SpCas9MT3-dSaCas9. The SpCas9MT3 is 
a R1335K mutant version that has substantially reduced activity (Bolukbasi et al., 2015), but 
the fusion of nuclease-dead SaCas9 (dSaCas9) to the C-terminus of SpCas9MT3 via an 
unstructured 66 amino acid linker restores the nuclease activity (Figure 5.14). dSaCas9 acts 
like a programmable DNA-binding domain (pDBD) to deliver SpCas9 to the target site, 
thereby permitting target site recognition through the increased effective concentration of 
the SpCas9MT3 nuclease (Bolukbasi et al., 2018). SpCas9MT3-dSaCas9 has the same lesion rate 
as wild-type SpCas9, but 10 times less off-target activity and 28 times more specificity 
(Bolukbasi et al., 2018).  
 SpCas9MT3 requires either NGG or NAG as a PAM sequence (Kuscu et al., 2014), which 
is more frequently found close to a target site in the DNA compared to PAM sequences like 
NNNNGATT, NGGNG etc. while dSaCas9 requires NNGRRT (Ran et al., 2015) in which N is 
any nucleotide, R is A or G nucleotide. Because the function of dead-SaCas9 is only to deliver 





SpCas9 to the target site, it can be targeted to most specific sites in the DNA with several 
various gaps making its site easy to find. To be delivered to the nucleus, the SpCas9MT3-
dSaCas9 protein was designed to contain 6 nuclear localization signal/sequence (NLS) in the 
middle and at the ends of the protein (Figure A.6). To identify Cas9 expression by Western 
blot, it also contains 3xHA tags in the middle.  
 SpCas9MT3-dSaCas9 was purchased in a plasmid (pCSDest2) transformed into the 
DH5alpha strain for replication, and expression in mammalian cells was driven by a CMV 
promoter. Plasmids were reproduced and extracted as described in sections 2.3.2 and 2.3.3. 
For verification of plasmid DNA, these were digested with EcoRI and analyzed on a 1% 
agarose gel (Figure A.7 A), where the left two lanes demonstrate undigested and digested 
Cas9 plasmids confirming the expected plasmid size (11.7 kb).  Then, the new plasmids were 
transfected into mCCD cells and protein expression levels were identified by Western blot 
assay as described in section 2.5. However, by Western blot experiments no expressed Cas9 
was detected in mCCD cells suggesting the plasmids are not easily transfected into these cells. 
A new method of transfection was established – lipofection in suspension (section 2.6.3.2). 




A, Agarose gel electrophoresis (1%) results of original and digested Cas9, Cre recombinase, I and II donor 
plasmids. B, Western blot (analyzed on a 6% SDS-PAGE) results showing expression levels of Cas9 protein 
















A.2.2 Synthesis of guide RNA by cloning-free methods 
 
gRNAs were designed using the design tool Sanger CRISPR finder as described in section 
A.1.1. Two gRNAs were designed for each target gene due to the utilization of a Cas9-Cas9 
chimera. gRNAs were synthesized in vitro using a cloning-free method that comprises of 
an oligo annealing and extending reaction and a RNA synthesis reaction as described in 
section A.1.6.  
After DNAse treatment gRNA was precipitated (section 2.4.2). 5 μl of the assembled oligos 
and 3 µL of gRNA product were analyzed on a 2.5% agarose gel in TAE buffer using 
standard protocols (section 2.4.5). The correctly assembled oligos were expected to have 
a size of 117-120bp (Figure A.8 A) while two bands of approximately 100bp and 200bp 
size (200bp is due to the secondary structure of the gRNA) indicated successful synthesis 
of gRNA (Figure A.8 B). As the results show, assembled oligos and gRNAs detected at the 













A, Analysis of 5 μl of assembled oligos on a 2.5% agarose gel in TAE buffer showing expected sizes for all 
samples. B, Analysis of 3 µL of gRNA product on a 2.5% agarose gel in TAE buffer showing expected sizes 












A.2.3 Synthesis of donor DNA for Homology Directed Repair (HDR) 
 
HDR can be very efficient when the donor DNAs are linear (Paix et al., 2016). According 
to the synthesis-dependent strand-annealing (SDSA) model for gene conversion, linear 
donors do not appear to integrate at the DSB, but instead are used as templates for DNA 
synthesis (Pâques & Haber, 1999; Jasin & Haber, 2016; Mehta et al., 2017). Donors for 
SDSA can be single (single-stranded oligodeoxyribonucleotides (ssODNs)) or double 
stranded (PCR fragments) and can require only short homology arms (∼35 bases) to 
engage the HDR (Paix et al., 2016). Applying these parameters (double stranded -PCR 
fragments and ∼35 base homology arms), Paix and colleagues obtained 31% editing 
efficiency in a mouse model (Paix et al., 2017). The repair process is sensitive to insert 
size and prone to template switching, where synthesis can “jump” between two 
overlapping donors (Paix et al., 2016). They also showed that ∼35 base-long homology 
arms allowed edits ranging from 1 to 1,000 nucleotides (Paix et al., 2017).  
 Homology arms and insertion sequences for donor DNA for HDR were designed 
for all four target genes (COMMD10, VPS35, VPS35-L, and Clta) as described in sections 
A.1.2 and A.1.3, respectively and the insertion sequences were purchased in plasmids. The 
size of the plasmids was confirmed by agarose gel electrophoresis (Figure A.7 A).  Using 
Phusion® High-Fidelity DNA Polymerase homology arms were assembled to the ends of 
the insertion sequences by classic PCR as described in section A.1.7. Through the classic 
PCR, the gene-specific 3’ end of homology arms served as primers (as tailed primers) in 
the first 5 cycles of PCR (with low annealing temperature) and then the whole homology 
arm oligonucleotides have acted as primers in the next 35 cycles of the PCR reaction (with 
high annealing temperature). 3 μL of the PCR product – the donor DNA was analyzed on a 
1.5% agarose gel to confirm the expected DNA 
size which was ~1020 kb for I donors and ~1120 
kb for II donors (Figure A.9).  
 
Two different cycles were set up for this PCR reaction as the 
homology arms that served as tailed primers required low 
annealing temperature for the first 5 cycles and then served 
as a whole primer requiring higher annealing temperature 
for the next 35 cycles. The expected size of donor DNAs 
(~1020 kb for I donors and ~1120 kb for II donors) was 
confirmed by analyzing the PCR products on a 1.5% agarose 
gel.  





A.2.4 Transfection of CRISPR plasmids, gRNAs and donor DNA into the cells  
 
The particles for Crispr-mediated gene editing were transfected into mCCDcl1 cells as 
described in section A.1.8. In the first trials, Cas9 plasmids were transfected in suspension 
where the overnight period was expected to be sufficient for Cas9 protein expression and 
to be ready to function immediately when the gRNA and donor DNA was transfected the 
next day which is important to reduce gRNA degradation. On the second day, gRNA and 
donor DNAs for each strand of target DNA was transfected into the cells by lipofection as 
explained in section 2.6.3.1. In later experiments, all of the three components - 
CRISPR/Cas9 plasmid, gRNA and donor DNA were transfected simultaneously by 




A.2.5 Selection and recovery of modified cells  
 
As described in section A.1.3, donor DNAs contain a blasticidin resistance gene. Blasticidin 
S reagent is a nucleoside antibiotic isolated from Streptomyces griseochromogenes that 
inhibits protein synthesis in both prokaryotic and eukaryotic cells. Blasticidin S inhibits 
translation by trapping deformed tRNA on the ribosome (Svidritskiy et al., 2013). 
Resistance to Blasticidin S was expected to occur by expression of the Blasticidin S 
deaminase gene inserted into the donor DNAs. This deaminase converts Blasticidin S to a 
nontoxic deaminohydroxy derivative. To identify the required concentration of 
Blasticidin S reagent as a selection marker, firstly a cell death curve assay was performed 
(section A.1.9). The results showed that at the 2.5 μg/mL (final) concentration, cells start 
to die (Figure A.10).  
 The 2.5 μg/mL concentration was chosen for future experiments, however, 3 and 
4 μg/mL (final) concentrations were also tested to optimize protocols when issues were 







mCCDcl1 cells were grown in 35 mm plates, and 48 hours after seeding, the cells were treated with 
Blasticidin S reagent at 0, 2.5, 5, 10, and 20 µg/mL concentrations. The medium was changed every second 
day and supplemented with the mentioned concentrations of Blasticidin S each time. 2.5 µg/mL antibiotic 
concentration was found to be optimal for mCCD cells. 
 
Generally, four sequential treatments at 2.5 µg/mL concentration were required to 
achieve total cell death. It was not known if cells expressing blasticidin deaminase could 
survive prolonged exposure to Blasticidin S therefore only three sequential treatments at 
2.5 µg/mL concentration were performed and the surviving cells were screened for 
insertions. Finding this optimal concentration for the blasticidin deaminase expressing 
cells is only possible by treating them after confirming the insertion. According to the 
designed strategy, the selection should select only homozygous knockouts. 
 The surviving cells were recovered after 8-10 days supplementing the cells with 
fresh, Blasticidin S-free growth medium. To reduce the time of the recovery period, the 
concentration of epidermal growth factor (EGF) was increased from 10 ng/mL to ~17 
ng/mL (final concentration) and cells reached 100% cell confluency in 5 days. 
 
 





A.2.6 Screening for insertions 
 
To identify if the surviving and recovered cells contained the insertion sequence, a set of 
experiments was performed including PCR assays using validation primers as explained 
in section A.1.10. Firstly, validation primers designed (see section A.1.4, and list of 
validation primers, Table A.3) for the two insertion sequences that are universal for all 
for targeted genes were tested. For that purpose, 4 ng of original purchased (Figure A.11, 
left panel) or in-house reproduced plasmids that encode the I and II insertion sequences 
(Figure A.11, right panel) were used in classic PCR. The PCR products were analyzed on a 
2% agarose gel. This method would also detect cells that do not contain the blasticidin 
gene but survived after stopping the treatment. 
 The results show that the primer pairs produce the expected size of products 











4 ng plasmid and 2 pmol of each primer was used in 10 μL PCR reaction. The PCR products were analyzed 
on a 2% agarose gel. 
 
Then, Blasticidin S resistant mCCD cells were tested at the end of each recovery period as 
described in section A.1.10. Touchdown PCR was performed using, firstly, the same 
primers (used above) targeting the start and the end parts of the two insertion sequences 
(targeted sites of validation primers are described in Figure A.12 A) and, secondly, the 
primers designed for sequencing that cover the sequences upstream and downstream of 


















Figure A.11. Primer test with insertion sequence encoding original plasmids (left) and with 





designed for non-insertion primers (targeting up- and downstream of the cut site, Figure 
A.12 C).  
However, throughout the study, mostly 5 PCR reactions were prepared for each 
target gene: 
 Sample 1 for the first insertion (encoding BlastN-GFP11):  
  for the start part of the insertion - SeqPrimTG-F and SeqPrim-In1R,   
  for the end part of the insertion - SeqPrim-In1F and SeqPrimTG-R  
          (Figure A.12 B). 
 Sample 2 for the second insertion (encoding BlastC-GFP1-10):  
  for the start part of the insertion - SeqPrimTG-F and SeqPrim-In2R, 
  for the end part of the insertion - SeqPrim-In2F to SeqPrimTG-R  
      (similar to the first insertion, Figure A.12 B). 
 Sample 3 for non-insertion identification as control:   
  SeqPrimTG-F and SeqPrimTG-R (Figure A.12 C). 
 
(SeqPrim – sequencing primer, TG – target gene, In – insertion sequence, F – forward, R – reverse (see 




A, primers for non-insertion. B, primers for the start and the end parts of the insertion sequences. C, primers 
covering sequences upstream and downstream of cut site including insertion sequences, the sets designed 















PCR products were analyzed on 1.5 or 2% agarose gels. Figure 5.21 A below demonstrates 
PCR products of the start and the end parts of the insertion sequences (produced by the 
primers given in the Figure 5.20 A) and PCR products of non-insertion (produced by the 
primers given in the Figure 5.20 C) in all cells of the four targeted genes. Interestingly, the 
insertion product sizes were as expected, and very similar to the products produced from 
plasmids directly (see Figure 5.18 above). Non-insertion sizes were also as expected 
Figure 5.21 A.  
 The Figure 5.21 B below demonstrates PCR products of the start and the end parts 
of the insertion sequence flanked by upstream and downstream sequences of the cut site. 
Some of the DNA sizes were as expected, i.e. the start of I and II insertion sequences for 
all four target genes. However, the others were not of the expected size or there were 




















































Small amount of cells (for each of four targeted genes) was boiled and used in PCR directly. After PCR, the 
products were analyzed on 1.5 or 2% agarose gels. A, PCR amplicons produced with primers targeting the 
start and the end parts of the I and II insertion sequences. B, PCR amplicons produced with primers 
targeting the start and the end parts of the insertion sequences flanked by upstream and downstream 
sequences of the cut site. 
 
To ensure the PCR products were the expected sequences, the amplicons were prepared 
for Sanger sequencing as described in section A.1.10. 4 µl of the PCR mixture from each 
sample was purified by ExoSAP-IT and then sent to the University’s DNA Sequencing 
Service. However, the sequencing was not successful, possibly because the amplicon 
dilution was not optimal or there were no insertions and PCR amplicons were non-
specific amplicons. 
 The experiment was repeated several times with very similar PCR and gel 
electrophoresis results being obtained. However, reproducing the amplicons using the 
same primers (before sending sequencing) failed suggesting that most possibly, the 
amplicons were non-specific products or maybe the conditions for amplicon reproducing 
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A.2.7 Removing the positive selection marker  
 
The donor DNAs were designed to also encode a split GFP-tag which should slide into an 
open reading frame (ORF) after rescuing the target gene from the knockout state using 
Cre recombinase. The two loxP sites in the same orientation in the donor DNA should 
enable the Cre recombinase to excise the blasticidin resistance gene (see section A.1.11). 
The Cre recombinase plasmid was replicated and tested on an 1% agarose gel along with 
its digested form (Figure A.7, above). 
 Recovered cells were transfected with Cre recombinase and Western blot analysis 
and confocal microscopy analysis was performed to validate knock-ins. For Western blot, 
samples were analyzed with anti-Flag-HRP as the rescued target proteins should possess 
a Flag-tag together with a GFP-tag. However, both of the analyses gave negative results, 
leaving it in doubt whether the negative results were due to insertion failure or Cre-




A.2.8 Summary of Crispr-mediated gene editing: problems encountered and future 
directions 
 
As a result of this study, eight cell lines were expected to be generated; four with 
COMMD10, VPS35, VPS35L, Clta gene knockouts and four with GFP-fused COMMD10, 
VPS35, VPS35L, Clta after rescue of the genes. If the genetic modification had been 
successful, the cell lines would have been used to address the proposed objectives listed 
below: 
 
1. Measuring the knockout effect of COMMD10, VPS35, and VPS35L on endogenous ENaC 
current. 
2. Evaluating the colocalization of ENaC with COMMD10, VPS35, VPS35L, and Clta. 
 
Furthermore, cytoskeleton organization and shape of mCCDcl1 cells could have been 





The unsuccessful results could be due to many reasons, and identification of the issue will 
inform future directions: 
1) poor cutting efficiency of Cas9 nuclease – although the Cas9-Cas9 chimera used in this 
study was reported to have similar cutting efficiency as the wild type in HEK cells, it is 
unknown whether it has the same cutting efficiency in other cell types. This could be 
identified by an in vitro cleavage assay, however extra primers, and extra kits would be 
required. 
 
2) failure of gRNA perfect match – although gRNAs for this study were designed very 
carefully, it is known that sometimes they do not work for unknown reasons, and this is 
why usually up to four gRNAs are designed for one target (Seki & Rutz, 2018). 
 
3) split intein splicing efficiency – the sequences of split inteins conjugated to a split 
blasticidin resistance gene was carefully analyzed in its reported source sequence (Jillette 
et al., 2019) to match the intein flanking sequences with the sequences flanking intein in 
I and II insertion sequences. However, because of the slight flanking sequence differences 
at the start of N terminal intein and end of the C-terminal intein, the folding and splicing 
properties of the intein could be changed in the design. 
 To identify if the split blasticidin selectable marker can function in mCCD cells both 
plasmids encoding the I and II insertion sequences including the blasticidin gene were 
transfected into mCCD cells. The blasticidin gene sequence was designed to start with a 
start codon which is located after the CMV promoter in the plasmid and ends with a stop 
codon immediately after the end of blasticidin sequence which suggests that the split 
blasticidin gene should be expressed from plasmids. The transfected cells were treated 
with 2.5 μg/mL Blasticidin S antibiotic after 48 hours for three times. However, the cells 
did not survive suggesting that splicing efficiency of split intein is very low or splicing 
doesn’t occur. 
 However, another reason for this cell death observed could be due to the long 
Blasticidin S treatment time after transfection during which plasmids could be degraded. 
To determine if the blasticidin gene has been expressed or split intein spliced correctly, 
an HA-tag could be inserted into one part of either the blasticidin deaminase protein or 
intein protein. Western blot analysis would show if the part of split blasticidin deaminase 





can be tested for both for plasmid expression or for evaluating the insertion sequence as 
knock-ins. 
 
4) If there will still issues after exploring 1-3 above, then common gene knock-in failure 
reasons like donor DNA end degradation (Little, 1981), low insertion efficiency of double-
stranded donor DNA (Bassett et al., 2013; Irion et al., 2014), insertion-induced alternative 
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Log DNA Dilution COMMD4 
4^-5 33.5777 
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Log DNA Dilution COMMD7 
4^-5 32.9262      
4^-4 29.7571      
4^-3 27.7926      
4^-2 25.9197      
4^-1 23.9156      
4^-0 22.3164      
slope -2.0699      
E 1.95373      
% Efficiency 95.3729      
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4^-4 25.0251      
4^-3 22.2199      
4^-2 19.8907      
4^-1 17.9189      
4^-0 16.2469      
slope -2.0833      
E 1.94533      
% Efficiency 94.5331      
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C. Table 1. RT-qPCR data for all COMMD1-10 and SGK1. 
  
  
30m Vehicle vs Aldo-treated 
Veh Aldo  ± SD P value N of exper. 
COMMD1 1.00 1.03 ± 0.06 P>0.05 N=7 
COMMD2 1.00 0.96 ± 0.16 P>0.05 N=7 
COMMD3 1.00 1.04 ± 0.33 P>0.05 N=7 
COMMD4 1.00 1.02 ± 0.15 P>0.05 N=7 
COMMD5 1.00 0.87 ± 0.14 P>0.05 N=7 
COMMD6 1.00 0.93 ± 0.12 P>0.05 N=7 
COMMD7 1.00 0.95 ± 0.30 P>0.05 N=7 
COMMD8 1.00 1.04 ± 0.24 P>0.05 N=7 
COMMD9 1.00 1.00 ± 0.29 P>0.05 N=7 
COMMD10 1.00 0.99 ± 0.20 P>0.05 N=7 
SGK1 1.00 3.81 ± 2.45 *P<0.05 N=7 
  3 h Vehicle vs Aldo-treated 
  Veh Aldo  ± SD P value N of exper. 
COMMD1 1.00 0.83 0.17 P>0.05 N=4 
COMMD2 1.00 0.87 ± 0.17 P>0.05 N=4 
COMMD3 1.00 0.91 ± 0.05 P>0.05 N=4 
COMMD4 1.00 0.90 ± 0.10 P>0.05 N=4 
COMMD5 1.00 1.00 ± 0.11 P>0.05 N=4 
COMMD6 1.00 0.79 ± 0.23 P>0.05 N=4 
COMMD7 1.00 0.94 ± 0.27 P>0.05 N=4 
COMMD8 1.00 1.10 ± 0.37 P>0.05 N=4 
COMMD9 1.00 0.90 ± 0.02 P>0.05 N=4 
COMMD10 1.00 0.94 ± 0.12 P>0.05 N=4 
SGK1 1.00 33.58 ± 10.28 **P<0.01 N=4 
  24 h Vehicle vs Aldo-treated 
  Veh Aldo  ± SD P value N of exper. 
COMMD1 1.00 1.00 ± 0.28 P>0.05 N=4 
COMMD2 1.00 0.93 ± 0.06 P>0.05 N=4 
COMMD3 1.00 1.05 ± 0.53 P>0.05 N=4 
COMMD4 1.00 0.87 ± 0.08 P>0.05 N=4 
COMMD5 1.00 1.05 ± 0.50 P>0.05 N=4 
COMMD6 1.00 1.08 ± 0.20 P>0.05 N=4 
COMMD7 1.00 0.92 ± 0.10 P>0.05 N=4 
COMMD8 1.00 1.08 ± 0.20 P>0.05 N=4 
COMMD9 1.00 1.24 ± 0.51 P>0.05 N=4 
COMMD10 1.00 1.16 ± 0.13 P>0.05 N=4 
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After fixing and permeabilization, mCCDcl1 cells were 
double immunostained for endogenous ENaC and 
retromer subunit VPS35 (pAb- rabbit anti-α-ENaC, 
goat polyclonal anti-VPS35 and sAb- anti-rabbit-AF-
488, and anti-goat-AF-546) and mounted with 
VECTASHIELD® HardSet™ Mounting Medium with 
DAPI. A. a representative confocal image.  Nikon AIR 
60x. B. a representative 3D image C. quantification of 
co-localization. Pearson correlation coefficient (PCC, 
0.723 ± 0.109, ****P<0.05), MOC-Mander’s overlap 
coefficient (M1, 0.8394 ±0.128, **P<0.005; M2, 
0.7923±0.139, ***P<0.0005). One-sample t-test. N=3, 





Figure E. 1. ENaC co-localization with retromer. 
